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ABSTRACT OF DISSERTATION 
Calcium Remodeling through Different Signaling Pathways in Heart Failure: Arrhythmogenesis 
Studies of Pyk2, Dystrophin, and β-adrenergic Receptor Signaling  
By 
Di Lang 
Doctor of Philosophy in Biomedical Engineering 
Washington University in St. Louis, 2013 
Professor Igor R. Efimov, Chairperson. 
 
Heart failure is a common clinical syndrome that ensues when the heart is no longer able to 
generate sufficient cardiac output to meet the demands of the body. It is one of the leading causes of 
death worldwide but with limited and non-ideal therapies at the moment. One reason behind this 
may be the complexity of significant alterations in multiple signaling pathways and concomitant 
structural and functional remodeling, especially Ca handling. Ca is critical in both the electrical and 
mechanical properties of cardiac myoctyes, and much is known about ionic currents and the normal 
excitation-contraction coupling process. In heart failure, distinct impaired signaling pathways induce 
significant alterations in how cardiac Ca handling is regulated. These alterations either directly cause 
certain arrhythmias or facilitate arrhythmias by association with electrical remodeling. The goal of 
this dissertation was to investigate the mechanisms of calcium remodeling through different 
signaling pathways in heart failure, and mechanisms on how the intricate and dynamic interactions 
between Ca handling and signaling pathways impairment facilitate arrhythmias in heart failure. To 
achieve this goal, a dual optical mapping system was designed to investigate electrical activity and Ca 
transient simultaneously. High spatio-temporal resolution mapping allows for quantifying 
conduction, repolarization and Ca cycling, especially on the interactions between action potential 
   xii 
and Ca handling. In this dissertation, I investigated Ca remodeling in three different signaling 
pathways: stress activated signaling, cytoskeletal signaling and β adrenergic receptor signaling 
pathway. 
 Proline-rich tyrosine kinase 2 (Pyk2) is a non-receptor protein kinase regulated by 
intracellular Ca. It mediates a typical stress activated signaling pathways along with c-Src, P38 
MAPK and regulates a broad range of key biological responses. By optically mapping the genetically 
engineered mouse model: Pyk2 knockout, I detected a protective role of Pyk2 with respect to 
ventricular tachyarrhythmia during parasympathetic stimulation by regulation of gene expression 
related to calcium handling.  
 The mdx mouse model was introduced in the investigation of cytoskeletal signaling pathway. 
mdx mice is a common model for Duchenne muscular dystrophy, which is a clinical syndrome 
resulted from recessive of dystrophin and eventually develops into heart failure. The project 
suggested the association of mechanical stimulation and deficiency of dystrophin account for the 
cardiac mechanical defects and resulting Ca mishandling, but not either of the two above-mentioned 
entities alone. Ca mishandling leads to Ca cycling dispersion, which facilitates generation of 
arrhythmias. 
 β Adrenergic receptor signaling pathway was investigated on explanted donor and failing 
human hearts. Distinct β adrenergic receptor subtypes were found to regulate remodeling differently. 
The association between remodeling of action potential and Ca transient provides crucial arrhythmic 
drivers and substrate in heart failure. 
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Chapter 1 
Introduction 
 
1.1 Heart failure 
Heart failure (HF) is a common, progressive and lethal clinical syndrome that ensues when 
the heart is no longer able to generate sufficient cardiac output to meet the demands of the body. 
During HF, the heart undergoes a complex series of changes in both myocyte and non-myocyte 
compartments in an attempt to compensate for the reduction in cardiac function.[1] These changes 
are associated with a number of cardiac and hemodynamic abnormalities that impair the 
electrophysiology of myocardium, excitation-contraction (EC) coupling and contraction. Specifically 
chronic hyperadrenergic state, altered calcium (Ca) signaling, prolongation of action potential 
duration and conduction slowing are the hallmarks of HF.[1-5] These abnormalities are initiated by 
functional and proliferative responses that are regulated by different signaling pathways.[6-8]  
In the United States, HF has been diagnosed in more than 5 million people and in almost 
10% of individuals over the age of 65. [9] Based on a long-term follow-up study reported in the 
American Heart Association (AHA), 80% of men and 70% of women under the age of 65 who have 
HF will die within 8 years.  The one-year mortality rate of HF is also extremely high, with one out of 
five dying after this period. This high mortality rate is largely attributable to an electrical abnormality 
known as ventricular arrhythmia. Ventricular arrhythmia has been noted frequently in the patients 
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with HF and reported to be the major cause of cardiac sudden death. It is responsible for up to 50% 
of the mortality in HF.[9]  
 
1.2 Arrhythmia 
Arrhythmias result when the normal sequence of electrical activation and recovery in the 
heart is disrupted.[10] Multiple mechanisms may be responsible for arrhythmias in HF. They may 
arise from abnormalities in impulse formation and/or impulse conduction. Abnormal impulse 
formation is mainly due to abnormal or enhanced automaticity and triggered activity; while abnormal 
conduction mainly refers to reentry mechanism. All three mechanisms are related to remodeling of 
Ca homeostasis.  
 
1.2.1 Abnormal automaticity and enhanced automaticity 
Automaticity refers to the spontaneous electrical discharges in the form of action potentials 
that can originate in a specific group of cells within the heart even in the absence of any external 
input. Abnormal or enhanced automaticity may result in arrhythmias from diverse pacemaker cells. 
Sinus bradycardia and tachycardia are common atrial arrhythmias that are associated with alterations 
in the rate of impulse initiated by the sinus node, the main pacemaker of the heart. Secondary 
pacemaker activities from the atrio-ventricular node (AV node) or His-Purkinje system may also be 
enhanced or dysregulated and lead to arrhythmias. In HF, remodeled expression of and/or 
remodeled regulation of ion channels such as outward delayed rectifying K+ channel, T type and L 
type Ca2+ channels could lead to abnormal depolarization or accelerated depolarization overdriving 
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sinus rhythm. Such abnormality could originate even from a region of ventricular cells and forms 
abnormal/enhanced automaticity. Although automaticity is not responsible for the most rapid 
arrhythmias, it can precipitate or trigger reentrant arrhythmias. 
 
1.2.2 Triggered activity 
Triggered activity refers to the depolarization arising from membrane potential oscillations 
that occur during or following an action potential. Triggered action potentials may be the source of 
another triggered response, thus leading to self-sustaining triggered activities and arrhythmias. There 
are two types of triggered activity: early afterdepolarization (EAD) and delayed afterdepolarization 
(DAD). For both types of triggered activities, remodeling of Ca homeostasis plays a crucial role by 
inducing net inward current. 
EAD refers to the oscillatory potentials that occur during the plateau phase or late 
repolarization phase during action potential. A net inward current of L-type Ca window current is 
responsible for the generation of EADs. This current occurs when the channel undergoes a 
transformational change from inactivated to closed and then to opened states. Thus, Ca channels 
that inactivate during the action potential upstroke may reopen as the action potential repolarizes 
toward the voltage range of L-type Ca window current. In HF, action potential prolongation 
resulting from a decrease in outward current and/or an increase of inward current is frequently 
observed. This remodeling facilitates the evocation of window currents and the formation of EADs. 
DAD induced triggered activity occurs after full repolarization. Initiation of DAD is mainly 
associated with cytoplasmic Ca overload that can result from a variety of physiological and 
pathological conditions, such as β-adrenergic stimulation, hypertrophy and ischemia. In HF, Ca 
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overflow from an overloaded sarcoplasmic reticulum (SR) may be the main cause for increased 
intracellular Ca concentration ([Ca2+]i), thus inducing Ca overload.[11] High intracellular Ca initiates 
a transient inward current (ITi) that depolarizes membrane potential, and when it reaches the 
threshold for activation, DADs are elicited. This inward current is mainly composed of the net 
current from a membrane exchanger: Na/Ca exchanger (NCX) while pumping out one Ca2+ with 
three Na+ into the cytoplasm. A Ca-dependent nonspecific ion channel also slightly contributes to 
this current.[12]   
 
1.2.3 Reentry 
Reentry arrhythmia is the circulation of the cardiac impulse around an obstacle, leading to 
repetitive excitation of the heart at a frequency that depends on the conduction velocity and the 
perimeter of the obstacle. Historically, reentry has been classified as either anatomical or functional. 
Anatomical reentry is defined when there is a clear relationship between the reentry pathway and the 
underlying tissue.  Functional reentry occurs where there is no obvious connection to the tissue 
structure. Both reentries occur when an activation wavefront is blocked by a ring-like region of 
tissue and is forced to propagate around it. This unexcitable region of tissue could be an anatomical 
structure such as a scar or fibrosis. The path around the unexcitable obstacle should be long enough 
so that the revolution time could exceed the refractory period time of the tissue, and the impulse 
could reenter the originally excited area and form the reentry circle. Thus, the occurrence of reentry 
requires that the path-length is greater than the wavelength.[13, 14] Wavelength is defined in 
Equation 1.1.  
Wavelength = Conduction velocity × Refractory period (1.1) 
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Another requirement for reentry is unidirectional block. It assures that the wave does not 
propagate around both sides of the unexcitable obstacle in the same time course, which could 
reduce the path-length and extinguish both waves through collision. Moreover, trigger excitation 
sometimes is needed to evoke reentry. Programmed electrical stimulation can be used to induce 
trigger excitations in the reentry studies. The idea of programmed electrical stimulation (PES) was 
first proposed by Durrer group [15] and Coumel group [16] independently, which was later extended 
for the study of ventricular arrhythmia. In HF, focal activations play the role of triggers to initiate 
reentry arrhythmias.  
 
1.3 Arrhythmic substrates 
The development of arrhythmia typically requires complicated arrhythmic factors. It has 
been postulated that arrhythmia occurs under a particular combination of arrhythmic substrate, 
triggers and modulators.[17] Two main requirements are needed to initiate reentrant arrhythmias: the 
formation of a unidirectional block pathway and wavelengths short enough to assure the 
propagation along this pathway. Arrhythmic substrates appear during pathological conditions in 
which significant structural, mechanical and electrophysiological remodeling occurs. Typical 
arrhythmic substrates include conduction remodeling, repolarization, electrical or mechanical 
dynamic instability, amplification of heterogeneity and dysfunctional Ca cycling. Detailed mechanism 
of each substrate will be discussed below. 
 
1.3.1 Conduction 
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The spread of electrical activation through the normal heart is a discontinuous process.[18] 
This discontinuous conduction is affected by several factors including the underlying architecture of 
the myocardium, the rate and magnitude of rise of the inward currents and the excitation threshold. 
Abnormal conduction can be involved in several arrhythmogenic mechanisms. 
Slow conduction is a key promoter for the initiation of reentrant arrhythmias. In healthy 
hearts, conduction velocity is too rapid to accommodate a reentrant circuit within the atrium or 
ventricle. Reduction of conduction velocity results in the shortening of wavelength and could evoke 
arrhythmias when a unidirectional block forms. Three different mechanisms cause conduction 
slowing in HF. Connexin 43 (Cx43) is a hemichannel protein that is mainly located at intercalated 
disc. Cx43 can form channel-like structure called gap junctions that provide the primary means of 
electrical continuity between myocytes.[19] Reduction and lateralization of Cx43 in HF result in 
decreased internal resistance[20], thus leading to slowing conduction. Conduction also slows down 
when amplitude of plasma membrane depolarization current deceases or excitation threshold 
increases. 
Conduction heterogeneity also increases the chances of arrhythmogenesis. In the heart, the 
fiber orientation rotates continuously through the thickness of the ventricular wall and is non-
uniform in planes parallel to the epicardial surface.[21] Conduction of excitations along fiber 
orientation is faster than that in the perpendicular direction due to gap junctions at the intercalated 
disks.[22] This is known as axial anisotropy. Increased anisotropy would facilitate the initiation of 
arrhythmia as it could contribute to the formation of the unidirectional block loop.  
Furthermore, upstroke velocity of conduction also affects arrhythmia initiation. Upstroke 
velocity is a determinant of excitability. Rate and magnitude of inward currents decide the upstroke 
velocity and activation distance of a propagating impulse. In cardiomycoytes, this inward current 
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mainly consists of a Na current. Different upstroke velocity determines whether unidirectional block 
is formed. Normal tissue can activate resting muscle up to a certain distance. In failing hearts, when 
the excitable wave propagates along a piece of gradient impaired tissue, the activation distance 
shortens as the excitability progressively decreases and eventually dies out at the most severely 
depressed region even if the length of this region is less than the normal activation distance. The 
wave from retrograde direction might propagate through the most severely depressed region when 
this region is shorter than normal activation distance, thus forming the unidirectional block.  
 
1.3.2 Repolarization 
Action potential represents the net electrical activity of a group of membrane ion channels. 
Repolarization in human heart is largely attributed to the rapid and slow K+ currents, L type Ca 
current, Na/Ca exchanger current, IKATP and Ik1 current. Remodeling of repolarization contributes to 
in different arrhythmogenesis mechanisms. 
 As discussed previously, two main conditions are needed for the initiation of reentrant 
arrhythmias: unidirectional block and short wavelength to assure the reentry to ensue around it. The 
remodeling of repolarization actually contributes to both conditions.  
Clinically, either prolongation or reduction of APD due to repolarization remodeling has a 
significant relevance for arrhythmias. APD prolongation is a hallmark of HF that is attributed mainly 
to remodeling of K currents. Reduction of APD could occur in tissue experiencing ischemia or 
pathological condition resulting in strong parasympathetic stimulation. Clinically, remodeling of 
repolarization could be measured by ECG and is quantified by the parameter known as QT interval. 
Both long QT syndrome[23] and short QT syndrome[24] are recognized to be associated with 
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increased risk of ventricular arrhythmias and sudden cardiac death. Prolongation of APD along with 
other factors that facilitate the initiation of triggered activities is the major arrhythmogenesis 
mechanism for long QT syndrome (torsade de pointes arrhythmias for example). Reduction of APD 
is associated with the reduction of refractory period, which in turns shortens the wavelength.  
 
1.3.3 Dynamic instability: alternans 
Cardiac alternans is another important arrhythmogenic substrate that has been recognized to 
predict and is associated with arrhythmias development over the course of decades.[25] Cardiac 
alternans refers to mechanical (contractile) electrical (repolarization) oscillations that occur every 
other beat.  
Association of dynamic repolarization alternans with arrhythmogenesis started with the 
observation of beat-to-beat changes of T-wave morphology from ECG recordings. This T-wave 
alternans is thought to reflect cyclic changes of APD that is known as APD alternans or 
repolarization alternans. APD alternans occurs due to instability in the kinetics of membranes 
channels that govern cardiac action potential. Since the recovery time of each channel varies, APD 
of proceeding beat is dependent on the time period between the recoveries of the channels from the 
previous beat to the onset of the next one. This period of time is known as diastolic interval (DI). 
As the heart rate increases, APD shortens to preserve the coronary flow and DI. The relationship 
between APD and DI can be plotted as a restitution curve. Repolarization alternans generated by 
the dynamic perturbation of APD or DI is amplified by interactions between them. This process can 
be depicted by a cobweb diagram plotting APD against the preceding DI (Figure 1.1).[26] Basically, 
when the heart is paced at a fixed cycle length, APD and DI are directly related to the basic cycle 
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length (CL) as shown in Equation 1.2 that shows that APD of the current beat depends on the DI 
from the previous beat. 
CL = APDn+DIn-1 (1.2) 
The relationship in Equation 1.2 can be illustrated by a straight line with slope of -1 as 
shown in Figure 1.1. The slope of the restitution curve represents the electrical stability of the 
myocardium.[27, 28] Restitution curve with a steep slope (>1) is inherently unstable as small changes 
in DI are translated into large and alternating shifts in APD. As seen in Figure 1.1, a small 
perturbation of DI of beat 0 started at * leads to the next beat (beat 1: in purple) with a relatively 
short APD (point a), and results in a prolonged DI of beat 1. This DI then creates a longer APD of 
beat 2 (in yellow) shown at point c, which in turn causes an even shorter DI at point d. This 
perturbation is amplified in this pattern until typical alternans formed as the figure depicts. The 
resulting alternans have been proven to be closely associated with arrhythmias.[29] Alternans 
resulting from steep restitution can significantly amplify repolarization gradients that can then 
facilitate formation of unidirectional block, thus eliciting reentrant excitation even in absence of 
structural heterogeneities. Under baseline condition, the spatial gradient is the same over all regions; 
however, as heart rate increases, the depolarization of neighboring region starts to alternate with an 
opposite phase and forms a unidirectional block. During this process, the orientation of 
repolarization undergoes nearly a complete reversal in direction from beat to beat making the heart 
vulnerable to the initiation of reentrant arrhythmias. Moreover, repolarization alternans could also 
increase dynamic wave instability, enhance wave break and promote degeneration of VT to VF.[28-
32]  
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Figure 1.1 Cobweb diagrams of repolarization alternans. 
 
 
1.3.4 Heterogeneity or dispersion  
As previously discussed, one of the arrhythmogenesis mechanisms associated with the 
alternans is the amplification of repolarization heterogeneity. As an important arrhythmic substrate, 
heterogeneity not only results from repolarization dispersion but also from non-homogeneous 
conduction.[14] Transmural (between subendocardium and subepicardium) and spatial (focus more 
on the surface of ventricular free wall) heterogeneities have been investigated in cardiac 
arrhythmogenesis. 
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Transmural heterogeneity 
Multiple sources of heterogeneity exist in ventricular myocardium that may have functional, 
structural or dynamic basis. One source is due to the intrinsic electrophysiological difference 
between myocytes. A typical example is the transmural heterogeneity through the ventricular free 
wall. The ventricular free wall consists of three functionally and electrophysiologically 
distinguishable groups of myocytes: endocardial, midmyocardial and epicardial myocytes. These 
distinct cells compose the three layers of ventricular wall (subendocardium: endo; midmyocardium: 
mid and subepicardium: epi) that differ principally with respect to repolarization characteristics, 
leading to different APD. As electrical impulse propagates from the endo to epi layer under normal 
conditions, repolarization heterogeneity assures the optimized timing for the contraction of the 
heart. However, amplification of transmural heterogeneity is closely associated with reentrant 
arrhythmias as it could facilitate the formation of unidirectional block.  
 
Spatial heterogeneity 
Heterogeneity could exist not only through the transmural pattern but may also be exhibited 
between left and right ventricles[33, 34] or across different regions of the ventricular free wall. Such 
spatial heterogeneity can be attributed to structural change under different pathological conditions 
such as acute myocardial ischemia, chronic myocardial infarction and fibrosis. Spatial heterogeneity, 
e.g. between cardiac base and apex, is reported to largely occur during cardiac dysfunction due to 
regionally distinct stimulation or regulation [35][35] such as during mechanical stress.  
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1.4 Ca handling 
Ca handling is crucial in cardiac function under normal physiological and pathological 
conditions such as HF. A major role of cardiac Ca handling is to regulate heart contractions that are 
activated by electrical signals known as electrical-contraction (EC) coupling. Intracellular Ca 
dynamics is regulated by a variety of Ca regulatory mechanisms including key Ca handling proteins 
such as L type Ca channel, Ryanodine receptor (RyR), sarco(endo)plasmic reticulum Ca2+-ATPase 
(SERCA) and Na-Ca exchanger (NCX). Moreover, it also responds to and participates in different 
stimulations through distinct signaling pathways. In HF, abnormal Ca dynamics can result from a 
variety of causes and be affected by different signaling pathways. Defective Ca handling not only 
affects ventricular mechanics but also affects electrophysiology. Intracellular Ca and action potential 
are intricately linked by a variety of Ca medicated channels and transporters. Thus, Ca handling is 
also an important arrhythmogenic substrate and its investigation will bridge its related signaling 
pathways to arrhythmogenesis effects.  
 
1.4.1 Ca and EC coupling 
Ca is a highly versatile intracellular signal that can regulate many different cellular functions, 
such as cell proliferation and EC coupling [3, 36]. Basic EC coupling in ventricular cardiac myocytes 
begins with the action potential. The initial depolarization of the plasma membrane activates 
voltage-gated L-type Ca current, which triggers calcium release from SR mediated by local Ca 
induced Ca release (CICR) through Ca channel - ryanodine receptor-2 (RyR2)[37] and 
Ins(1,4,5)P3Rs[4]. Both channels are sensitive to Ca[4]. This process elevates cytosolic Ca level, 
which causes Ca binding to the myofilaments protein troponin C and make contraction. The 
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contractile force in myocardium is determined by the amplitude of the Ca transient.[38, 39] Many 
calcium-signaling effectors (such as calmodulin, troponin C), calcium-sensitive enzymes (such as 
Ca/calmodulin-dependent protein Kinases (CaMK)) and transcription factors are also activated, 
driving  events such as gene transcription to regulate cellular functions. During relaxation, Ca2+ must 
be transported out of the cytosol, thereby allowing Ca2+ dissociation from troponin and deactivation 
of the myofilaments. The decline of intracellular calcium concentration may be mediated in 
following ways: 1) sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2a), 2) sarcolemmal Na-Ca 
exchanger 1 (NCX1), 3) sarcolemmal Ca-ATPase, and 4) mitochondrial Ca2+ uniporter. Under 
normal conditions, SERCA takes up about 70% of the Ca involved in the Ca transient back into SR, 
whereas nearly 30% is extruded via NCX from the cardiomyocyte [40],.  The activity of SERCA2a is 
regulated by the binding of phospholamban (PLB)[41]. In its non-phosphorylated form, PLB 
inhibits SERCA2a activity. The amount of Ca that enters the cell with each steady-state beat must 
equal the amount that is extruded. Thus the integrated Ca entry via Ica is about the same as that 
extruded via NCX, and the amount released by the SR is the same as that taken back up.[2] Given 
that both Ca entry via Ica and Ca extrusion via NCX cause inward current, Ca movements are 
strongly coupled to electrophysiological effects. 
 
1.4.2 Ca remodeling in HF 
Impaired Ca homeostasis has been characterized to play a crucial role in the onset and 
progression of cardiac hypertrophy and HF.[3] In HF, there is typically a down-regulation of 
SERCA2a and up-regulation of NCX function.[42, 43] Both of these effects tend to shift Ca out of 
the cell and reduce SR's Ca content. Bers DM et al. also found that a large increase in NCX function 
can compensate for a moderate decrease in SERCA2a function in HF [43]. Most HF studies have 
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found relatively unaltered L type Ca channel density in ventricular myocytes. However, some have 
suggested that there may be a reduction in the number of Ca channels while at the same time there 
is a higher activity per channel; this effect could also affect the membrane potential [44].  Calcium 
transients are small in HF and there may be a greater integrated Ca influx due to less Ca-dependent 
inactivation of L type Ca channels. This property may then affect the intracellular Ca concentration 
and SR Ca concentration, which furthermore affects overall Ca signaling.  
While the majority of calcium-regulatory proteins studied in HF were focused on LTCC, 
RyRs, NCX, SERCA, PLN and CaMK, a great number of other calcium-sensitive or calcium-
dependent effecter proteins and signaling pathways may also affect electrophysiological properties 
and are implicated in calcium signaling and regulation of calcium homeostasis. Investigations of 
these proteins and the role of Ca in these signaling pathways will help to complete the understanding 
of calcium handling and pathways in HF and provide potential therapeutic targets.   
 
1.4.3 Ca and arrhythmia 
Ca has been reported to associate with a variety of mechanisms of arrhythmias. It has been 
discussed in the previous section that Ca plays a key role in the arrhythmias resulting from abnormal 
automaticity and triggered activity. Furthermore, it associates and promotes electrical arrhythmic 
substrates and contributes to arrhythmia.  
 
Ca and impulse propagation 
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Both theoretical and experimental models have suggested that under specific circumstances 
the L type Ca current and intracellular Ca concentration could affect cardiac conduction.[45-47] 
Accumulation of intracellular Ca could initiate the inactivation of L type Ca channel L type Ca 
currents of the myocyte at the region of a current-to-load mismatch is crucial for the impulse 
conduction. Moreover, intracellular Ca concentration can regulate gap junction conductance, thus 
affecting excitation propagation. 
 
Ca alternans and repolarization dynamic instability 
Like repolarization, intracellular Ca cycling is also a dynamic active process. It has been 
reported that repolarization alternans is driven by the Ca oscillations.[48-50] Underlying mechanism 
may be due to several key membrane currents that govern action potential activity also participate Ca 
cycling in cardiomyocytes, such as L-type Ca current, NCX current and non-selective Ca-dependent 
current. Intracellular Ca transient alternans have been related to the amount of Ca released from the 
SR, which is determined by several factors including the trigger (L type Ca current), the SR load, the 
metabolic and phosphorylation state as well as the sensitivity of RyR. The amount of Ca released 
during any beat depends on the Ca influx during the preceding action potential. When SR Ca storage 
ability is diminished, APD determines concomitant Ca release. The acute changes of [Ca2+]i result 
from the alteration of Ca release turns out to affect the membrane currents and thus provide a 
feedback mechanism that controls APD of the concurrent beat.  
 
1.5 Murine model for arrhythmia studies 
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Murine hearts have been suggested to offer a versatile and robust model for cardiac studies 
especially for the human ventricular arrhythmias. Mice share a great degree of genetic homology 
with human. Murine model are small, inexpensive and easily maintained and reproducible. The low 
cost of technology and feasibility for genetic engineering in this species make it a convenient tool for 
cardiac studies. Transgenic and knockout murine models have dramatically widened investigation on 
the role of target proteins in specific signaling pathways that have helped to facilitate the 
understanding of mechanisms of arrhythmia initiation and maintenance.[51-53]  
 
Electrical similarities and differences between humans and mice 
The significant difference between human and murine lies in the properties of ionic currents 
responsible for action potential repolarization as shown in Figure 1.2. Repolarization in human heart 
is largely attributed to the rapid and slow K currents, mainly Ikr and Iks. In mice, it is the fast and slow 
transient outward K currents named Ito,f and Ito,s which take the dominant role for the ventricular 
repolarization. Such difference results in the absence of the plateau phase and a shorter action 
potential duration (APD).   
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Figure 1.2 Ionic currents underlying human and murine ventricular action potentials. From 
Nerbonne et al.[54]  
 
Despite the electrical difference and notable difference in the size and basal heart rate, 
human and murine hearts share a number of key features that make mice an eligible model for 
arrhythmia studies. In both species, ventricular action potential share a rapid depolarization phase 
attributable to Na current carried by the voltage-activated Na channel.[55] IKAPT and IK1 play 
important role in repolarization and during diastole in both humans and murine.[56] Despite a 
significantly shortened APD, the refractory period in mice still follows a common pattern with the 
human case: the refractoriness precedes complete repolarization and this qualifies the murine model 
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for the study repolarization as arrhythmic substrate. Furthermore, determinates of conduction 
regulation in both spices are identical.[57] Due to great genetic homology, it is important to notice 
both humans and mice share similar functional and proliferative regulating signaling pathways and 
makes it convenient to study the arrhythmogenic role of specific proteins or signaling pathways. 
 
1.6 Motivation and scope of dissertation 
Ca is critical in both the electrical and mechanical properties of cardiac myoctyes, and much 
is known about ionic currents and the normal excitation-contraction coupling process. However, in 
HF, there are significant alterations in how cardiac Ca is regulated through different stimulatory and 
signaling pathways. These alterations are critical for dictating contractile dysfunction and facilitating 
the arrhythmias that are characteristic of heart failure directly or associated with other 
electrophysiological arrhythmic substrates. A numbers of studies focused on key regulatory proteins 
such as L-type Ca channel, RyR, SERCA, PLB and NCX. Yet, the signaling pathways that regulate 
Ca handling upstream are not clearly elucidated. These pathways could be severely impaired or 
modified in HF, thus solving the nature of these intricate and dynamic interactions promises to be 
an important area of research for a better recognition and understanding of the nature of Ca and 
arrhythmias. These investigation would then further bridge dysfunction of different signaling 
pathways result from either acute stimulations or genetic modifications with arrhythmic effects in 
HF. 
In this dissertation, I aim to investigate the remodeling of Ca handling in different signaling 
pathways that underlie different damages form HF, and bridge these remodeling to arrhythmia 
effects. Here I studied the role of proline rich tyrosine kinase 2 (PYK2), which is a key protein in 
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stress-activated signaling pathway; dystrophin for mechanical stimulation signaling pathway and β 
adrenergic receptor signaling pathway in HF.  
I first developed a dual optical mapping system combined with monophasic action potential 
recording technique to build up a platform that promises to not only study the dynamics of Ca on 
the whole heart or tissue level but also the association of Ca with electrical arrhythmic substrates and 
eventually to explain the nature and mechanism of impaired signaling pathways to facilitate 
arrhythmias in HF. For these purposes, I introduced genetically manipulated murine models and 
also applied experiments with human heart tissue. 
Chapter 2 contains a description of the dual optical mapping system. Chapter 3 focuses on 
role of Ca activated PYK2 in arrhythmogenesis. Chapter 4 will discuss regional remodeling of Ca 
handling under mechanical stretch in an mdx mouse heart model. Chapter 5 describes how different 
β adrenergic subtype receptors behave and facilitate arrhythmogenesis in HF. Finally summary and 
future direction are presented in Chapter 6. 
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Chapter 2 
Designing a Dual Optical Mapping Platform 
for Transmembrane Potential and Ca 
Transient detection 
 
 
2.1 Abstract 
Fluorescence imaging has revolutionized the investigation of cardiac electrophysiology. 
Currently, single fluorescent parameter imaging is most commonly used. Given the growing 
emphasis on the simultaneous imaging of more than one cardiac variable and the importance of Ca 
in cardiac electrophysiology, I have designed a dual optical mapping system that allows for the 
simultaneous measurement of both transmembrane potential (Vm) and intracellular Ca transient 
(CaT) from the same region of a heart. This system can be rapidly set up, permits dichroic imaging 
separation, dual-rate imaging, and offers high temporal-spatial resolution. In addition, the system is 
applicable to any two-camera measurement. Experiment on intact mouse hearts suggested accuracy 
and reliability on Vm and CaT morphology, time scale and the time relations between these two 
dynamic parameters. 
Contents of this chapter were published in Journal of Visualized Experiments[58] and 
reprinted with the permission of the publisher. 
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2.2 Introduction 
Synchronous contraction of the heart depends on regular propagation of electrical impulse 
by the flow of local electrical currents between excited and resting cells.[59] Remodeling of normal 
propagation patterns and electrical parameters of the myocardium is closely associated with 
arrhythmias. Investigations of the mechanism underlying arrhythmias have relied on the visualization 
of activation spread. Although much has been learned regarding the ionic basis of cardiac action 
potential using intracellular microelectrodes, single cell impalements cannot be used to record action 
potentials from a large number of recording sites simultaneously. Visualization of activation, 
conduction velocity, action potential duration, and other parameters at a myriad of sites cannot be 
achieved using cellular studies or surface electrogram techniques with low spatial resolution, but is 
solved by optical mapping.[60-62] EC coupling is characterized by action potentials and intracellular 
calcium dynamics; therefore it is critically important to map both Vm and CaT simultaneously from 
the same location. [25, 35, 60, 63] However, current techniques based on surface unipolar and 
bipolar electrograms cannot be practically applied for the studies of non-electrical parameters such 
as Ca. Optical mapping, on the other hand， makes it feasible to simultaneously record Vm and CaT 
dynamics with high temporal and spatial resolution by using proper intracellular Ca and voltage 
probes.  
Mouse heart is a popular model used for cardiovascular studies due to the low cost 
technology available for genetically modifying this species as discussed in Chapter 1. Cardiovascular 
physiological phenotyping of the mouse heart could be easily done using fluorescence imaging that 
employs various probes for Vm, CaT, and other parameters. Simultaneous optical mapping from 
Langendorff perfused mouse hearts has the potential to elucidate mechanisms underlying heart 
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failure, arrhythmias, metabolic disease, and other heart diseases. In this chapter, I designed a voltage-
Ca dual optical mapping system in combination with monophasic action potential (MAP) recordings 
on mouse heart to build an efficient platform for studying the interaction and association of cardiac 
electrical signals and Ca dynamics as well as their roles in arrhythmogenesis. I will present the 
instrumentation setup and experimental conditions. Consistent optical recordings obtained with this 
system illustrate that simultaneous optical mapping of Langendorff perfused mouse hearts is both 
feasible and reliable.  
  
2.3 Material and Methods 
2.3.1 Vm and CaT Fluorescent Dyes 
Optical mapping uses different fluorescence probes to stain cardiac tissue. Visualization of 
different parameters relies in the registering changes in optical dye properties. By using photo-
detectors with appropriate optical setup, fluorescent signals could be captured and carefully 
interpreted. Different probing mechanisms of fluorescent dyes require different design on optics 
and signal acquisition.   
Voltage sensitive dye 
Voltage sensitive dye is a group of dyes that could bind to the cell membrane. Figure 2.1 
showed an example of a typical voltage sensitive dye: di-4-ANEPPS. After embedding in the 
membrane, optical properties of voltage sensitive dyes such as light absorption or emission 
fluorescence vary when membrane potential changes. This correspondence change is linear and 
occurs on the microsecond level, which ensures the accuracy of voltage sensitive dyes representing 
cardiac electrical activities. Briefly, as the membrane depolarizes, the emission spectrum shifts 
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towards the direction of a shorter wavelength, so that a decrease in fluorescence (∆F) from 
background fluorescence (F) would be observed. By collecting the sum of fluorescence of 
wavelength longer than a specific value, such decrease could be maximally detected and represent 
the membrane potential change (Figure 2.2). To maximize the change of fluorescence captured, it is 
best to choose this filter wavelength at a steep portion of the spectrum. In this way the electrical 
signals from alteration of membrane potential could be expressed as ∆F/F. 
  
Figure 2.1 Voltage sensitive dye. Spectrum property and voltage sensing mechanism of di-4-
ANEPPS. When the dye is embedded in the outer side of the membrane, it could be excited at a 
specific wavelength. During depolarization, the emission spectrum shifts towards direction of short 
wavelength, thus generating a decrease of total fluorescence (∆F). 
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Figure 2.2 Probing mechanism of voltage sensitive dye. Emission spectrum shifts towards short 
wavelength as Vm depolarized. When Vm changes from -80 to -40 mV, the sum intensity of 
fluorescence decreases as well, as depicted on the right side. Fluorescence intensity dynamics 
represents the membrane potential change. Real time sum intensity is plot out and action potential 
can be visualized. 
 
Spectral properties of RH-237 and Rhod-2AM 
Many aspects need to be considered in the choice of dye for a given experiment (e.g. how 
sensitive is the dye to potential changes). For the dual optical mapping system, it is extremely 
important to differentiate voltage signals and Ca signals effectively, meaning that the emission of 
both dyes should avoid spectral overlap.   
N-(4-Sulfobutyl)-4-(6-(4-(Dibutylamino)phenyl)hexatrienyl)Pyridinium, Inner Salt (RH-237) 
is a widely used voltage sensitive dye whose molecular structure is shown in Figure 2.3. Its excitation 
peak wavelength (Ex) is around 528 nm and emission peak wavelength is around 782 nm (It is 
reported to be 782 nm when diluted in methanol solution. In cell membranes, spectra of styryl dyes 
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are typically blue-shifted by as much as 80 nm for emission).[64] The long emission spectral peak of 
RH237 makes it a good candidate for multiple probe imaging. 
 
 
Figure 2.3 Molecular structure of RH-237. 
 
Xanthylium, 9-[4-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]-3-[2-[2-[bis[2-
[(acetyloxy)methoxy]-2-oxoethyl]amino]phenoxy]ethoxy]phenyl]-3,6-bis(dimethylamino)-, bromide, 
also known as Rhod-2 AM was selected as probe Ca for couple of reasons. The molecular structure 
is shown in Figure 2.3. Its excitation/emission is 556nm/576nm. The emission fluorescence 
spectrum is easy to separate from RH-237.[65] The spectral overlap does not affect the accuracy of 
the signals. Furthermore, its excitation wavelength is close to RH-237, which makes the light source 
for excitation of both probes more effective.  
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Figure 2.4 Molecular structure of Rhod-2 AM. 
 
Optical modalities are determined according to the different properties of dyes. Based on the 
spectral emission, a dichroic mirror of 635nm cut off was used to separate fluorescence signals. For 
RH237, a 700 nm long pass filter is applied, so that the maximum ∆F can be collected at every 100 
mV alternation of membrane potential. Rhod-2 AM has a different mechanism for probing 
intracellular [Ca2+]i The emission fluorescence intensity fluctuates only when [Ca2+]i changes. 
Without spectral shifting, the peak wavelength of emission is relatively stable, thus a band pass filter 
of 590±15nm is used to collect the Ca fluorescent signals. 
The feasibility of using these two dyes in dual optical mapping can be evaluated by the 
degree of spectral overlap errors. The error from spectral overlap of the two dyes could be 
calculated as the amplitude of the signal error (fake signal collected due to the other probe) 
normalized to the amplitude of its real signal as shown in Formula 2.1 and 2.2. The errors in spectral 
overlap for both dyes are reported as being less than 5%[65] and proved to not affect outcome in 
our experiments. 
   (2.1)  
 (2.2) 
 
2.3.2 Dual Optical Mapping Setup 
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Light source 
The light source was selected according to the preparation type, side of the imaging area, 
wavelength and desired signal to noise ratio. Four types of light sources are currently being used in 
optical mapping: tungsten-halogen (TH) lamps, short arc lamps, lasers and light emitting diode 
(LED). TH lamps and LED have a moderate light intensity and a flat spectrum in the visible range, 
which provides flexibility in choosing the excitation wavelength. TH lamps generate low noise level 
while LEDs are usually low cost. Arc lamps have a flat spectrum in the visible range but provide 
strong intensity. Lasers, on the other hand, only emit light at discreet wavelengths.  
Considering the effects of dye bleaching, photodynamic tissue damage that might be caused 
by a strong intensity light source as well as the wide band wavelength of excitation needed in the 
experiment, halogen lamp and LED are chosen as the light sources for the dual optical mapping 
system. 
Focusing Optics 
To collect and focus the emitted fluorescent signals on the photo detector, lenses are used 
with the properly design optics. Based on the desired optical magnification, single and tandem lens 
configurations are used. In a single lens configuration, as shown in Figure 2.5A, when the distance 
between the lens and photo detector is fixed (f+xi), magnification (M=xi/f) depends on the working 
distance of the system, in other words, when using the single lens configuration, for a specific field 
of view, the working distance is fixed. When this working distance is not convenient for conducting 
the experiment or when the desired magnification could not be achieved from using a single lens, 
tandem lens configuration is used as shown in Figure 2.5 B. In the tandem lens configuration, 
magnification can be calculated by the ratio of focal length of two lenses (f1/f2) and is not 
dependent on the lens separation. However, extension of distance between two lenses would 
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increase the loss of marginal light rays and lead to vignetting. Tandem lens configuration also 
provides better light collection efficiency. According to Libbus group, the signal-to-noise ratio of 
recordings made with the tandem lens configuration was significantly greater than that made with 
the single lens configuration. Signal-to-noise ratio depends on magnification and numerical aperture 
(NA) of the lens. For a single lens configuration, there is a linear relationship between the 
magnification and signal-to-noise, while for tandem lens configuration, different magnifications are 
obtained with different lens combination therefore resulting in a nonlinear relationship between 
them.  
An important parameter for choosing objective lens is the NA, which in photographic lenses 
that in an optical mapping setup is given by the F-number, which is equal to 1/(2NA). NA is 
proportional to the number of photons collected by a lens. Therefore in the mapping system, the 
lens with smallest F-number or highest NA should be chosen. Microscope lenses with NA ranges 
from 0.25 to 1.3 provide the best light collection efficiency.  
Single lens configuration was used in the dual optical mapping system for the mouse heart 
preparation (Figure 2.8) and tandem lens configuration was used for human heart preparation 
(Figure 2.9). The lenses used in the setups are Nikon NIKKOR 55 mm 1:1.4 235052 with NA =0.36 
and Nikon NIKKOR 50 mm 1:1.2 384854 with NA=0.42. The choice of lens is also dependent on 
the size of the photo detector.  
   29 
 
Figure 2.5 Single and tandem lens configuration. A. Single lens configuration, magnification (M) 
of such configuration depends on focal length (f) and the distance the object is away from the lens. 
When this distance is fixed, the focal distance is also fixed. B. Tandem lens configuration. M in this 
configuration is defined by the ratio of length of two lenses (f1/f2) and is not dependent on the lens 
separation. However extension of d would increase the loss of marginal light rays and lead to 
vignetting. 
 
Photodetector 
Photodiode arrays (PDA), CCD cameras and CMOS cameras are frequently used in optical 
mapping systems. All camera types consist of two-dimensional arrays of silicon elements that 
transduce the energy of light photons into electrical charges. 
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PDA usually offers the highest temporal resolution while CCD camera has the higher spatial 
resolution. CMOS cameras can be considered in between both sides. It can acquire data fast enough 
for cardiac electrophysiological investigations while also providing high spatial resolution to visualize 
and reconstruct the propagation of excitation impulses. I used a MiCAM ULTIMA CMOS camera 
from SciMedia in our dual optical mapping system. The actual sensor size of this camera is 10 by 10 
mm2 with a spatial resolution of 100 by 100 pixels. It can acquire data up to 3,300 frames per 
second. For the two-camera setup, the acquisition alternates for each camera, so that the actual 
temporal resolution for the dual optical mapping system is up to 1,650 frames per second. Data is 
saved as the structure shown in Figure 2.6. The import of data and separation of voltage and Ca2+ 
signals are based on such a data structure. 
 
Figure 2.6 Data structure of the acquisition system. 
 
Dual optical mapping system 
To precisely align its different components, the whole mapping setup is built on an optical 
breadboard. Optical rails and other mounting equipment are used. The schematic diagram of the 
setup is shown in Figure 2.7. Briefly, after staining with both voltage and Ca2+ probes, preparation is 
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excited by the light source with the specified wavelength. The emission fluorescence signals 
propagate through the tandem lens optics and are separated by the dichroic mirror before they are 
collected by photodetectors. The acquisition process is aligned with the light source shutter. Both 
excitation light source and acquisition system are controlled by computer. The detailed description 
of the setup is as follows. 
 
Figure 2.7 Schematic diagram of dual optical mapping setup. 
 
The dual optical mapping apparatus consists of two MiCAM Ultima-L CMOS cameras 
(SciMedia, Costa Mesa, CA) that have high spatial (100x100 pixels, 230±20 µm per pixel) and 
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temporal (up to 3,000 frames/sec) resolution. A band-pass filter (590±15 nm, Thorlabs, Newton, 
NJ) is fixed in front of the designated calcium imaging camera; while, a long-pass filter (>700 nm, 
Thorlabs, Newton, NJ) is positioned in front of the designated voltage imaging camera. The cameras 
are arranged perpendicularly to one another by a holder, which contains a dichroic mirror (635 nm 
cutoff, Omega Optical, Brattleboro, VT). Immediately below the dual camera holder is a lens (Nikon 
NIKKOR 85 mm 1:1.4 235052), which focuses the emission light coming from the heart onto the 
dichroic mirror (Figure 2.8). For larger field of view experiments such as with human and rabbit 
hearts, different magnifications are needed, thus a tandem lens configuration is designed as shown in 
Figure 2.9 with an adjustable working distance. 
The excitation light is generated by a halogen lamp (Newport Oriel Instruments, Stratford, 
CT; SciMedia, Costa Mesa, CA) and is passed through a heat filter, shutter, and excitation band-pass 
filter (520±45nm). A flexible light guide directs the band-pass filtered light onto the preparation, and 
a computer-controlled shutter ensures that the preparation is exposed to light only during image 
acquisition in order to avoid photo bleaching of the dyes.  
Custom made Ag/AgCl2 electrodes for pacing and sensing are installed in the chamber prior 
to the experiment and placing of the heart. Amplifiers and filters are adjusted to the appropriate 
levels. Real-time monophasic action potential recording is also combined with the setup to capture 
acute changes in the experiment that may not be completely recorded by the mapping system. 
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Figure 2.8 Dual optical mapping setup for intact mouse heart preparation.[58] 
 
Figure 2.9 Dual optical mapping setup for human ventricular wedge preparation. 
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2.3.3 Experimental Protocol  
A detailed dual optical mapping procedure on Langendorff-perfused isolated intact mouse 
heart is described in the following section. A brief flow chart is shown in Figure 2.10. 
 
Figure 2.10 Flow chart for experimental protocol.[58] 
 
Part1: Advanced preparation of stock solutions. 
1. Prepare stock solutions of Tyrodes’ solution (16×) in advance in deionized water and store 
at 4oC:  
a. Stock I (119.872g/L NaCl, 3.056g/L CaCl2 (2H2O), 5.6g/L KCl, 2.6274g/L 
NaH2PO4, 3.408 g/L MgCl2 (6H2O), (Fisher Scientific, Fair Lawn, NJ));  
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b. Stock II (26.88g/L NaHCO3, (Fisher Scientific, Fair Lawn, NJ)). 
2. Prepare stock solutions of fluorescent dyes. To avoid repeated freezing and thawing, store 
30 µl aliquots of both dyes, which corresponds to one experiment, at -20°C:  
a. Voltage-sensitive dye RH237 (Invitrogen, Carlsbad, CA) stock solution, 1.25mg/ml 
solution in dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO);  
b. Calcium indicator Rhod-2AM (Invitrogen, Carlsbad, CA) stock solution, 1mg/ml 
solution in DMSO.  
3. Prepare excitation-contraction uncoupler Blebbistatin stock solution (Tocris Bioscience, St. 
Louis, MO, 2mg/ml solution in DMSO) in advance and store the dissolved blebbistatin 
frozen at 4°C.  
Blebbistatin is a commonly used EC uncoupler that helps to stop the contraction of the 
heart while maintaining normal electrical activities. Contraction in optical mapping 
experiments creates large artifacts that can confound the accurate interpretation of the 
fluorescent signals. In Figure 2.11, signals on the left were collected while the heart was 
beating. Multiple humps resulted from contraction were observe. While on the right side, 
signals from same field of view turned stable and accurate after perfusion of Blebbistatin. 
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Figure 2.11 Optical mapping signals before and after application of Blebbistatin. Left picture 
shows membrane potentials with movement artifact from contraction. Right picture is the optical 
signals from same field of view after application of Blebbistatin.   
 
Part 2: Prepare perfusion solutions and experimental setup [66]: 
4. Freshly prepare 2L of Tyrode’s solution (128.2mM NaCl, 1.3mM CaCl2 (2H2O), 4.7mM 
KCl, 1.05mM MgCl2 (6H2O), 1.19mM NaH2PO4, 20mM NaHCO3, 11.1mM D-Glucose in 
distilled water, pH=7.35±0.05). If a stock solution is being used to make 2L of Tyrode’s 
solution (sufficient for one experiment), take 1750mL of deionized water and mix in 125mL 
of Stock I, 125mL of Stock II, and 4g of glucose. 
5. Turn on the two pumps of the perfusion systems.  Set the peristaltic pump (Peri-Star, WPI, 
Sarasota, USA) that retrogradely perfuses the heart. Set the other peristaltic pump (Cole-
Parmer Masterflex Peristalic Pump L/S, Cole-Parmer Instrument Company, Vernon Hills, 
Illinois) that is used for superfusion and to return of the perfusate back to the holding and 
oxygenating reservoir to 80 ml/min.  
6. Wash the perfusion system with 70% ethanol for 30 min and then with 2L deionized water.  
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7. Once all of the deionized water is evacuated from the chamber, circulate the Tyrode’s 
solution and pass it through a 5-μm filter (Millipore, Billerica, MA, USA). Warm the 
perfusate to 37oC with a water jacket and circulator (ThermoNESLAB EX7, Newtown, 
USA), maintain the temperature by implementing a heating system in the perfusion 
chamber[67], and oxygenate the perfusate by bubbling O2/CO2 (95% / 5%) gas into the 
solution. Monitor the pH of the solution with a pH meter (Oakton Instruments, Vernon 
Hills, IL) and adjust the rate of O2/CO2 bubbling to keep the pH at 7.35 ± .05. Continue 
monitoring the pH and temperature during experiment.  
Part 3: Harvest the mouse heart; cannulate, and set up Langendorff perfusion. 
8. Anesthetize the mouse with ketamine/xylazine (ketamin, 80mg/kg bodyweight; xylazine, 10 
mg/kg bodyweight) and Heparin (100 units) by intraperitoneal injection. Assure appropriate 
level of anesthesia by the lack of pain reflex.  
9. After a mid-sternal incision, quickly remove the heart and wash it in oxygenated (95% O2, 
5% CO2), maintain constant-temperature (37±1oC) Tyrode’s solution. 
10. Using dissection microscope, rapidly identify the aorta and make a clean cut across the 
ascending aorta below the right subclavian artery. A short section of the aorta is then 
attached to a custom made 21-gauge cannula with extra edge for silk fitting around its tip. 4-
0 black-braided silk (Surgical Specialties Corporation, Reading, PA) is used to fix the heart 
onto the cannula. After cannulation, the heart is retrogradely perfused and superfused with 
Tyrode solution. The retrograde perfusion rate is adjusted in the range of 2-5 mL/min to 
keep the aortic pressure between 60 and 80 mmHg (Pressure transducer, World precision 
instruments Inc (WPI), Sarasota, USA; Bridge Amplifier TBM4M, WPI, Sarasota, USA). 
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11. After the heart is cannulated, lung, thymus, and fat tissue are then removed. 
12. The isolated heart is pinned (Fine Science Tools) at the apex to the bottom of the perfusion 
chamber (Sylgard coated) to prevent stream-induced movement. The right and left atrial 
appendages are also stretched and pinned (Fine Science Tools, Inc, Foster City, CA) to the 
bottom of the chamber, which provides maximal surface area for optical measurements of 
the atria in the up-right configuration.  
A small silicon tube is inserted into the left ventricle through the pulmonary veins and fixed 
by silk to nearby connective tissue.  This prevents solution congestion and acidification of 
the perfusate trapped in the left ventricle, which is especially important after the suppression 
of ventricular contractions with an excitation-contraction uncoupler.  
13. A custom made electrode is placed on the surface of the heart to conduct the pacing 
stimulations, which is generated by Mater-8 (A.M.P Instruments Ltd, Jerusalem, Israel) or 
PowerLab 26T (AD Instruments, Sydney, Australia). 
14. A small cover glass is fixed on the surface of the solution over the heart to reduce motion 
artifact from the vibrating solution. 
15. Focus the excitation light on the heart. In addition, adjust the distance between the dual 
camera apparatus and the heart so that maximum resolution will be obtained. 
16. Turn off all lights in the room and commence electrical recordings using PowerLab 26T.  
Part 4: Load voltage and calcium sensitive dyes and excitation-contraction uncoupler.  
17. Warm-up 0.6 ml of blebbistatin (10 µM). Mix 0.5 ml of the blebbistatin with the perfusate in 
the holding reservoir. Dilute the remaining 0.1ml of blebbistatin in 1 ml of Tyrode’s solution 
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and slowly inject it (over a 20 minute period) through a drug port located near the cannula. 
Observe as blebbistatin gradually reduces the motion artifact.  
18. Dilute 30µL of voltage sensitive dye RH237 stock solution in 1mL Tyrode’s solution and 
slowly inject over 5-7 minutes into the same injection port as blebbistatin.  
19. 30µL calcium indicator Rhod-2 AM is 1:1 mixed with Fluronic F127 (Invitrogen, Carlsbad, 
CA, 20% solution in DMSO) and then diluted in 1mL Tyrode’s solution and slowly applied 
over 5-10 min to perfusion system to the heart through the same injection port. 
20. Wait for 5-10 minutes for Blebbistatin and dyes to reach the cell membrane and cytosol. 
Continue with the protocol when motion is completely suppressed.  
21. Continuously monitor ECG recordings over the entire procedure to assure normal electrical 
function of the heart.  
22. Commence fluorescent signal recordings using the SciMedia custom software (SciMedia, 
Costa Mesa, CA). 
 
2.4 Representative Results 
Mouse heart experiment results suggest the accuracy and reliability on Vm and CaT 
morphology, time scale and the time relations between these two dynamic parameters from designed 
system. 
 
2.4.1 Typical experimental preparation and optical mapping signals 
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A photo of a typical cannulated intact mouse heart with Langendorff-perfusion as described 
in the protocol section is presented in Figure 2.12. Optical mapping signals of action potential and 
Ca are collected from the black dots labeled in the image. Dramatically distinct morphology of both 
signals are observed from the right atrium and left ventricle. Atrium signals have a shorter APD 
compared to ventricular signals. The presence of fluorescence scattering is one of the limitations of 
optical mapping. In the atrium signals, I observed small humps that are the results of the fluorescent 
signal scattering coming from the ventricles. Since the signals are collected during ventricular pacing, 
the hump precedes to atrium activation. 
 
Figure 2.12 Experimental preparation and signal examples recorded during ventricular 
pacing. Left: ECG signals are collected from Ag/AgCl2 disk electrodes (Top) and an example of 
S1S1 stimulation protocol is shown (Bottom). Center: Langendorff mouse heart preparation. Right: 
Representative optical action potentials and calcium transient signals from atria (Top) and ventricles 
(Bottom) are shown. The yellow arrow (Top) points to the fluorescent signal scattering coming from 
the ventricles, which is seen in the atrial recordings.[58] LV=left ventricle; RV=Right ventricle; 
LA=left atrium; RA=right atrium. 
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2.4.2 High Temporal-Spatial Resolution of Optical Mapping 
Optical mapping provides electrical and Ca fluorescent signals with high temporal-spatial 
resolution. Typical signals were presented from an array of adjunct locations in Figure 2.13. High 
spatial resolution allows for imaging precise details of electrical property of the cardiac tissue as 
slight distinctness can be differentiated from locations with tiny distance. Propagation pattern can be 
reconstructed by plotting the activation time point at each pixel. 
Time relation between Vm and CaT can be studied with high temporal resolution of the 
system. During normal contraction, activation of membrane potential precedes the release of Ca. 
The time scale between the activation of AP and Cat varies with different species due to different 
ionic basis. This time difference can be precisely detected in the dual mapping system as the 
sampling frequency can go quite high up to 1,650 frames per second, which is sufficient for this 
parameter.  
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Figure 2.13 Representative optical recordings of Vm and calcium transients (CaT) from the 
ventricles of a wild type mouse heart. Vm (blue) and calcium transients (red) are shown (C) from 
an array of evenly spaced locations marked by the black dots (A). (B) Example tracings of Vm and 
CaT from a central on the array. Signals were binned 3x3. CMOS camera system allows up to 10,000 
pairs of recordings of Vm and CaT.[58] 
 
2.4.3 Mapping of Activation and Repolarization: Conduction 
Optical mapping has made significant contributions to functional studies of the fundamental 
mechanisms of impulse generation (activation) and transmembrane potential recovery 
(repolarization). Activation time can be determined by calculating the maximum first derivative of 
the upstroke: dV/dt (Figure 2.14B). Alternatively, this time can also be determined when the 
upstroke reaches 50%. Time points of dV/dt from different pixels over whole surface of the 
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preparation can be plotted out and used to reconstruct the conduction pattern called activation map. 
Activation map of mouse heart with ventricular pacing is depicted in Figure 2.14A. It is observed 
that conduction along longitudinal directions (Labeled as L) is faster than that along transverse 
directions (Labeled as T). 
 
Figure 2.14 Action potential conduction. A. An example activation map from a wild type mouse 
heart with transverse (T) and longitudinal (L) directions indicated by white arrows. B. Vm signals 
(Top) and dV/dt (Bottom) corresponding to the three points seen in A (T1, T2, T3; L1, L2, L3).[58] 
 
2.4.4 Mapping of activation and repolarization: APD and CaD 
AP represents the net activities of a group of membrane ion channels. Different channels 
contribute distinctly during disparate phase of action potential. APD at different repolarization levels 
offers information regarding the contribution of different ion channels. Dysfunction of ion channels 
in HF underlies the appearance of APD remodeling at different repolarization level. An experiment 
of isoproterenol (ISO) was applied to validate the sensitivity and reliability for detection on time 
scale of different phase of action potential (Figure 2.15). 
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Accordingly, CaT represents Ca handling in the myocytes and is mediated by various Ca 
handling proteins as described in Chapter 1. Dysfunction in Ca handling due to those proteins 
results in remodeling on CaT morphology and can be quantified by CaD. 
 
Figure 2.15 Action potential and calcium transient duration analysis.  A. APD80 and CaD80 
maps are shown from a heart under control conditions (Left) and after 30nM isoproterenol 
application (Right). The yellow/green color in the ventricles (Right) indicate isoproterenol shortened 
APD80 and CaD80. B. Action potential duration at 80% repolarization (APD80) and calcium transient 
duration at 80% relaxation (CaD80) from a wild type mouse heart.[58] 
 
2.5 Discussion 
 In this chapter, I described the design of a dual optical mapping system. This system has 
proven its accuracy and reliability in probing action potential and Ca transients. Both signals are 
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recorded simultaneously, so that time relation between them can be thoroughly investigated, such as 
how much is action potential activation preceding Ca release. Thus, this mapping system provides a 
reliable tool to visualize the dynamics of both electrical activity and Ca handling, especially on their 
association. 
In the experimental method, I modified the Langendorff perfusion method by adding a 
small but important silicon tube. It is used to prevent solution congestion, subsequent endocardial 
LV ischemia after suppression of ventricular contractions, acidification of the perfusion solution and 
development of ischemia in the left ventricle. The mouse heart is very sensitive to hypothermia and 
temperature variations, which can both, cause artificial variations in action potential durations. It is 
imperative to maintain temperature at 37 oC during the whole experiment by implementing a heating 
system in the perfusion chamber as previously described [67]. Since Langendorff model does not 
retain innervations of the heart, one needs to consider adding neurotransmitters to the perfusates in 
order to maintain normal sympathetic and parasympathetic tone [68]. Addition of superfusion of the 
heart to Langendorff perfusion helps to maintain environment parameter like pH and temperature. 
In this method, the Langendorff perfused heart was placed horizontally. Vertical Langendorff 
perfusion setup can also be used [69], which may result in slightly different cardiac mechanics [70]. 
Application of CMOS cameras of high spatio-temporal resolution ensures the accuracy of 
recordings. However, optical mapping signals are not from a single cell but from hundreds or 
thousands of cells, depending on optical magnification. Alternative detectors are also available and 
could be applied to mapping Vm and CaT simultaneously [71]. Optical scattering could distort atrial 
signals by the presence of much higher ventricular fluorescence; therefore careful interpretation of 
the optically recorded signals is required. Another limitation of the mouse preparation in this 
protocol is the signal distortion and noise induced by the curvature of surface due to the small size 
of the mouse heart [72]. Conduction velocity measurements can also be distorted by electrode 
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polarity and virtual electrode in addition to the curvature of the heart. To increase accuracy for 
conduction velocity, activation anisotropy and repolarization maps, correct focus at the surface of 
the heart is very important. In this method, real time ECG recording could potentially supplement 
optical investigation of cardiac electrophysiology. Because of the fast response, similar excitation and 
distinctly different emission spectra of the two dyes, voltage-sensitive dye (RH237) and calcium 
indicator (Rhod-2AM) are used in the protocol [25, 66]. There are alternative combinations of dyes 
that can be used to measure Vm and CaT other than RH237 and Rhod-2AM [25]. A novel voltage 
sensitive dye, PGHI, with a large Stoke’s shift (>200nm) was found to generate better Vm and CaT 
signals because of the greater separation of the emission wavelengths between PGHI and Rhod-
2AM[73]. Future improvements may focus on exploration of novel fluorescent probes, which may 
improve the quantitative measurements achieved using optical mapping, development of new 
imaging sensors, and improved image processing software. Higher resolution and novel optical 
imaging modalities for 3D optical mapping are also important directions for optical mapping in 
future developments [61].  
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Chapter 3 
 
The Role of Pyk2 in Cardiac 
Arrhythmogenesis 
 
 
 
3.1 Abstract 
Proline-rich tyrosine kinase 2 (Pyk2) is a non-receptor protein kinase regulated by 
intracellular Ca2+, CaMK, and PKC, and can be activated by different stress signals involved in 
ventricular hypertrophy and heart failure. However, Pyk2 has not been investigated in the human 
heart, and cardiac function of Pyk2 signaling at the whole heart level has not been elucidated. I 
hypothesize that Ca-dependent activation of Pyk2 is involved in cardiac autonomic regulation, 
conduction, repolarization and arrhythmogenesis. I examined expression of Pyk2 in non-failing 
versus ischemic and non-ischemic failing human hearts (n=6/group) by Western blot. To investigate 
Pyk2 function, I optically mapped Langendorff-perfused hearts from wild type (WT, n=7) and Pyk2 
knockout (Pyk2-/-, n=8) mice in control and during autonomic stimulation. I used Illumina beadarray 
approach for transcriptional profiling of WT and Pyk2-/- mouse ventricles. Western blot using 
phospho-specific antibodies revealed a doubling of Pyk2 activation in non-ischemic failing human 
hearts compared to non-failing hearts. In mouse hearts, I observed a much higher probability of 
ventricular tachyarrhythmia during ACh perfusion in Pyk2-/- vs WT mice. Parasympathetic 
stimulation resulted in a dose-dependent decrease of atrial action potential duration (APD) in both 
WT and Pyk2-/- mice, while in ventricles it induced APD shortening in Pyk2-/- but not WT mice. 
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Deficiency of Pyk2 abolished prolongation of AV-delay induced by ACh in Pyk2-/- mouse but did 
not affect heart rate. Lower mRNA and protein levels of SERCA2 and higher mRNA level of 
Na+/Ca2+ exchanger 1 (NCX1) were detected in Pyk2-/- hearts compared with WT hearts. My results 
suggest a protective role of Pyk2 with respect to ventricular tachyarrhythmia during parasympathetic 
stimulation by regulation of gene expression related to calcium handling. I hypothesize that 
activation of Pyk2 in the human heart during heart failure may contribute to protection against 
arrhythmia.  
Contents of this chapter were published in Am J Physiol Heart Circ Physiol[74] and 
reprinted with the permission of the publisher. 
 
3.2 Introduction 
Stress signaling is dramatically remodeled in HF. Not only functional responses are affected, 
but also gene expression is rapidly modified when cardiac mycotyes are subjected stresses such as 
injury, ischemia. Such stress can be mimicked experimentally by UV light, heat shock, osmotic 
shock.[75] Proline-rich tyrosine kinase 2 (Pyk2) mediates a typical stress activated signaling pathways 
along with c-Src, P38 and regulates a broad range of key biological responses. In this chapter, I 
investigated the role of Pyk2 in cardiac arrhythmogenesis. 
Cardiac arrhythmias account for the majority of the sudden cardiac death, which comprises 
11% to 15% of all deaths in developed countries [76]. Many arrhythmias result from an underlying 
pathology and are characterized by aberrant signal transduction mechanisms. A dysfunction of 
calcium handling, due to the abnormalities of various signaling regulatory pathways, is widely 
recognized as the mediator of certain forms of cardiac arrhythmias [77]. Therefore, a better 
understanding of the signaling pathways that mediate and regulate cardiac calcium handling is 
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increasingly important for elucidating the mechanisms as well as new treatment targets of cardiac 
arrhythmias.  
Pyk2 is a non-receptor protein tyrosine kinase closely related to focal adhesion kinase (FAK). 
Pyk2 activity is induced by G protein coupled receptor (GPCR) agonists, hormones, growth factors, 
inflammatory cytokines, integrin-mediated cell adhesion, membrane depolarization, and stress 
signals[78], via a mechanism that involves an increase in intracellular calcium levels and activation of 
protein kinase C (PKC) [79]. Pyk2 activation is mediated by intermolecular autophosphorylation of 
tyrosine 402 (Y402), resulting in an increase in the activity of Pyk2 and the recruitment of Src-family 
tyrosine kinases, which in turn phosphorylate several other tyrosine residues of Pyk2 and Pyk2 
interacting proteins [79-82]. These phosphorylation events are important for enhancing activation of 
Pyk2 and signaling to downstream targets. And this activation can be medicated by Acetylcholine 
(ACh) stimulation. [83] Acting at a crossroads of multiple intracellular signaling pathways [79, 84], 
Pyk2 has been shown to regulate a broad range of key biological responses, including cell 
proliferation, differentiation, apoptosis, survival, cell motility and polarity, cytoskeletal regulation and 
calcium homeostasis, in a cell context- and stimulus-dependent manner (Figure 3.1). 
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Figure 3.1 Pyk2 signaling pathway. After its phosphorylation activated by stress signals, Pyk2 
mediates a typical signaling pathway upstream of c-Src, P38, and regulates several ion channels.[74] 
 
 
Pyk2 is expressed in cardiomyocytes, cardiac fibroblasts, vascular smooth muscle and 
vascular endothelial cells [85-89]. Pyk2 signaling has been implicated in the induction of pressure 
overload-induced left ventricular hypertrophy (LVH) and the transition to heart failure (HF) [90]. 
Pyk2 expression and phosphorylation are increased in a mouse genetic model of dilated 
cardiomyopathy [91]. Pyk2 over-expression in neonatal rat ventricular myocytes (NRVM) results in 
down-regulation of sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2) mRNA level, indicating a 
potential role for Pyk2 signaling in abnormal cardiac calcium handling in LVH and HF [92]. Studies 
in cultured neonatal and adult rat ventricular myocytes suggest the roles for Pyk2 in cytoskeletal 
remodeling and in mediating both cardioprotective and proapoptotic pathways [93-96]. Adenoviral-
mediated expression of a dominant-negative inhibitor of Pyk2 signaling following myocardial 
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infaction (MI) in rat results in improved survival, increased LV function, and altered expression of 
MHC isozymes, indicating an attenuation of LV remodeling post-MI [97]. These data implicate Pyk2 
in promoting deterioration of LV post-MI. However, the role of Pyk2 has not been investigated in 
human heart, and function of Pyk2 signaling, especially the relationship between Pyk2 and 
arrhythmias, has not been elucidated. 
Therefore, I aimed to study expression of Pyk2 in the failing and non-failing human hearts. I 
also aimed to study electrophysiology of isolated Langendorff-perfused mouse hearts from wild type 
(WT) and Pyk2 knockout (Pyk2-/-) mice in control condition and during autonomic stimulation.  
 
3.3 Materials and Methods 
3.3.1 Patient Groups 
Failing human hearts (n=12, Table 1) with cardiomyopathy of different etiologies were 
obtained during transplantation at the Barnes-Jewish Hospital, Washington University in Saint 
Louis, MO. Non-failing donor hearts (n=6, Table 1) that were rejected for transplantation due to 
various reasons including age, atrial fibrillation, or mild coronary disease, were used as non-failing 
controls. Donor hearts were provided by the Mid-America Transplant Services (Saint Louis, MO). 
The clinical data that are known regarding each specimen is shown in Table 1. Usage of human 
hearts for research was approved by the Institutional Review Board at Washington University. 
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Table 3.1 Clinical information Clinical information of patients from whom heart tissue was 
collected and used for western blot experiment. Information of age, gender and clinical diagnosis 
were listed according to heart number. 
 
Human hearts were harvested as described in the published paper [66]. Briefly, explanted 
hearts were cardioplegically arrested and cooled to 4-7oC in the operating room following cross 
clamping of the aorta. Cardioplegic perfusion (in mM: NaCl 110, CaCl2 1.2, KCl 16, MgCl2 16, 
NaHCO3 10, 4°C) washed out the blood and protected the hearts during the subsequent period of 
wedge isolation. Arrested heart was maintained at 4-7oC to preserve tissue during 15-20 minutes 
delivery from the operating room to the research laboratory.  
 
3.3.2 Western Blot Analysis 
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Tissue samples from human left ventricles were flash frozen in liquid nitrogen and 
pulverized, then lysed in RIPA buffer (1% NP-40, 1% Na Deoxycholate, and 0.5% SDS) and 
homogenized, followed by centrifugation at 14,500 rpm for 10 min.  The protein content of the 
samples was quantified using the BCA Protein Assay (Pierce, Thermo Scientific, Rockford, IL), and 
40µg total protein was loaded per well. Then proteins were separated by SDS-PAGE 
electrophoresis, followed by transfer onto nitrocellulose. Primary antibodies (Anti-Pyk2, Poly6053, 
Biolegend, San Diego, CA; Anti-SERCA2, MA3-919, Thermo Scientific, Rockford, IL) incubations 
were performed overnight at 4°C and were carried out in 5% dry milk, for anti- Pyk2 (Anti-
Pyk2[pY402], 3291S, Biosource, Carlsbad, CA; Anti-Pyk2[pY580], ST1021, Biosource, Carlsbad, CA). 
Secondary antibody incubations were performed at room temperature for 1.5 hrs. Detection was 
performed using the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, 
Rockford, IL), and membranes were exposed using the LAS-4000mini (Fujifilm). Following 
exposure, membranes were washed and stripped using Restore PLUS Western Blot Stripping Buffer 
(Thermo Scientific, Rockford, IL).  Membranes were reprobed using an antibody against GAPDH 
(Anti-GAPDH, Sigma, MO) as a loading control.  Images were processed using Multi Gauge 
software (Fujifilm). 
 
3.3.3 Mice and Genotyping 
All procedures complied with the standards for the care and use of animal subjects as stated 
in the Guide of the Care and Use of Laboratory Animals, and protocols were approved by the 
Animal Studies Committee at Washington University School of Medicine. Pyk2 knockout mice have 
been previously described [98]. The animals were maintained in C57BL/6 genetic background. 
 Genomic DNA samples were extracted from ear biopsies according to standard techniques. 
Genotyping PCR was performed as described [99]. PCR products were separated on a 2% agarose 
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gel and visualized by ethidium bromide staining. PCR primers used in this study were: 5’-
GGAGGTCTATGAAGGTGTCTACACGAAC-3’ (forward, WT), 5’-
GCCAGCTCATTCCTCCCACTCAT-3’ (forward, targeted), 5’ 
CCTGCTGGCAGCCTAACCACAT-3’ (reverse, targeted or WT). Genotyping PCR using genomic 
DNA samples purified from WT, Pyk2-/- and Pyk2+/- mice is shown in Figure 3.2.  
 
Figure 3.2 PCR analysis of genomic DNA isolated from ear biopsy samples. Inserted gene 
was detected at 560 bp, while corresponding gene piece in WT mouse is at 372 bp. The mouse with 
only targeted gene is the knockout mice, with only WT gene is WT mouse and with both bands are 
heterozygous mouse which are used for breeding. 
 
3.3.4 Isolated Heart Preparations 
Fifteen Langendorff-perfused hearts from adult (aged 11 to 20 weeks) mice were separated 
into two groups (WT, n=7; and Pyk2-/-, n=8) and used in this study.  The isolated heart preparation 
was according to a Langendorff perfusion protocol modified for murine hearts [66]. Mice were 
anesthetized using mixture solution of Ketamine and Xalazine. 100 Units of Heparin was applied 
used to treat and prevent blood clots in the veins and arteries. After mid-sternal incision, heart was 
removed and washed in oxygenated (95% O2, 5% CO2) constant-temperature (37±1oC), modified 
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Tyrode solution (in mM: NaCl 128.2, KCl 4.7, NaH2PO4 1.19, MgCl2 1.05, CaCl2 1.3, NaHCO3 20.0, 
and glucose 11.1 (pH=7.35±0.05)). Lung, thymus, and fat tissue were then dissected and removed. 
A short section of aorta was attached to a custom made 21-gauge cannula. After cannulation, the 
heart was superfused and retrogradely perfused with Tyrode solution passed through a 5-μm filter 
(Millipore, Billerica, USA) and warmed (37oC) through a water jacket and circulator 
(ThermoNESLAB EX7, Newtown, USA). Perfusion was performed using a peristaltic pump (Peri-
Star, WPI, Sarasota, USA) under constant aortic pressure of 60 to 80 mm Hg measured by pressure-
amplifier (TBM4M, WPI, Sarasota, USA).  
The isolated heart was pinned at the apex to the Sylgard bottom of the chamber to prevent 
stream-induced movement. The right and left atrial appendages were stretched and pinned to be flat 
that allows optical measurements from maximal surface of the atria. A small silicon tube, fixed by 
silk to the nearby connective tissue, was inserted into the left ventricle through the pulmonary vein, 
left atria, and tricuspid valve to prevent solution congestion and subsequent ischemia after 
suppression of ventricular contractions. This also prevented acidification of the perfusion solution 
and development of ischemia in the left ventricle (Figure 3.3).  
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Figure 3.3 Membrane potential signals from atrium and ventricle during sinus rhythm and 
pacing condition. A photo of intact mouse heart preparation is shown at left. Typical membrane 
potential signals are collected from atrium and ventricle during sinus rhythm and pacing condition, 
based on which, activation map was conduced and depicted in the model.[74]  
 
Excitation-contraction uncoupler blebbistatin (10 µM, Tocris Bioscience, USA) was used to 
prevent the effect of motion artifact on the action potential duration estimation. Application of 
blebbistatin induced a transient (5-10 min) increase of cycle length. However, blebbistatin did not 
induce any shifts of leading pacemaker location or action potential duration changes induced by 
other contraction blockers.  
 
3.3.5 Imaging System 
Coronary perfused hearts were stained by perfusion with voltage-sensitive dye (RH-237, 
Invitrogen, Carlsbad, CA, 5μL of 1 mg/mL dimethyl sulfoxide, DMSO in Tyrode solution), for 5-7 
minutes. Excitation light was generated by a 250-W xenon arc lamp with a constant-current, low-
noise, power supply (Oriel Instruments, Stratford, CT). The light was passed through a heat filter, a 
shutter, and excitation filter (530/540 nm). A flexible light guide directed the band-pass-filtered light 
onto the preparation, and a shutter was used to ensure that the preparation was exposed to light only 
during image acquisition. The fluorescent light emitted from the preparation was long-pass (>700 
nm) filtered using an edge pass filter (Thorlabs, NJ) before reaching the camera. Emitted light was 
directed towards a MiCAM Ultima-L CMOS camera (SciMedia, CA) with high spatial (100x100 
pixels, 230±20 μm per pixel) and temporal (1,000-3,000 frames/sec) resolution. Fluorescent signal 
acquired was digitized, amplified, and visualized by the custom software (SciMedia, CA) (Figure 3.4). 
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Figure 3.4 Experimental imaging setup for Pyk2 knockout and WT mice.[74] 
 
3.3.6 Experimental Protocols 
After isolation and cannulation, motion suppression, and dye staining, preparations were 
equilibrated for 5-10 min before imaging. To estimate the effects of Pyk2 in the cardiac system, 
three different concentrations of acetylcholine (ACh, 1μM, 3μM and 10μM) were applied to the 
heart through perfusion. Atropine (2μM), a competitive antagonist for the muscarinic acetylcholine 
receptor, was used to block the action of ACh, after which isoproterenol (ISO 1μM) was applied. 
Details are depicted in Figure 3.5. 
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Figure 3.5 Experimental protocol for Pyk2 knockout mice investigation. [74] 
 
 I optically mapped the heart during both spontaneous rhythm and ventricular pacing under 
control and 10 minutes after applying autonomic interventions. Typical signals from both conditions 
were depicted in Figure 3.3. 
Pacing was induced by the electrode located on the anterior ventricular epicardium midway 
between apex and base. Current value was set as twice of the threshold. The S1-S1 restitution 
protocol was applied to induce ventricular tarchyarrhythmia (VT). Hearts were paced with a basic 
cycle length from 150 to 40 ms in steps of 10 ms until 1:1 capture failed or ventricular 
tarchyarrhythmias, including ventricular fibrillation, occurred.   
3.3.7 Classification of Fast Pacing-Induced Arrhythmia 
Due to small size of the mouse hearts as compared with the wavelength sustained VT/VF 
was not readily induced. I defined occurrence of one or more extra beats as fast pacing-induced 
arrhythmia, which can be further divided into sustained or non-sustained arrhythmia. In agreement 
Langendorff 
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with Fabritz et al. [100], I define fast pacing-induced arrhythmia as sustained if 6 or more irregular 
extra beats were observed.  
 
3.3.8 Data Processing 
A custom-built Matlab computer program [101] was used to analyze optical mapping signals. 
The signals captured were filtered using a low-pass Butterworth filter at 256 Hz. All action potentials 
were averaged and normalized to a range from −85 to +15 mV. Action potential duration was 
calculated at 80% of repolarization (APD80). Activation maps were constructed from activation 
time sequence that was determined using the dV/dtmax definition. AV-delay was measured based on 
PR interval from pseudo-ECG signals. Local conduction velocities were calculated from the gradient 
of activation times along both longitudinal (CVL) and transverse (CVT) directions. Recordings near 
the stimulating electrode and at a distance from the electrode were excluded to remove virtual 
electrode artifacts and the effects of 3-dimensional propagation. Anisotropy is defined as the ratio 
between longitudinal and transversal conduction velocities (CVL /CVT). 
 
3.3.9 RNA Microarray 
Isolation of total RNA from mouse left ventricles was performed using RNeasy Fibrous 
Tissue Min Kit. Integrity of total RNA samples was estimated by the RNA integrity number (RIN) 
comparing to RNA Integrity Database (RINdb) before RNA level measurement using MouseWG-6 
v2.0 Expression BeadChip Kits (Illumina). The intensity of the fluorescence from beadchip was 
normalized and revealed the mRNA level. I analyzed calcium handling proteins mRNA level in this 
study.  
 
   60 
3.3.10 Transverse Aortic Constriction  
The constriction of the transverse thoracic aorta was performed on 10 to 12 week-old mice 
by the Mouse Cardiovascular Phenotyping Core in Washington University in St.Louis as 
described.[102, 103] In brief, mice was anesthetized and incubated. Following blunt dissection 
through the intercostal muscles, the aorta and pulmonary artery was identified and freed by 
additional blunt dissection. 7.0 silk suture was place around the great vessel of interest and tied 
around a blunt needle. The blunt needle was rapidly removed. The surgical incision was closed in 
two layers with an interrupted suture pattern.   
 
3.3.11 Statistical Analysis 
Group data were represented as mean ± SEM. Comparisons between groups of data were 
performed using ANOVAs analysis with Scheffe test. A value of P<0.05 was considered statistically 
significant. 
 
3.4 Results 
3.4.1 Pyk2 Activation is Increased in Non-Ischemic Failing Human Hearts 
I first assessed the expression levels and the activation status of Pyk2 in non-failing and 
failing human hearts of different etiologies: ischemic and non-ischemic cardiomyopathy.  
Immunoblot analysis using Pyk2-specific antibody (Anti-Pyk2, Poly6053, Biolegend, San Diego, CA) 
showed that Pyk2 protein is expressed at comparable levels in the tissue samples from non-failing 
control and diseased human left ventricles (Figure 3.6A, top panel). Pyk2 kinase activity was assessed 
by tyrosine phosphorylation. Notably, phosphorylation of Pyk2 on Y402, a major site of Pyk2 
autophosphorylation upon activation, is significantly increased in non-ischemic failing hearts, 
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compared with non-failing hearts and ischemic failing hearts, as measured using phospho-Y402-
specific antibody (Anti-Pyk2 [pY402], 3291S, Biosource, Carlsbad, CA) (Figure 3.6A, B).  
Phosphorylation of Pyk2 on Y580  (Anti-Pyk2 [pY580], ST1021, Biosource, Carlsbad, CA) in the kinase 
domain activation loop was also elevated and observed increased activation in non-ischemic failing 
hearts (Figure 3.6A, B). These data show that Pyk2 is expressed in human ventricles and is activated 
in non-ischemic cardiomyopathy, indicating a potential involvement of Pyk2 signaling in this 
pathology.  
 
 
 
Figure 3.6 Pyk2 is activated in non-ischemic failing human ventricle. (A) Pyk2 expression and 
activation in non-failing, ischemic failing and non-ischemic failing human ventricle. Pyk2 activation 
was assessed using phosphorylation on tyrosine 402 (Y402) and tyrosine 580 (Y580). (B) Statistical 
analysis of Pyk2 activation levels. Pyk2 activation by phosphorylation on tyrosine 402 (Y402) and 580 
(Y580) in non-ischemic group is significantly higher than in non-failing and ischemic failing 
groups.[74]   
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3.4.2 Autonomic Regulation of Spontaneous Heart Rhythm in WT and Pyk2-/- 
mice 
First, I explored the effect of Pyk2 deletion on the sino-atrial nodal (SAN) function. Both 
WT and Pyk2-/- mice showed an ACh dose dependent decrease of spontaneous heart rate, which 
was abolished by atropine. ISO accelerated the heart rate in both WT and Pyk2-/- mice (Figure 3.7A). 
In WT and Pyk2-/- mice, respectively, after normalizing to control group, heart rate decreased to 
75.1% and 79.2%; 63.7% and 61.9%; 50.9% and 50.4% under 1, 3 and 10 µM ACh, then went back 
to 116% and 101% under atropine. However, no significant difference was observed between the 
two groups under all conditions (Figure 3.7A). During the measurements of heart rate, both ECG 
and optical maps showed clear 1:1 conduction, excluding the possibility of AV-junction rhythm 
playing any role in heart rate under our experimental conditions. 
I next assessed the atrio-ventricular (AV) nodal function. AV-delay showed a markedly 
different response to autonomic stimulation in Pyk2-/- mice versus WT. As expected, an ACh dose 
dependent prolongation of AV-delay was observed in WT mice (value normalized to control group: 
ACh 1µM: 1.24±0.05 versus ACh 10µM 1.93±0.23, p=0.024), which was completely abolished by 
deficiency of Pyk2 in Pyk2-/- mice (ACh 1µM: 1.06±0.04 versus ACh 10µM 1.16±0.05, p=0.19) 
(Figure 3.7B). No significant change of AV-delay was detected during the application of autonomic 
stimulation in Pyk2-/- mice at all (Figure 3.7B). Significant differences of AV-delay were observed 
between WT and Pyk2-/- mice during perfusions of three different ACh concentrations (P=0.021, 
0.043, and 0.0035 for 1, 3 and 10 µM ACh respectively).  
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Figure 3.7: Functional change of heart rate and AV-delay in mouse hearts.  (A) Heart rate was 
normalized to control condition. Values of both WT and Pyk2-/- mice showed ACh dose-
dependent decrease, which was abolished by Atropine. No significant difference in heart rate was 
detected between WT and Pyk2-/- groups under autonomic stimulations. (B) Ach-induced increase 
in AV-delay was detected in WT, but not in Pyk2-/- mice. * - p<0.05 between same group; # - 
p<0.05 between WT and Pyk2-/-.[74]  
 
These data suggest that Pyk2 deficiency did not have any effect on SAN function, but had a 
significant effect on AVN: it abolished the sensitivity of AV conduction to cholinergic stimulation. 
This observation indicates that Pyk2 expression and activation is involved in AVN function, and not 
involved in SAN function in the mouse.  
 
 
3.4.3 Fast Pacing Induced Reentrant Tachyarrhythmia in Pyk2-/- Mice after 
ACh Application 
Next we assessed a possible role of Pyk2 deficiency in vulnerability to the ventricular 
tachyarrhythmia. I applied a rapid pacing to induce ventricular tachycardia or fibrillation (VT/VF) in 
both groups of mice. As shown in Table 3.2, Pyk2-/- mice had a significantly higher vulnerability to 
pacing induced tachyarrhythmia during high concentrations of ACh (3 μM and 10 μM), compared to 
the WT group (37.5% versus 14.3% and 75% versus 0% (p<0.001), respectively). Arrhythmia was 
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not readily inducible in WT mice at any concentration of ACh, nor in Pyk2-/- mice at low 
concentration of ACh (1 μM). In this experiment, I observed that spontaneous arrhythmia occurred 
in three Pyk2-/- mice (indicated by # in Table 2), after which the application of rapid pacing also 
induced arrhythmia. In contrast, no spontaneous arrhythmia was observed in WT mice.  
 
 
 
Table 3.2 Statistics analysis of ventricular tachycardia induced in Pyk2-/- and WT mice. 
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To investigate the pattern of tachyarrhythmia induced by rapid pacing in the Pyk2-/- mouse 
heart during autonomic stimulations, I optically mapped the heart during tachyarrhythmia. The 
activation maps revealed reentrant arrhythmia. Figure 3.8 shows a representative example of the 
reentry circuit in Pyk2-/- mouse heart that occurred on the anterior ventricular epicardium of the 
heart with the reentrant cycle length of 38 ms. Five consecutive activation maps illustrate the 
reentrant arrhythmia during 196 ms, in which dark blue represents the earliest activation time while 
dark red represents the latest.  Most of the observed reentrant arrhythmias were driven by stable 
reentry circuits lasting more than 4 s, which is the limitation of our data acquisition system. Some of 
the reentrant arrhythmias terminated spontaneously, as summarized in Table 3.2.  
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Figure 3.8 Typical VT induced in Pyk2-/- mouse heart. (A) Activation map shows 5 cycles (a to 
e) of clockwise reentrant VT induced by rapid pacing during 10 mM ACh perfusion. The cycle 
length is 38 ms. The reentrant paths are indicated by white dashed arrow curves. (B) Optical 
mapping recordings of five points chosen to illustrate reentry (Figure 3.5a) are shown at the same 
time scale. The pink solid arrows clearly show the direction of action potential propagation that goes 
from point 1 to 5 in one reentrant arrhythmia cycle.  
 
 
3.4.4 Spatiotemporal characteristics of activation and repolarization in WT and 
Pyk2-/- mice 
Enhanced arrhythmogenesis in Pyk2-/- mice could be explained by several alternative 
hypotheses, which are based on abnormalities of conduction and/or repolarization. To explore the 
underling arrhythmogenesis substrate I characterized repolarization and conduction in both groups 
of mice. APD at 80% of repolarization levels (APD80) at cycle length of 120 ms pacing were 
detected in atria and ventricles respectively from both groups of mouse hearts. As expected, ACh 
decreased atrial APD80 in both WT and Pyk2-/- groups (32.3±2.6ms, 18.0±1.5ms, 16.7±2.2ms and 
13.4±1.9ms versus 30.1±3.5ms, 20.6±2.2ms, 18.8±1.7ms, and 14.0±2.8ms under control condition, 
1, 3 and 10 μM ACh, respectively). Unexpectedly, there was a significant difference in response of 
WT and Pyk2-/- mouse ventricles to high concentration ACh. As expected, APD80 of WT mouse 
ventricles did not exhibit dependence on ACh. In contrast, ACh significantly decreased APD80 in 
Pyk2-/- group at 10 μM ACh stimulation. APD80 was 57.8±2.7ms, 60.7±3.8ms, 65.5±4.6ms and 
63.5±5.0ms versus 60.0±3.9ms, 54.9±4.9ms, 51.4±2.8ms and 46.7±2.4ms under control condition, 
1, 3 and 10 μM ACh for WT and Pyk2-/- groups, respectively (Figure 3.9B). 
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Figure 3.9 Functional change of APD in WT and Pyk2-/- mouse heart mouse heart.  (A) 
Optical signal and APD map of WT and Pyk2-/- mice under control condition and stimulation of 10 
mM ACh. (A), Time scale from 20 to 100 ms (20 ms: indicated by dark blue color; 100 ms: indicated 
by dark red color) was applied to depict the APD80 distribution. ACh significantly decreased 
APD80 in atrium but not in ventricle. On the contrary, APD80 map of Pyk2-/- mouse heart showed 
a decrease in both areas after application of 10 µM ACh. (B) Statistical analysis showed that in atria 
ACh dose-dependently decreased action potential duration at 80% repolarization level (APD80) in 
both WT and Pyk2-/- mice, while in ventricles ACh did not change APD80 in WT mice but decreased 
it in Pyk2-/- mice.  
 
 
To explore possible conduction abnormalities, I also measured average transverse and 
longitudinal conduction velocities (CV), and anisotropy in WT and Pyk2-/- mice. Figure 3.10 
illustrates a representative example and summary data for pacing at cycle length of 120 ms. I found 
no significant differences of CV or anisotropy between WT and Pyk2-/- mice groups. However the 
Pyk2-/- group showed a trend of higher mean anisotropy values than WT group, which was not 
statistically significant (p=0.051, 0.084, 0.133, 0.199, 0.613 for control, 1 μM, 3 μM, 10 μM ACh, 
and 2 μM ISO groups respectively). 
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Figure 3.10 Conduction anisotropy in WT and Pyk2-/- mouse heart mouse heart.  (A) Optical 
signals showed different conduction velocity under control condition along transverse and 
longitudinal direction, which are indicated in the activation map. The fronts of electrical signals from 
three random places along two directions represented by different colors are shown beside the 
activation map, which indicates different conduction velocity along the two directions. (B) No 
significant difference of anisotropy under control condition and autonomic stimulations were 
detected between WT and Pyk2-/-mice.  
 
 
My data suggests that Pyk2 deficiency resulted in a gain of cholinergic sensitivity of 
ventricular repolarization. There was no effect on atrial repolarization and on conduction velocity or 
anisotropy. Therefore, Pyk2 deficiency could account for a significant shortening of ventricular 
wavelength during cholinergic stimulation, which could explain increased vulnerability of reentrant 
arrhythmia.  
 
3.4.5 Pyk2-Null Hearts Exhibit Changes in Expression of Calcium Handling 
Regulators 
To investigate the transcriptional changes potentially caused by Pyk2 deficiency, I performed 
whole genome microarray analysis using RNA samples isolated from left ventricles of WT and Pyk2-
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/- mice. I found that SERCA2 mRNA and protein levels were significantly lower in ventricles of 
Pyk2-/- hearts relative to WT hearts (Figure 3.11). NCX1 mRNA level was also observed significantly 
higher in ventricles of Pyk2-/- hearts relative to WT hearts (Figure 7). Data from other calcium 
handling proteins including voltage-gated and other calcium channels (L-type: Cav1.2, Cav1.3; T-type: 
Cav3.1, Cav3.2, Inositol-1,4,5-trisphophate receptors (Ins(1,4,5)P3R) and Ryanodine receptor2 
(RyR2)), channel regulator (phospholamban (PLN)) and calcium-sensitive enzyme 
(Ca2+/calmodulin-dependent protein kinase II (CaMKII), protein kinase C alpha (PKCα)) were also 
analyzed (Figure 3.12). I detected significant increase in Cav1.4 and NCX3 mRNA levels in Pyk2-/- 
mice; however the functional implications of these findings in the cardiac system remain to be 
elucidated since neither of these proteins has been reported to be expressed in cardiomyocytes 
(Figure 3.12 boxed). 
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Figure 3.11 SERCA2 mRNA and protein levels in Pyk2-/- mouse heart. SERCA2 mRNA and 
protein levels are reduced in left ventricles of Pyk2-/- mice. (A) Microarray data using RNA samples 
isolated from left ventricles show down-regulation of SERCA2 expression in Pyk2-/- versus wild-
type counterparts; (B) Western blot shows decreased expression of SERCA2 protein (Anti-SERCA2, 
MA3-919, Thermo Scientific, Rockford, IL) in Pyk2-/- versus WT group.  
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Figure 3.12 Gene expression of calcium handling regulators. Gene expression of calcium 
handling regulators NCX1, NCX3, and Cav1.4 is altered in Pyk2-null hearts. Microarray data using 
RNA samples isolated from left ventricles of WT and Pyk2-/- hearts show relative mRNA expression 
levels for calcium handling proteins including voltage-gated and other calcium channels (L-type: 
Cav1.2, Cav1.3; T-type: Cav3.1, Cav3.2, Ins(1,4,5)P3R, RyR2 and NCX1), channel regulator PLN, 
and calcium-sensitive enzymes (CaMKII, PKCα). NCX1 mRNA level is significantly higher in 
ventricles of Pyk2-/- hearts relative to WT hearts. Cav1.4 and NCX3 mRNA levels (boxed) are also 
significantly altered in Pyk2-/- hearts compared with WT counterparts.  
 
 
3.4.6 Pyk2-/- Hearts Display Increased Sensitivity to Ventricular Arrhythmia 
after Transverse Aortic Constriction  
I then hypothesized that pressure overload could further exacerbate disease phenotype in 
Pyk2-/- mice. I performed a study using transverse aortic constriction model of hypertrophy. 
Contrary to our hypothesis, both Pyk2-/- and WT mice showed similar phenotype. However, a 
higher vulnerability to arrhythmia in Pyk2-/- in comparison with WT mice was retained (Figure 3.13). 
 
 
Figure 3.13 APD analysis of TAC mice. APD80 was statistically analyzed. Significant drease of 
APD was observed at high concentration ACh application, as being accord to mice without TAC 
surgry. 
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3.5 Discussion 
This study presents evidence of expression of Pyk2 in the human heart and its significant 
activation in end-stage heart failure due to non-ischemic cardiomyopathy, but not in ischemic 
cardiomyopathy.  
Pyk2 function has been investigated in a variety of cell types (reviewed in[79, 84]), including 
neuronal [79, 104] and immune system cells [98], in which Pyk2 has been shown to act as a key 
integrator of multiple signaling pathways and play important roles in cell migration, cytoskeletal 
remodeling, cell proliferation, survival, differentiation, pH regulation and calcium homeostasis. 
Recent studies have begun to focus on Pyk2 function in cardiomyocytes [85] as well as cardiac 
fibroblasts, vascular smooth muscle and vascular endothelial cells.[75, 87-89] In this study I 
investigated the in vitro functions of Pyk2 on whole heart level using mice with germline deletion of 
Pyk2 gene.[98] 
Previous studies have reported that Pyk2 is activated by vagal stimulation through 
acetylcholine receptor [80, 89]. I explored this phenomenon in the whole heart in order to probe its 
possible role in arrhythmogenesis. I found that Pyk2 deficiency leads to two distinct phenotypes 
related to cholinergic system. On the one hand, Pyk2 deficiency leads to a loss of cholinergic 
function in the AV node. On the other hand, Pyk2-/- mice exhibit a significant shortening of 
ventricular APD80 during cholinergic stimulation in a dose-dependent fashion, which results in 
increased vulnerability to pacing induced ventricular arrhythmogenesis. These results suggest that 
Pyk2 plays an important role in patterning vagal control of the heart structures and may play a role 
in protecting ventricular myocardium against tachyarrhythmias in the settings of vagal stimulation.  
The mechanisms of arrhythmogenesis in the Pyk2-/- mice are related to ACh-sensitive APD 
shortening and not due to conduction abnormalities. I did not explore the mechanisms of APD 
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shortening in this study, but it is likely due to a gain of function of potassium channels or a loss of 
function of calcium currents. Previous studies showed that Pyk2 is involved in the calcium-induced 
regulation of ion channels including potassium channels and calcium channels. For example, Pyk2 
was shown to regulate the delayed rectifier-type potassium channel (Kv1.2) [80], calcium-activated 
potassium channels (BKCa) [105] and voltage-gated calcium channels that mediate their response by 
and are sensitive to intracellular calcium concentration [80, 92]. These ion channels may contribute 
to the observed shortening of APD in the Pyk2-/- mouse ventricles.  
In addition to acute functional consequences induced by deficiency of Pyk2 in the mouse 
heart, I also found a chronic remodeling of calcium handling proteins using gene expression 
profiling. I found that SERCA2 mRNA level is decreased in Pyk2-/- ventricles compared with WT 
ventricles. In contrast to our findings, Pyk2 overexpression has been reported to downregulate 
SERCA2 mRNA level in neonatal rat ventricular myocytes [92]. Interestingly, overexpression of 
catalytically inactive (kinase-dead) and phosphorylation-site mutant forms of Pyk2, which are known 
to exert dominant-inhibitory effect on the endogenous Pyk2 signaling, has also resulted in reduction 
in SERCA2 mRNA levels.[92] It should be noted that the study by Heidkamp et al.[92] utilized a 
“gain-of-function” approach to overexpress various forms of Pyk2 via adenoviral gene transfer in 
cultured neonatal rat cells, whereas our study uses a knockout mouse model approach. The differing 
results between our study and that by Heidkamp et al. may therefore reflect the differences in the 
experimental approaches and/or the experimental systems employed in each study. Remodeling of 
NCX1 related with Pyk2 has not been reported. Microarray results indicate that Pyk2 signaling 
regulates calcium handling on transcriptional level. Additional studies are needed to elucidate the 
mechanisms underlying the Pyk2-dependent regulation of SECRA2 and NCX1 gene expression. 
Previous cardiac studies of Pyk2 were mainly focused on ventricular cells; therefore its role 
in the SAN, atria or AVN has not been explored. In this study, I measured heart rate and AV-delay 
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to estimate the effect of Pyk2 on SAN and AVN. I found that Pyk2 deficiency does not alter 
autonomic regulation of heart rate and atrial APD. However, autonomic regulation of AV 
conduction is significantly altered.  Unexpectedly, AVN lost sensitivity to cholinergic stimulation in 
Pyk2-/- mice. This data indicates that Pyk2 may participate in patterning of cholinergic control of the 
mammalian heart.  
Pyk2 expression in cardiomyocytes was first reported by Bayer et.al in 2001,[85] but it has 
not been reported in the human hearts until this report. I show for the first time a robust expression 
of Pyk2 in human ventricles with a constant level of expression across disease states including end 
stage heart failure of ischemic and non-ischemic etiologies. Furthermore, I also found that Pyk2 is 
significantly activated in non-ischemic but not in ischemic cardiomyopathy. Overall, our findings 
suggest that Pyk2 activation could be involved in cardiac protection against arrhythmia in non-
ischemic cardiomyopathy. Pyk2 has been shown to be expressed at much higher levels in cultured 
neonatal compared to adult cardiomyocytes.[85]  Therefore, a possibility needs to be considered that 
at least some of the electrophysiological effects observed in the Pyk2-/- mice might be potentially due 
to Pyk2 ablation in non-cardiac cell types (i.e. neuronal, vascular endothelial, immune cells, all of 
which normally express abundant levels of Pyk2). Additional studies, using conditional tissue-
specific Pyk2 gene targeting, are needed to elucidate the mechanisms underlying this important issue. 
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Chapter 4  
Regional Calcium Mishandling in Aged mdx 
Mouse during Ventricular Stretch Conditions  
 
4.1 Abstract 
Cytoskeletal signaling allows cell deformation and mechanical stress to adapt form to 
function mediated by cytoskeletal proteins. Duchenne Muscular Dystrophy (DMD) is a clinical 
syndrome due to recessive dystrophin which an important protein bridges extracellular matrix and 
actins. Cardiac dysfunction is a primary cause of patient mortality in DMD, potentially related to 
deleterious effects of elevated cytosolic calcium. However, the regional versus global functional 
consequences of cellular calcium mishandling have not been defined in the whole heart. Here, we 
sought to elucidate potential regional dependencies between calcium mishandling and myocardial 
fiber/sheet function as a manifestation of dystrophin-deficient cardiomyopathy. Isolated-perfused 
hearts from 16 month-old mdx and wildtype were experimentally used to detect myocardial sheet 
architecture by MRI and optically mapped to evaluate Ca handling. Compared to WT, mdx hearts 
exhibited normal systolic sheet architecture but a lower diastolic sheet angle magnitude (|β|) in the 
basal region. The regional diastolic sheet dysfunction was normalized by reducing perfusate calcium 
concentrations. Optical mapping of calcium transients in isolated hearts suggested deficiency of 
distrophin is not enough to induce Ca handling at baseline, thus a mechanical stretch stimulation 
setup was designed. Result of optical mapping on mdx hearts with this setup revealed a stretch–
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inducible regional defect of intracellular calcium reuptake, reflected by a 25% increase of decay times 
(T50) and decay constants, at the base of mdx hearts.  The basal region of mdx hearts also exhibited 
greater fibrosis than did the apex, which matched the regional sheet dysfunction. We conclude that 
myocardial diastolic sheet dysfunction is observed initially in basal segments along with calcium 
mishandling, ultimately culminating in increased fibrosis. The preservation of relatively normal 
calcium reuptake and diastolic/systolic sheet mechanics throughout the rest of the heart, together 
with the rapid reversibility of functional defects by reducing cytosolic calcium, points to the 
significance of regional mechanical factors in the progression of the disease. 
Part of the contents of this chapter were published in Am J Physiol Heart Circ Physiol[106] 
and reprinted with the permission of the publisher. 
 
4.2 Introduction 
Cardiac myocytes possess a complex cellular architecture, which is maintained by a protein 
framework called the cytoskeleton. Cytoskeletons perform structural functions in the cell, such as 
organizing functionally related proteins and facilitating mechanical interactions with adjacent cells 
and the extracellular matrix (ECM). In addition, cytoskeletal structures also regulate proliferation 
through pathways activated by cytoskeletal signaling. Cytoskeletal signaling allows cell deformation 
and mechanical stress to adapt form to function by modifying the size, shape and even molecular 
composition of the heart. This role is especially important in HF where cytoskeletal signaling 
contributes to various responses leading to functional remodeling in myocytes. Mechanical 
dysfunction remains one of the best predictors of sudden cardiac death in HF. However, the 
relationships between mechanical dysfunction and electrical instability are not fully understood.[107, 
108] 
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The mechanical and signaling functions of the cytoskeleton stem fromthe interactions of 
dozens of proteins. One of these proteins, dystrophin, anchors the actin microfilaments to 
dystroglycan, which spans the plasma membrane to bind such ECM proteins such as fibronectin and 
laminin. Within the cytosol, dystrophin and dystroglycan form a signaling complex with dystrobrevin 
and syntrophins to participate in cytoskeletal singaling (Figure 4.1). Mutations in dystrophin can 
cause dilated cardimyopathies by destabilizing cell-matrix linkages and increase chances of HF. 
Duchenne muscular dystrophy (DMD) is a typical disease of such underlying pathology. 
 
 
Figure 4.1 Structure diagram of Dystrohin. From McGavin group.[109] Dystrophin formed 
complex bridges sarcolemma and actin.  
 
DMD is a fatal X-linked genetic disease that affects 1 in 3500 of newborn boys who 
manifest unremitting deterioration of all muscle groups over time. Cardiac dysfunction accounts for 
10~20% of all mortality in DMD, making it the second leading cause of patient death following 
respiratory failure [110]. Advances in respiratory support and patient care allow many patients to 
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survive into their late 20s and 30s.[110-118] Accordingly, cardiac complications now are 
commanding closer scrutiny in the management of advanced disease in DMD patients.[117, 118] 
The clinical DMD phenotype reflects the absence of normal dystrophin due to mutation of 
the dystrophin-encoding gene on the X-chromosome. Dystrophin is a key component of the 
transmembrane dystrophin-associated glycoprotein complex (DGC) that bridges intracellular actin 
and the ECM to facilitate mechanical coupling and signal transduction, and to stabilize the 
sarcolemma membrane.[119, 120] Previous studies using MR tagging uncovered, abnormal wall 
strains occurring regionally at the base of heart in DMD patients. A subsequent report by Li et al has 
also suggested that cardiac mechanical strain abnormalities are more prominent in the basal 
segments of hearts in mdx mice.[121] These observed regional dependencies for DMD cardiac 
mechanical dysfunction remain to be explained as the mutation is present homogeneously in all 
cardiomyocytes.[122-126] 
With respect to pathophysiological features of dystrophin deficiency potentially responsible 
for mechanical dysfunction, several recent studies using isolated cardiomyocytes from mdx mouse 
have suggested that [Ca2+]i mishandling is a key causative factor.[127-129] How calcium mishandling 
influences cardiac mechanical dysfunction in whole heart preparations has not been clarified, 
especially when considering cellular and mechanical events that are spatio-temporally distributed 
(e.g., excitation-contraction coupling) and regionally heterogeneous (stress and strain).[130, 131] 
Given the known abnormal and regionally heterogeneous wall strains in DMD hearts[132], the 
present work will evaluatethe hypothesis that the functional consequences of dystrophin deficiency 
are played out regionally in DMD hearts over time, despite there being genetic abnormality in all 
cardiomyocytes. 
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Accordingly, I sought to elucidate such regional mechanical consequences of the disease on 
local myocardial fiber-sheet function using diffusion tensor MRI, in concert with whole heart optical 
calcium mapping.  Complete global 3D information set acquired from isolated, perfused, and 
beating mdx hearts should allow the delineation of cycle dependence (diastole vs. systole) of 
principle cardiac defects in dystrophin-deficiency and potentially shed light on whether these defects 
might be reversible (i.e. functional) consequences of calcium mishandling or be nonreversible 
consequences of fibrosis (i.e., remodeling).  
 
4.3 Part I. MRI Reveals Focal Diastolic Sheet Dysfunction in mdx 
Mouse Heart 
MRI experiment was conducted were performed by Ya-jian Cheng as a collaboration with 
Dr. Samuel Wickline’s group.  
 
4.3.1 Material and Methods 
4.3.1.1 Animals 
Adult male mdx (C57BL/10ScSn-Dmdmdx/J, N=14) and age matched male wild type (WT: 
C57BL/10SnJ, N=10 and C57BL/6, N=3) mice were purchased from Jackson Laboratory (Bar 
Harbor, ME, USA) and the National Institute on Aging (NIA, MD, USA)[133] and housed under a 
AAALAC-approved facility to 16-month of age. All mice were housed in the same animal facility 
and cared for under approval by Washington University’s animal study committee.  
 
4.3.1.2 Isolated Heart Preparation for diffusion tensor MRI 
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Ten mdx mice and ten WT mice (C57BL/10SnJ) were used for diffusion tensor MRI (DTI) 
measurement. Mice were heparinized (1000 U/kg) and anesthetized with 0.05 isoflurane. Hearts 
were excised and cannulated for retrograde perfusion using a procedure modified from Chen et 
al.[134] Briefly, hearts were first perfused with Krebs buffer at 60 mmHg constant pressure for 
approximately 5 min to wash out the residue blood. Five mdx hearts and five WT hearts were 
perfusion-arrested in diastole (perfusion pressure = 60 mmHg) with the regular St. Thomas’ 
cardioplegic solution containing normal [Ca2+] of 1.2 mmol/L (denoted as mdx-NC and WT-NC, 
respectively) under room temperature.  DTI of diastolic arrested hearts were performed for 1.5 
hours. After that, hearts were reperfused with 37 C Krebs buffer to resume beating. Upon 
stabilization of cardiac work (~6 min, up to 300 beats per min), 2.5 mmol/L BaCl2 was introduced 
to induce cardiac contracture.[134-136] All solutions were equilibrated with 95% O2 plus 5% CO2 
(PH 7.4) and contained adenosine (45µmol/L) to maximally dilate the coronary vessels.[137] Bovine 
serum albumin (BSA; 61 µmol/L) was added to the perfusate to minimize interstitial edema. [138, 
139] DTI of systolic hearts were imaged for ~1.5 hours. Upon the completion of MRI, all hearts 
were perfused with 10% formalin to fix in diastole or systole for histological study.  
To evaluate the effect of [Ca2+] on the cardiomyocyte architecture in dystrophin-deficient 
mice, another five mdx hearts and five WT hearts were perfusion-arrested in diastole with the a 
modified cardioplegic solution containing low [Ca2+] of 0.078 mmol/L (denoted as mdx-LC and WT-
LC, respectively). The 0.078 mmol/L [Ca2+] was chosen over the calcium-free condition to minimize 
the risk of complete depletion of intracellular calcium, which can cause calcium overload upon 
reperfusion with solutions containing normal [Ca2+], thereby exerting unfavorable effects on certain 
ion channels. [135, 140]  
A dedicated MRI-compatible retrograde mouse heart perfusion system was used to acquire 
high signal to noise (SNR) diffusion tensor MR images. This system provides a quantitative and 
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non-destructive assessment of diastolic and systolic myocardial architecture from the same heart. 
The system includes: (1) a custom-built 15 mm-diameter solenoid coil, which provides high SNR: 65 
for non-diffusion weighted images; and 40 for diffusion weighted images; (2) a Langendorff 
constant-pressure perfusion apparatus that allows arrest of a viable heart sequentially in diastole and 
then in systole.  
 
4.3.1.3 DTI 
All MRI experiments were performed on a Varian 11.7-T small animal MR scanner (Varian 
Associates; Palo Alto, CA) and a custom-built 15mm-diameter solenoid coil was used to acquire 
images. Long-axis scout images were acquired as previously described.[134] A multislice spin-echo 
sequence with diffusion-sensitizing bipolar gradient were used to acquire short-axis, diffusion 
weighted images. Diffusion-sensitizing gradients were applied in six noncolinear directions. Imaging 
parameters are as follows: echo time, 46 ms; time interval between diffusion-sensitizing gradients, 30 
ms; b-value, 0 and 800 s/mm2; in-plane resolution, 125 × 125 µm2, repetition time, 3 s; and image-
acquisition time, 1 h. For diastolic arrested hearts, eight contiguous slices (thickness = 0.7 mm) 
extending from the base to apex were acquired. For systolic arrested hearts, eight contiguous slices 
were acquired with slice thickness adjusted to 0.55–0.65 mm based on the fraction of longitudinal 
shortening after barium induced contracture. Attention was paid to keep the slice selection and the 
heart orientation the same between diastole and systole imaging.  
All MR images were processed using custom-developed software written in Matlab (The 
MathWorks Inc., M.A. USA.) as described previously [134]. Fiber helix angle (α) and sheet angle (β) 
are calculated from the tensor according to literature [134]. Briefly, the fiber helix angle (α) was 
calculated as the angle between the circumferential cardiac axis and the projection of the first 
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eigenvector of the diffusion tensor onto the circumferential-longitudinal plane; the right-handed 
helix was set as positive [141]. Sheet angle (β) was determined as the angle between the secondary 
eigenvector and the radial axis; the sheet inclined toward the base from endocardium to epicardium 
was set as positive (Figure 4.2) [141, 142]. Because regional wall thickening is accompanied by a 
reduced magnitude of the sheet angle (|β|) despite the sign of sheet angle [134, 143], the |β| was 
used to analyze regional diastolic and systolic sheet function. LV wall thickness was calculated as the 
mean distance between epicardial and endocardial borders. The through-wall difference of α, 
defined as the difference in endocardial and epicardial helix angles, i.e., ∆α = αendocardium-αepicardium, was 
used to quantify transmural changes of fiber orientation. 
 
 
Figure 4.2 Representative DTI and histology images of sheet architecture in WT mouse 
hearts. A, A local cylindrical coordinate system was used to determine LV myocardial structures. 
The primary eigenvector of the diffusion tensor is characterized by helix angle (α), which is the 
angle between the circumferential axis and the projection of the first eigenvector onto the 
circumferential-longitudinal plane; the α shown in A is set as negative. The secondary eigenvector is 
characterized by sheet angle (β), which is the angle between the secondary eigenvector and the radial 
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axis; the β shown in A, toward base and toward endocardium, is set as negative. B & C, short-axis 
views of DTI determined sheet angle (β) in a basal slice of WT heart that was sequentially arrested in 
diastole (B) and systole (C). The posterior-lateral wall of LV manifested two populations of β, 
exhibiting positive (red) and negative (blue) values. D, Histology of sheet organization in a WT heart. 
Images were acquired from the basal-lateral wall, which is highlighted on the H&E stained image 
(insert). Two populations of β were observed.  
 
 
4.3.2 Results 
4.3.2.1 mdx Hearts Manifest Abnormal Regional Diastolic Sheet Function 
DTI defined two populations of b with opposite signs in the LV wall of WT and mdx mice, 
as confirmed by several previous reports [134, 142, 144-147]. The |β| value is decreased in systole 
(Figure 4.2 B&C, Figure 4.3 A&B), reflecting the reorinetation of myocardial sheets, which 
contributes ~50% of systolic focal wall thickening [134, 143, 145, 148]. Under conditions of barium-
induced systolic arrest, at each short-axis location, the systolic |β| was comparable among all 
groups of hearts (p = N.S.).  However, the diastolic |β| of mdx hearts (mdx-NC) was ~10° lower 
than that of WT hearts (WT-NC) at the base when perfused with regular cardioplegic solution (p < 
0.05, Figure 2). The |β| at the apex of mdx-NC hearts appeared normal (p = N.S. compared to 
WT-NC at each corresponding short axis imaging slice), demonstrating that sheet diastolic 
dysfunction in mdx hearts occurred focally at the base. By reducing the [Ca2+] of the cardioplegic 
solution to 7% of its regular concentration, a complete and rapid restoration of diastolic |b| in mdx 
hearts (mdx-LC) to normal values was observed. No effect of calcium manipulation on WT cardiac 
sheet function was observed (WT-LC, p = N.S. compared to WT-NC at each corresponding short 
axis imaging slice), indicating that the diastolic sheet dysfunction in mdx hearts was substantially 
calcium dependent. These data suggest that even at this advanced age, a principle mechanical 
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abnormality in mdx mice likely is associated with incomplete sarcomere relaxation that is regionally 
dependent.  
At the base, further regional analysis indicated that the maximal decrease of diastolic |β| in 
mdx-NC hearts occurred in the endocardium and in the posterior-lateral wall. Compared to WT-
NC, mdx-NC exhibited 13° lower |β| (75°± 2°vs. 62°± 3°) in the endocardium (inner 1/3 wall-
depth in transmural direction); 10°lower |β| (74°± 1°vs. 64°± 2°) in the midcardium (middle 1/3 
wall-depth in transmural direction); and 8° lower |β| (68°± 2°vs. 60°± 2°°) in the epicardium 
(outter 1/3 wall-depth in transmural direction) (Figure 2C). In the posterior-lateral wall, the diastolic 
|β| was 51°± 6° in mdx-NC (Figure 2F). This value was approximately 20° lower than that of mdx-
LC (70°± 4°), as well as that of WT-NC (72° ± 4°) or WT-LC (72°± 6°) groups (p < 0.05 for all 
comparisons). Together these findings indicate a clear regional and transmural dependence of 
incomplete relaxation, despite the ubiquitous dystrophin mutation. 
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Figure 4.3 DTI-determined diastolic and systolic |β| in short-axis slices. A, mdx hearts 
exhibited abnormally lower diastolic |β| that was recovered to normal value after reducing [Ca2+] 
in the perfusate.   For hearts perfusion-arrested in diastole with normal calcium solution, mdx hearts 
(mdx-NC) exhibited lower |β| than did WT (WT-NC) hearts with the maximal ~10° difference 
occurred at the basal region. In contrast, mdx hearts perfused with the low calcium solution (mdx-
LC) exhibited normal diastolic |β|. Varying [Ca2+] had no effect on diastolic |β| in WT hearts 
(WT-LC). B, systolic |β| exhibited no difference among four groups of hearts. C, diastolic |β| in 
the epicardium, midcardium, and endocardium at the base of WT and mdx hearts.  In all regions, 
diastolic |β| of mdx-LC hearts were comparable to that of WT-LC and WT-NC hearts, but all are 
higher than that of mdx-NC hearts. The largest difference in diastolic |β| between mdx-LC and 
mdx-NC was observed in the endocardium. D & E, representative DTI-determined diastolic |β| 
maps on short-axis slices at the base of mdx-NC and mdx-LC hearts. The lower |β| in mdx-NC 
heart, indicated by fewer regions with red color, was visually appreciable. F, in the posterior-lateral 
region (the areas enclosed by dashed line in D & E), the diastolic |β| of mdx-NC hearts was 
approximated 20° lower than that of mdx-LC hearts and of all WT hearts. Data represent mean ± 
SEM. N = 5 for each group. *, p < 0.05; †, p <0.005 for the indicated short axis location. 
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4.4 Part II Mechanical Stretch Induced Regional Ca Mishandling 
underlies Sheet Dysfunction 
Dysfunction of sheet angle indicates dysregulation of cardiac contractions, which is mainly 
mediated by Ca signaling. To explore the mechanism underlying the dysfunction of sheet angle, I 
conducted optical mapping of intact mdx mouse hearts. Experiments were designed to: 1) evaluate 
the relationship between Ca dysfunction and mechanical stretch (relation experiment) and 2) 
investigate several parameters of Ca release and Ca reuptake to evaluate Ca dysfunction from 
mechanical stretch (dysfunction experiment). 
 
4.4.1 Material and Methods 
4.4.1.1 Animal 
Animal information is the essentially the same as described in section 4.3 except with the 
addition of young WT and mdx mice in the experiment. Two aged WT and 3 aged mdx mice are used 
in baseline experiments. 
Four groups of mice are used in the relation experiment: aged WT (n=5); aged mdx mice 
(n=5); young WT (n=5); young mdx mice (n=5). Another 4 aged WT and 4 aged mdx mice are used 
in the dysfunction experiment.  
 
4.4.1.2 Isolated Heart Preparation and Ca Dye Loading            
Langendorff-perfused hearts from 16 months and 12 weeks old mice were separated into 
four groups (aged WT, n=5; aged mdx, n=5; young WT, n=5; young mdx, n=5 and aged WT, n=4 
and aged mdx, n=4 for relation and dysfunction experiment respectively). The isolated heart was 
   88 
prepared according to a Langendorff perfusion protocol modified for murine hearts [74]. Briefly, 
after anesthesia and heart excision, a short section of aorta was attached to a 21-gauge cannula. After 
cannulation, hearts were superfused and retrogradely perfused with oxygenated (95% O2, 5% CO2) 
and  modified Tyrode solution (in mmol/L: NaCl 128.2, KCl 4.7, NaH2PO4 1.19, MgCl2 1.05, CaCl2 
1.3, NaHCO3 20.0, and glucose 11.1 (pH=7.3)) that was passed through a 5 µm filter (Millipore, 
Billerica, USA) and held at a constant-temperature (37±1oC). Perfusion was performed using a 
peristaltic pump (Peri-Star, WPI, Sarasota, USA) under a constant aortic pressure of 60 - 80 mm Hg. 
The isolated heart was pinned at the edge of ventricular apex to a Sylgard base in order to 
prevent stream-induced movement. A small silicon tube was inserted into the left ventricle through 
the pulmonary vein, left atria, and tricuspid valve to prevent solution congestion and subsequent 
ischemia. A small black tape was used to cover the atria to prevent fluorescence scattering from the 
atria (Figure 4.4). Excitation-contraction uncoupler blebbistatin (10 µM, Tocris Bioscience, USA) 
was used to prevent the effect of motion artifact when estimating action potential duration. The 
heart was then stained with a calcium indicator (Rhod-2 AM, Invitrogen, Carlsbad, CA, 30µL of 1 
mg/mL dimethyl sulfoxide, 1:1 mixed with Fluronic F127, Invitrogen, Carlsbad, CA in Tyrode’s 
solution), for 5-7 minutes. 
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Figure 4.4 Intact mouse heart preparation. Small black tape covered the atria to prevent 
fluorescence scattering from the atria thus making it is possible to accurately analyze the regional 
difference of CaT over the ventricle. 
 
4.4.1.3 Optical Imaging System 
The excitation light was generated by a halogen lamp (Newport Oriel Instruments, Stratford, 
CT; SciMedia, Costa Mesa, CA) and passed through a heat filter, shutter, and excitation band-pass 
filter (520 ± 45 nm). A flexible light guide directs the band-pass filtered light onto the heart 
preparation. The optical mapping apparatus comprised an MiCAM Ultima-L CMOS camera 
(SciMedia, Costa Mesa, CA) with high spatial (100x100 pixels, 230±20 μm per pixel) and temporal 
(1,000-3,000 frames/sec) resolution. A band-pass filter (590±15 nm, Thorlabs, Newton, NJ) was 
fixed in front of the calcium-imaging camera.  
 
4.4.1.4 Mechanical Stretch Setup 
 A mechanical stretch setup was designed to apply appropriate mechanical stimulation on the 
heart while normal contraction is suppressed during optical mapping experiments. Mechanical 
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stretch is induced by manipulation of the inner pressure within left ventricle. As depicted in Figure 
4.4, the silicon tube inserted into the left ventricle was used to pump temperature-controlled and 
oxygenated Tyrode’s solution. Left ventricular inner pressure can be quantified and controlled while 
inflating Tyrode’s solution is placed at different height. Real-time monitoring of pressure is 
conducted by a pressure transducer held at the same level of the heart. For accuracy, the transducer 
was hooked up at the tip of silicon tube emerging out of the heart.   
 
Figure 4.5 Mechanical stretch setup design layout. Left ventricle is filled with Tyrode’s solution, 
and its inner pressure can be manipulated by gravitational effects when solution is place at different 
heights. 
 
 
4.4.1.5 Optical Mapping Protocols 
After isolation and cannulation, motion suppression, and dye staining, prepared hearts were 
equilibrated for 5-10 min before imaging. Optical mapping signals were recorded sequentially under 
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unloaded and stretched conditions. The unloaded condition was achieved by a pressure releasing 
silicon tube inserted into the LV chamber of the Langendorff heart preparation. The stretched 
condition was achieved by inflating the LV chamber with the mechanical stretch setup. Mapping of 
CaT was conducted at different loading conditions including baseline (0 mmhg pressure), 40, 60, 80, 
100 and 120-mmhg pressure. Design of pressure point is based on pressure-volume loop of rodent 
models (Figure 4.5). Physiological ventricular inner pressure ranged from 10 to 100 mmhg. An un-
physiological condition at 120 mmhg is chosen to evaluate the response of both WT and mdx mice 
heart under mechanical damage. Baseline recording was conducted to test the reversibility of such 
damage. The aortic perfusion pressure was increased from 60 to 100 mmHg to maintain the 
direction of the retrograde perfusion and the viability of the perfused heart. 200 ms and 100 ms 
pacing were conducted at each stretch condition. In the following experiment when 80 mmhg was 
chosen to detect the detailed regional dysfunction of Ca handing in aged mdx mice, a steady-state 
restitution (S1-S1)[74] pacing protocol was applied under both conditions. Briefly, hearts were paced 
with a basic cycle length from 200 to 100 ms in steps of 20ms and from 100 to 40 ms in steps of 10 
ms until 1:1 capture failed or ventricular tachyarrhythmia, including ventricular fibrillation, occurred.  
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Figure 4.6 Pressure-Volume loop of rodent animals. From Nielsen et al.[149] 
 
4.4.1.6 Optical Mapping Data Processing 
A custom-designed Matlab program was used to analyze optical mapping signals. The signals 
were filtered with a low-pass Butterworth filter at 256 Hz. Regional calcium dynamics were 
quantified in WT and mdx mouse ventricles (base vs. apex) under both unloaded and stretched 
conditions. Hand-drawn regions of interest were used to define basal (upper 1/3 area of left 
ventricle) vs. apical regions (lower 1/3 area of left ventricle). Ca relaxation time from the calcium 
transient peak value to 50% relaxation (T50) was calculated and used to define the calcium reuptake 
phase.  Ca decay constant was calculated using an exponential curve fitting program measuring from 
50% calcium peak value to full relaxation. Taken together, the T50 (for the early relaxation phase) 
and the decay constant (for the late relaxation phase) represent the process of Ca reuptake-
dependent relaxation.  
 
4.4.1.7 Statistics 
Statistical differences were assessed with the use of analysis of variance (ANOVA) or 
multivariate analysis of variance (MANOVA) as appropriate. Bonferroni correction was applied to 
post-hoc comparisons. A value of p < 0.05 was considered significant. Data were expressed as mean 
± standard error of the mean (SEM). All statistics were analyzed using the IBM SPSS Statistics 
program.  
 
 
4.4.2 Results 
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4.4.2.1 No dysfunction of Ca handling in mdx mouse heart at baseline 
(unloaded) condition 
CaT was optically mapped in aged mdx and WT mice hearts without mechanical stimulation. 
Isolated mouse heart was retrograde perfused by the Langendorff system as described. Under this 
condition, inner ventricular pressure was maintained at 0 throughout the whole experiment as 
perfusion solution does not defuse in and flow through heart chambers in Langendorff perfused 
hearts. CaD at different levels of Ca relaxation (30%, 50% and 80%) evaluates the morphology of 
CaT and represents Ca handling proteins’ function at various phases of CaT. Results showed that no 
dramatic morphological change was observed in mdx mouse heart compared to WT group, 
indicating Ca handling was not significantly dysregulated under this condition. Quantification of this 
data is shown in Figure 4.6. 
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Figure 4.7 CaD at different levels of relaxation suggests no morphological change. CaD at 
different level of Ca relaxation (30%, 50% and 80%) was calculated to evaluate the morphology of 
CaT in both mdx and WT mouse heart. 
 
4.4.2.2 Mechanical Stretch Stimulation Prolonged Ca Rise Time and CaD in 
Aged mdx Mouse Heart Following Pressure Dependent Pattern 
When the left ventricle was loaded with Tyrode’s solution, ventricular myocytes were 
stretched to different levels according to the inner ventricular pressure. CaD and Ca rise time were 
calculated under different loading conditions to evaluate the dysfunction of Ca handling. The sheet 
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angle experiment aimed to reveal whether Ca handling changes based on the region. CaT signals 
from the ventricular base, mid and apex were averaged and analyzed respectively. CaD values of all 
three regions from WT mouse hearts did not display a significant difference until the pressure 
increased to non-physiological pressures. In WT hearts, when the ventricular inner pressure 
increased to 120 mmhg, CaDs of the base and mid are dramatically prolonged while CaD of the 
apex is maintained at similar level as other conditions. This remodeling is reversible as CaD values 
returned to baseline level after pressure was released (Figure 4.7).  
 
 
 
Figure 4.8 CaD-pressure relation curves of aged WT mice. CaD values of the base mid and 
apex were plotted as the function of pressures. CaD of base and mid maintained similar level until 
ventricle was stretched to a nonphysiological condition. At 120-mmhg condition, CaD of base and 
mid regions were significantly prolonged but recovered after the pressure was released. CaD of the 
apex remains unchanged for all conditions. 
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In the aged mdx group, prolongation of CaD of base and mid appeared at physiological 
pressures, even at very low pressure like 40 mmhg. Ca dysfunction evaluated by CaD prolongation 
aggravated as the pressure increased. This aggravation plateaud around 80 mmhg. In completely 
reversal of what was seen in WT mice, CaD of the base from added mdx mice did not return to 
baseline level after pressure was released (Figure 4.17). Similar to WT, CaD of apex remained 
unchanged under all conditions.   
 
 
 
Figure 4.9 CaD-pressure relation curves of aged mdx mice. CaD of base and mid prolonged 
since 40 mmhg inner ventricular pressure. The prolongation aggravated as pressure increased. 
Prolongation of CaD of base did not recovery after pressure released. CaD of apex maintained 
unchanged under all conditions.    
 
 
CaD from young WT and young mdx mice were also calculated. CaD value of all regions 
remained unchanged for all stretch conditions in both groups of mice (Figure 4.9 and 4.10). 
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Figure 4.10 CaD-pressure relation curve of young WT mice. CaD maintained no change under 
all conditions in young WT mice. 
 
 
 
 
Figure 4.11 CaD-pressure relation curve of young mdx mice. CaD maintained no change under 
all conditions in young mdx mice. 
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CaT rise time is calculated as the time period from 10% peak value of upstroke to 90% peak 
value of upstroke. This parameter signifies the Ca release process. Similar to what was seen in CaD, 
rise time of base and mid in aged mdx mice prolonged as inner ventricular pressure increases. This 
prolongation has a logarithmic curve shape where at lower pressures, the slope is steeper, and after 
80 mmhg, the slope decreased. However, the apex of aged mice also displayed slightly prolonged rise 
time as pressure increased, but not as much when compared to base and mid (Figure 4.11).  
 
 
Figure 4.12 Ca rise time-pressure relation curve of aged mdx mice.  
  
Ca rise time in aged WT mice was not remodeled (Figure 4.12). In young group, both mdx 
and WT showed no change, which is similar to the CaD result (Figure 4.13). 
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Figure 4.13 Ca rise time-pressure relation curve of aged WT mice. 
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Figure 4.14 Ca rise time-pressure relation curve of young WT mice. 
 
 
 
Figure 4.15 Ca rise time-pressure relation curve of young mdx mice. 
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4.4.2.3 Regional Dysfunction of Ca Handling in Aged mdx Mouse Associated 
with Arrhythmogenesis 
Experiments investigating Ca handling dysfunction-pressure relation showed that a stretch 
stimulation could induce Ca handling dysfunction but only in aged mdx mice. The dysfunction does 
not correspond linearly to inner ventricular pressure. Dysfunction, as evaluated by CaD and rise 
time prolongation, does not dramatically worsen after 80 mmhg. Thus, detailed Ca dysfunction was 
evaluated below 80 mmhg. 
Dramatic change in CaT morphology was observed in aged mdx mouse ventricular base only 
(Figure 4.15 A). Prolongation of both Ca release and Ca extrusion were observed. Rise time as 
described in the previous experiment was calculated to evaluate Ca release. Ca extrusion, which in 
mouse heart as opposed to human, is mainly the process of Ca reuptake back into SR. The process 
is assessed by two parameters: T50 describes the time course from CaT peak to 50% relaxation 
value; Ca decay constant establishes the late phase of Ca reuptake. The decay constant is calculated 
by exponential curve fitting that the bigger value indicates a shorter process of Ca from 50% of peak 
value return to baseline.  
Similar to the relation experiments, remodeling regarding to Ca release and reuptake phases 
are observed in aged mdx mouse heart ventricular base. Prolongation of rise time, T50 was 
observed. Although the late phase of Ca reuptake is shortened from the increase of Ca decay 
constant, the whole CaD is dramatically increased. Ca dysfunction in aged mdx mouse ventricular 
base is defined as prolonged Ca release, early phase of Ca reuptake but shortened late phase of Ca 
reuptake (Figure 4.15, 4.16 and 4.17).  
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Figure 4.16 CaT signals and rise time under unloaded and stretched conditions. (A) 
Typical CaT signals from aged WT mouse ventricular base and mdx mouse ventricular base. 
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(B) Regional prolongation of Ca rise time in mdx ventricular base is appreciated from Ca rise 
time map. (C) Statistical analysis of Ca rise time. 
 
 
 
 
 
Figure 4.17 CaD80 from mdx and WT ventricles. (A) CaD80 map shows stretch 
stimulation induced prolongation of CaD in aged mdx mouse ventricular base. (B) CaT 
signals from both base and apex in WT and mdx are similar under unloaded condition, while 
after stretch, mdx ventricular base signal morphologically changed. (C) Statistical analysis of 
CaD from base and apex under different conditions. 
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Figure 4.18 T50 and CaT decay constant of mdx and WT mice. (A) and (C) are T50 and CaT 
decay constant map. (B) and (D) are statistical analysis of T50 and decay constant of base and apex 
from two groups of mice. 
 
 
Dysfunction of Ca release and reuptake results in remodeling of CaT functional refractory 
period (FRP). Under stretch conditions, prolonged FRP was observed in mdx mouse heart 
ventricular base, but in apex (Figure 4.18 A). Heterogeneity of Ca dynamics promotes 
arrhythmogenesis as discussed in Chapter 1. Resulting from regional dispersion of FRP, Ca alternans 
appeared in the base and apex at different pacing cycle lengths after stretch stimulation. The 
ventricular base in mdx mice started to show Ca alternans at a low pacing frequency. Figure 4.18 B 
shows CaT began to lose 1:1 capture at 90ms pacing in the base after stretch.   
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Figure 4.19 CaT functional refractory period analysis and regional occurrence of Ca 
alternans. (A) CaT functional refractory period was statistically analyzed. (B) CaT began to lose 1:1 
capture at 90ms pacing in base after stretch. 
  
 
4.5 Discussion 
Mechanical defect is suggested to be a key factor associated with deficiency of dystrophin. 
Together the mechanical damage induced dysfunction of Ca handling, which, in turns, results in 
dysfunction of contraction.  
This study shows for the first time that mdx hearts exhibit an abnormal myocardial sheet 
angle |β| during relaxation that is calcium dependent and rapidly reversible. Furthermore, regional 
gradients of diastolic dysfunction are evident, primarily in the more basal segments where abnormal 
calcium reuptake was been demonstrated. These colocalized abnormalities in calcium reuptake and 
diastolic sheet function strongly suggest that features other than the simple absence of dystrophin 
are critical to the evolution of heart failure in DMD. Indeed, it is well recognized that mechanical 
defect in the dystrophin encoding gene does not independently elicit DMD cardiac functional 
defects such as reduced circumferential wall strain,[132] which emerge in a regionally heterogeneous 
fashion over time, and not at loci where dystrophin is missing. In the baseline condition optical 
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mapping experiments, this hypothesis has been proved as no dysfunction of Ca handling has been 
observed in both aged WT and mdx mouse hearts. 
Abnormality in the basal region could be due to regionally different contraction load during 
a heartbeat. During left ventricular ejection, its cavity changes shape and help propel blood 
superiorly, according to Newton’s third Law, which states that for every action there is an equal and 
opposite reaction, the base of the heart moves inferiorly.[150] This movement, called decent of the 
base that doesn’t occurred at apex. 
Prior recognition of stretch induced calcium mishandling in isolated mdx cardiomyocytes 
informs the present work [151]. Specifically, mechanical stretching increases the probability of 
opening stretch-activated channels (SAC) [151] and developing transient membrane microruptures 
in mdx cardiomyocytes [151]. The resultant leakage of extracellular calcium into the cytosol then 
compromises calcium clearance during relaxation and renders mdx cardiomyocytes vulnerable to 
stretch induced injury [152]. In experiment with intact perfused hearts, I employed a stretch protocol 
to mimic cardiomyocyte activity under moderate strain regimes by inflating LV pressure to 80 
mmHg, which is similar to that used for investigating fibrillation[151]. Under stretched condition, 
mdx hearts exhibit a regional deficiency in calcium release and uptake, as shown by a prolonged Ca 
rise time, T50 and decay time constant at the base where the sheet functional defect was observed. 
Thus, my results indicate a regional correspondence between abnormal diastolic sheet mechanics 
and disturbed calcium kinetics.   
 Prolongation of Ca rise time reflects the dysfunction of Ca release, which is induced by small 
amount of Ca transport through L type Ca channel, but is mainly mediated by SR Ca released 
through RyR. This finding was not in agreement with previous study on isolated myocytes, which 
claims Ca release was observed shortened[151]. Despite differences between cellular and whole heart 
level studies, stretch stimulation which I to be found crucial in evoking Ca mishandling was not 
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applied in their study. RyR forms a chemically gated, non-energy consuming Ca release channel with 
relatively low Ca selectivity.[151] When the channel is in its open state, relatively large monovalent 
cations can be transported. Thus, the force for Ca release through RyR relies mainly on Ca diffusion, 
which is determined by the difference between SR and cytoplasmic Ca concentration. According to 
previous studies, this difference is dramatically decreased in aged mdx ventricular myocytes, as SR 
Ca concentration was observed decreased and cytoplasmic Ca was found increased comparing to 
normal heart.[151] Thus, prolongation of Ca release may be due to the decrease in force behind it.  
The prolonged T50 and decay constant observed in mdx mouse hearts may reflect calcium 
leakage through the destabilized sarcolemma as a direct effect of the lack of infrastructural integrity 
normally provided by the dystrophin-associated glycoprotein complex.  A therapeutic strategy to 
inhibit calcium leakage during the resting state (i.e., unrelated to the operation of voltage-gated L-
type channels for cell excitation), could be effective in restoring cardiac function in myopathic mdx 
heart. Promising results with compounds such as P188 that has been claimed to repair sarcolemma 
microruptures [151], and S107 that stabilizes RyR2 [151], together with the ineffectiveness of L-type 
calcium channel blockers as demonstrated in earlier clinical trials,[153] attests to the potential clinical 
utility of the approach.  
All the Ca mishandling shows regional dispersion and eventually results in the Ca alternans 
occurring ithe n base at a much lower pacing rate compared to the apex. The heterogeneity of Ca 
dynamics facilitates arrhythmogenesis. Moreover, both mechanical defects and Ca mishandling 
contribute to the development of HF. 
   108 
Chapter 5 
Arrhythmogenic Remodeling of β2 versus β1 
Adrenergic Signaling in Human Failing 
Heart 
 
5.1 Abstract  
β-Adrenergic receptor (AR) blockers remain a mainstay of heart failure (HF) therapy. 
However, the efficacy of β blockers in preventing fatal ventricular tachycardia (VT) remains 
controversial. I aimed to investigate the electrophysiological and arrhythmogenic implications of 
differential β1/β2 remodeling in patients with HF. Using programmed stimulation and optical 
mapping of action potentials (AP) and [Ca2+]i transients (CaT) I assessed β1 (Xamoterol) versus β2 
(Procaterol) adrenergic response in human donor (D, n=8) and failing (F, n=8) left ventricular 
wedge preparations. Molecular mechanisms were assessed with quantitative-PCR and Western blot. 
β1-stimulation significantly increased conduction velocity (CV), shortened action potential duration 
(APD) and calcium transient (CaT) duration (CaD) in D but not F hearts, due to desensitization of 
β1-AR in HF. β2-stimulation increased CV both in F and D hearts, while more potently shortening 
APD in F versus D suggesting switched coupling from Gi to Gs in HF. The transmural gradient of 
β2 effect on APD and CaD creates substrate for delayed after depolarization (DAD). Both β1 and β2 
stimuli augmented vulnerability and frequency of ectopic activity and enhanced substrate for 
ventricular tachycardia (VT) in F, but not D hearts. Two mechanisms of ectopy induced by β-
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stimulation were documented: Purkinje fiber (PF) automaticity and Ca-mediated premature 
ventricular contractions (PVCs). In human HF, β1-AR is desensitized, while β2-AR becomes a 
dominant player in electrophysiological regulation and arrhythmogenesis. HF remodeled β-AR 
signaling increases VT/VF vulnerability via Ca-mediated PVCs and enhanced Purkinje fiber 
automaticity. 
 
5.2 Introduction  
Increased sympathetic activity through β adrenergic signaling is common in HF, often leads 
to ventricular remodeling and, consequently, serious impairments of cardiac contractile function. Up 
to 50% of HF mortality is sudden, due to tachyarrhythmias.[9] β1 or non-selective adrenergic 
blockers are widely used and have been proven to reverse ventricular remodeling and reduce 
mortality in HF patients.[154-157] However, the efficiency of β blockers of preventing fatal VT in 
HF patients is controversial.[158-160] Recently, non-selective β-blockers or β2-blockers were 
advocated by several clinical trials and studies.[161-164] The mechanisms of subtype-specific 
adrenergic remodeling and its implications for arrhythmia in humans are not fully understood. 
Although effects of β1/β2 adrenergic system remodeling on contractility have been studied in human 
trabeculae,[165] the role of β1/β2 adrenergic system remodeling in arrhythmogenesis has not been 
thoroughly investigated in human myocardium.  
I hypothesized that differential remodeling of β1 versus β2 adrenergic signaling may have 
important arrhythmogenic effects in end-stage HF. Furthermore, we hypothesized that such 
molecular remodeling manifests anatomically as endocardial-epicardial gradient, contributing to 
arrhythmogenesis and dysfunction of excitation-contraction (EC) coupling. I sought to explore β1 
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versus β2 selective adrenergic effects by examining EC coupling using dual optical mapping of 
AP/CaT in left ventricular (LV) wedge preparations from human F and D hearts. 
 
5.3 Material and Methods  
5.3.1 Clinical Information for Human Hearts 
Usage of human hearts was approved by the Institutional Review Board of Washington 
University. Non-ischemic failing human hearts (F, n=8) were obtained during transplantation at the 
Barnes-Jewish Hospital of Washington University in St. Louis, MO. Donor hearts (D, n=8) that 
were rejected for transplantation for reasons such as age were used as controls. Donor hearts were 
provided by Mid-America Transplant Services (St. Louis, MO). Ejection fraction values were 
obtained from echocardiography, which was conducted at variable times. All donor hearts were 
characterized as hearts without history of heart failure. The clinical data of patients are shown in 
Table 5.1.  
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Table 5.1 Clinical information. Clinical information including gender, age, diagnosis, ejection 
fraction and arrhythmia history of the patients were provided. (NICM: non-ischemic 
cardiomyopathy; AFIB: atrial fibrillation; Aflutter: atrial flutter; VTACH: ventricular tachycardia) 
 
 
Explanted hearts were cardioplegically arrested in the operating room following cross 
clamping of the aorta. Immediately after the heart was received, 100 ml 0°C cardioplegic solution (in 
mmol/L: NaCl 110, CaCl2 1.2, KCl 16, MgCl2 16, NaHCO3 10; pH=7.3±0.05) was perfused through 
right and left coronary arteries respectively to remove the blood and to protect myocardium from 
ischemia. The heart was then bathed in 0°C cardioplegic solution for transportation, dissection and 
cannulation.   
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5.3.2 Left Ventricular Wedge Tissue Preparation 
The arterially perfused left ventricle wedge preparations were made as previously 
described.[166, 167] Briefly, preparations were dissected approximately from the same area of the 
hearts to minimize tissue differences. Before dissection, the quality of perfusion was verified by 
injection of Methylene Blue dye (Sigma, St. Louis, MO). A segment of left ventricular wedge along a 
posterior marginal artery was isolated based on the blue color in areas supplied by the dye solution. 
Each wedge contained a section of coronary artery along its length. The wedge was cannulated with 
a custom flexible plastic cannula. The quality of the perfusion was again tested by the blue dye, and 
poorly perfused surfaces were trimmed. Major arterial leaks in the wedges were ligated with silk 
suture to maintain pressure (Figure 5.1). 
 
Figure 5.1 Representative photos of human heart and left ventricular wedge preparation. 
Tissue was selected along left marginal artery as boxed in green dashed line in the left photo. Field 
of view and definition of different transmural layers are depicted in the right photo.  
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5.3.3 Simultaneous Optical Mapping of AP and CaT  
The isolated tissues were mounted in a warm chamber with the dissection exposed 
transmural surface up, facing the optical apparatus. The preparation was both superfused and 
coronary perfused with oxygenated Tyrode solution (in mmol/L: 128.2 NaCl, 4.7 KCl, 1.19 
NaH2PO4, 1.05 MgCl2, 1.3 CaCl2, 20.0 NaHCO3, and 11.1 glucose, and gassed with 95% O2-5% 
CO2; pH=7.35±0.05). I maintained a solution temperature of 37 °C and an arterial pressure of 60-70 
mmHg. Continuous monitoring of pH and temperature was conducted during the experiment. The 
preparation was fully immersed in the perfusion efflux, which assured proper superfusion.  
After 30 minutes of washout to remove excessive fat and blood residues, gradual warming 
after cold cardioplegia to 37 °C, tissue recovery, and stabilization, Blebbistatin (10 to 20μM; Tocris 
Bioscience, Ellisville, MO) was perfused into the preparation to suppress motion artifacts. After 
tissue was completely stabilized, RH237 and Rhod-2 AM were applied as probes for AP and CaT, 
respectively.  
The dual optical mapping apparatus consisted of two MiCAM Ultima-L CMOS cameras 
(SciMedia, Costa Mesa, CA) that have high spatial (100×100 pixels, with the field of view of 
3cm×3cm) and temporal (1,000 frames/sec) resolution. A band-pass filter (590±15 nm, Thorlabs, 
Newton, NJ) was placed in front of the calcium imaging camera; a long-pass filter (>700 nm, 
Thorlabs, Newton, NJ) was positioned in front of the voltage imaging camera. The cameras were 
arranged perpendicular to one another by a holder, which contained a dichroic mirror (635 nm 
cutoff, Omega Optical, Brattleboro, VT). Immediately below the dual camera holder were a group 
of lenses (100mm and 50 mm focal length, f 0.95; Navitar), which helped to focus the emission light 
coming from the heart onto the CMOS sensors with adjustable field of view. The excitation light 
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was generated by a halogen lamp (Newport Oriel Instruments, Stratford, CT; SciMedia, Costa Mesa, 
CA) and was passed through a heat filter, shutter, and band-pass filter (520±45 nm). A flexible light 
guide directed the band-pass filtered light onto the preparation, and a shutter was used to ensure 
that the preparation was exposed to light only during image acquisition to avoid photobleaching of 
the dyes. 
 
5.3.4 Experimental Protocols  
Specific agonists for β2-ΑΡ and β1-AR procaterol (1µM)[168, 169] and xamoterol (1µM)[170, 
171], respectively, and non-specific β-AR agonist isoproterenol (ISO, 100nM) (Tocris Bioscience, 
Ellisville, MO) were perfused into the preparation. The agonists were applied at saturate 
constrations according to previous cardiac studies [168-171] so that the maximum effective 
activation of the receptors could be achieved. Conclusions are carefully driven based on 
comparisons between D and F hearts under the effects of different β-AR selective agonists, 
respectively. 
Complete washout evaluated by the recovery of action potential duration (APD) was applied 
between Xamoterol and Procaterol. Extra blebbistatin and dye were loaded as needed. Programmed 
electrical stimulation (PES) S1S1 protocol was applied with the pacing electrode placed at 
subendocarium at twice the diastolic pacing threshold. Pacing cycle length (CL) ranged from 4000 to 
400 ms as shown in Figure5.2.  Representative mapping recordings were collected during each 
condition. Real time monophasic action potential (MAP) and pseudo ECG were continuously 
monitored in parallel with and in validation of optical mapping. 1 ml of Lugol’s solution was painted 
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to the endocardium surface after enhanced automaticity was observed, followed by quick 
superfusion of Tyrode solution.[172]  
 
 
Figure 5.2 Detailed experimental protocol. 
 
5.3.5 Data Analysis 
Transmural surface was subdivided into areas of interest: subepicardium (epi), 
midmyocardium (mid) and subendocardium (endo), as defined in Supplementary Figure 1. Mapping 
signal was low-pass filtered at 256 Hz. AP duration (APD) and CaT duration (CaD) were measured 
from time point of upstrokes (dV/dtmax and dCa/dtmax) to 80% repolarization and Ca relaxation. The 
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difference between CaD and APD (CaD-APD) was also calculated.[173] Conduction velocity (CV) 
was measured and plotted as a function of direction with transverse direction defined as zero degree 
(Figure 5.3 A). Action potential-Calcium delay map (AP-CaT Delay map) shows the time difference 
between AP activation and Ca release (dCaT/dtmax - dV/dtmax) with positive value indicating 
activation of AP precedes calcium release (CaT). CaT rise time was quantified to estimate the Ca 
release phase, which was defined as the time interval between 10% and 90% CaT upstroke value. T50 
and Ca decay constant were calculated to evaluate the Ca extrusion fast component and slow 
component respectively. T50 measures the time period from time point of CaT reaching peak value 
to 50% relaxation. Ca decay constant was investigated by fitting CaT signal from 50% to 100% 
relaxation with exponential curve (a*exp(-1/b*x)+c), where b was defined as decay constant.  
 
5.3.6 Western Blot Studies 
Additional tissue samples from human LVs were flash frozen in liquid nitrogen, pulverized, 
and lysed. Proteins were separated by SDS-PAGE, followed by transfer onto nitrocellulose 
membranes. Incubations with primary antibodies (β2-AR antibody, sc-569; p-β2-AR antibody 
(Ser345/Ser346), sc-16718; Santa Cruz Biotechnology, Santa Cruz, CA) were performed overnight at 
4°C and were carried out in 5% BSA. Incubations with secondary antibodies were performed at 
room temperature for 2 h. After exposure, membranes were washed and stripped using Restore 
PLUS Western Blot Stripping Buffer (Thermo Scientific). Membranes were reprobed using an 
antibody against GAPDH (anti-GAPDH, Sigma, St. Louis, MO) as a loading control. Images were 
processed using Multi Gauge software (Fujifilm). 
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5.3.7 Statistics 
Two-way ANOVA was used for the statistical analysis. The statistical analysis of dependent 
variables (APD, CaD, CV) on the interactions between two fixed factors (group factor: F/D heart, 
layer factor: tissue layers, condition factor: baseline and β stimulations) was carried out.  Bonferroni 
adjustment was applied as post hoc test. Values of P<0.05 were considered as statistically significant.  
 
5.3.8 Quantitative-Polymerase Chain Reaction 
Additional tissue samples from human LVs were preserved in RNAlater (Sigma, St. Louis, 
MO) before RNA extraction. Total RNA extracted was processed using RNeasy Fibrous Tissue 
Mini Kit and a High Capacity cDNA Reverse Transcription Kit (QIAGEN, Manchester, UK) 
according to the manufacture’s instructions. mRNA quantification for the different targets was 
assessed by quantitative PCR (q-PCR) using TaqMan gene expression assays by StepOne instrument 
(Applied Biosystems, Grand Island, NY). The thermal profile for the q-PCR reactions followed 
manufacturer’s instruction. Data analysis for q-PCR data used efficiency-corrected ∆Ct method to 
determine the relative amounts of the gene of interested that were normalized to an endogenous 
reference RNA of GAPDH. 
 
5.4 Results  
The interaction between arrhythmogenic triggers and substrates determines the initiation and 
maintenance of fatal ventricular arrhythmias. In HF, remodeled β-AR signaling regulates numerous 
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electrophysiological targets, including ion channels, calcium handling and sarcomeric proteins, which 
further induce remodeling of conduction, repolarization, calcium handling, and spatial 
electrophysiological heterogeneities of LV, ultimately providing arrhythmogenic triggers and 
substrates.  
 
5.4.1 Effects of β2 versus β1 AR stimulation on arrhythmic substrates in HF 
5.4.1.1 β2 AR stimulation Increased Longitudinal Conduction Velocity (CV) 
and Increased Anisotropy in Failing Hearts 
We quantified CV along transverse (CVT) and longitudinal (CVL) directions. β2 agonist and 
ISO significantly increased CVL, but only mildly increased CVT in both groups of hearts (Figure 5.3). 
β1-stimulation enhanced CV in D, but not in F hearts.  This differential, orientation-dependent 
increase of CV leads to significant increase of anisotropy (CVL/CVT) by β2-stimulation, but a 
decrease by β1-stimulation in F hearts (Figure 5.3E). 
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Figure 5.3 Effects of β adrenergic stimulation on conduction velocity and anisotropy. A) CV 
is measured and plotted out as a function of directions on activation map B) Quantified CV was 
plotted out in a radial coordinate system. Origin is defined at pacing location and 0° axis is along 
transverse direction. Averaged CV at each condition from D and F hearts was depicted with 
different colors (Baseline: blue; β2 agonist: red; β1 agonist: green; β1+β2 agonist: purple). C) CVs of 
longitudinal (CVL) and transverse (CVT) directions were statistically compared between different 
conditions. β-stimulation significantly increased CVL in D hearts but only moderately in F hearts (β1-
stimulation did not increase CVL in F hearts). D) β2-stimulation increased CV dramatically in 
longitudinal direction but mildly in transverse direction in both D and F hearts. β1-stimulation 
showed similar effect in D but not in F hearts. E) β1-stimulation increased anisotropy in D but 
decreased it in F hearts, while β2-stimulation increased anisotropy in F hearts. 
 
5.4.1.2 β2 AR Stimulation Increased Transmural Heterogeneity in Failing 
Hearts; while β1 Slightly Affects Repolarization  
In agreement with previous studies, APD was significantly prolonged in F hearts[174] (see 
details in Figure 5.4 and Table5.2).   
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Figure 5.4 Transmural average APD from Failing and Donor human hearts. Average APD80 
through the whole transmural surface for both D and F hearts were plotted. In F hearts, prolonged 
APD were observed at every pacing cycle length under all conditions. 
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Table 5.2 APD value at different pacing cycle length. Detailed average APD80 value under 
different pacing cycle length is provided for epi, mid and endo under all conditions. 
 
β2, β1 and non-selective β agonists all shortened APD at different pacing rates in all three LV 
myocardial layers, but with varying degrees as evident from the restitution curves (Figure 5.5). β2-
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stimulation resulted in an increase of spatial heterogeneity of APD in F hearts (quantified by 
APDendo-APDepi at pacing CL=1sec in Figure 5.6) due to unequal transmural reduction of APD. The 
reduction (∆APD) was calculated as the difference of APD values between baseline and after β 
stimulation, and ∆APD values were analyzed at pacing CL=1sec. In D hearts, both agonists reduced 
APD, and this reduction was greater in endo- than epicardium. However, β2-AR stimulation 
reversed ∆APD in F compared to D hearts. Specifically, APD reduction was significantly greater in 
epi- and mid-, but not in endocardium. β1-AR stimulation, on the other hand, only mildly reduced 
APD without a spatial gradient (Figure 5.5C).  
Western blot measurements of β2-AR protein expression showed a clear endo-to-epi 
gradient in D hearts, which was reversed in F hearts (Figure 5.5F). Thus, the reversal of functional 
transmural gradient of ∆APD observed during β2-AR stimulation is due to β2-AR protein expression 
remodeling in F hearts.   
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Figure 5.5 Effects of β adrenergic stimulation repolarization and Western blot test. A) 
Typical AP optical mapping recordings at 60 bpm pacing from endo, mid and epi under different 
conditions were plotted and labeled with different colors (Baseline: blue; β2 agonist: red; β1 agonist: 
green; β1+β2 agonist: purple). APD maps are shown for representative D and F heart. B) APD 
reduction (∆APD) resulting from stimulation by different β-agonists were calculated, and ∆APD 
maps of D and F hearts are shown. C) ∆APD resulting from β2-stimulation in D hearts showed a 
spatial gradient, which appeared to be significant in epi and mid but not in endo. β1-stimulation 
produced significant differences across the heart. Non-selective stimulation did not produce any 
significant differences. D) Restitution curves for F and D hearts. E) D hearts showed a significantly 
higher phosphorylation level of β2-AR with similar level of total β2-AR. F). β2-AR shows transmural 
differences of expression in F and D hearts, where D hearts had higher β2-AR in endo; F hearts had 
higher β2-AR in epi. 
 
 
 
Figure 5.6 APD heterogeneity was evaluated by APDendo-APDepi. No significant difference was 
observed at baseline condition. β2-stimulation significantly increased APDendo-APDepi, while β1-
stimulation did not change it. 
 
 
5.4.1.3 Phosphorylation of β2 AR by PKA Reduced in Failing human Hearts  
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Shortening of APD by β-stimulation is mediated by G protein and PKA downstream 
signaling. Unlike β1-AR, which only couples to stimulatory G protein (Gs), β2-AR can couple to 
either Gs or inhibitory G protein (Gi).[175] The mechanism underlying the increased ∆APD induced 
by β2-stimulation in F hearts may lie in this dual coupling with different G proteins. According to 
Lefkowitz group, phosphorylation of β2-AR by PKA can switch its coupling from Gs to Gi (Figure 
5.7).[176] I measured β2-AR phosphorylation level at PKA-phosphorylation site Ser345/Ser346[177] 
and normalized it to total protein expression. β2-AR protein phosphorylation was significantly 
reduced in F hearts, while total β2-AR protein expression was unchanged (Figure 5.5E), suggesting 
that β2-AR coupling to Gi is reduced and coupling to Gs is increased. This switching may augment 
β2-AR effects on APD.    
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Figure 5.7 Diagram of β adrenergic system signaling in cardiomyocyte. Both β1 and β2 
adrenergic receptors couple to Gs protein and regulate various membrane ion channels as well as 
calcium handling proteins. Such regulation is mediated by the activation of PKA signaling 
pathway.[178, 179] Paradoxically, β2 adrenergic receptor also couples to Gi protein that not only 
inhibits the activation of PKA but also regulates proteins that are not shared with Gs signaling such 
as NCX. By coupling to Gi, β2 adrenergic stimulation increases the activity of NCX.[180] The 
phosphorylation of β2-AR by PKA plays a key role in balancing the coupling of β2-AR with two 
types of G proteins. When β2 adrenergic receptor is phosphorylated by PKA, it switches its coupling 
from Gs to Gi, which forms a negative feedback control on its coupling with Gs.[176]  
 
 
5.4.1.4 β2 AR stimulation Lead to Similar ∆CaD in F and D hearts; while β1-
stimulation produced less effect on CaD reduction in F than D hearts  
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Along with optical AP, we simultaneously recorded CaT (Figure 5.8A). β1-agonist treatment 
shortened CaD significantly less in F vs. D hearts. In contrast, the β2-agonist shortened CaD to a 
similar degree in both F and D groups. Unlike with APD, neither agonist exhibited transmural 
spatial differences (Figure 5.8B). 
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Figure 5.8 Effects of β adrenergic stimulation on Calcium Signaling. A) Representative 
calcium signal and CaD80 maps color-coded for different β-stimulation conditions. CaD80 was 
reduced after all β-stimulations. B) ∆CaD produced from β2-stimulation showed no difference 
between two groups of hearts, however β1 produced significant difference between F vs. D hearts. 
No transmural spatial differences were observed under either condition. C) ∆(CaD-APD) at epi and 
mid in F hearts was significantly increased during β2-stimulation leading to a relatively higher [Ca2+]i 
level at the same membrane potential compared to that of the baseline condition as labeled with 
green arrow. β1-stimulation did not produce a significant effect. D) Representative CaD30/CaD80 
ratio maps during baseline and β-stimulations are constructed. E) Averaged CaD30/CaD80 ratio in F 
hearts was significantly greater than in D hearts under baseline conditions. β1 and non-selective 
stimulation did not change this difference, while β2-stimulation abolished this difference. F) 
Transmural ratio values were analyzed. In baseline condition, dramatic differences were observed in 
all three layers between two groups of hearts. Spatial differences were also observed between endo 
and epi in both D and F hearts. The difference of ratio between D and F hearts persisted during β1, 
but disappeared during β2-stimulation. G) T50 was dramatically decreased after β2-stimulation in both 
groups while similar Ca decay constant was observed in F hearts. 
 
5.4.1.5 Transmurally different ∆APD but similar ∆CaD resulted in transmural 
gradient of CaD-APD thus facilitating the initiation of delayed after-
depolarizations (DADs) in F hearts  
As shown above, β2-stimulation produced transmurally different ∆APD, but had similar 
effects on ∆CaD in F hearts. Such significant differences resulted in a transmural gradient of the 
CaD-APD difference, during which time intracellular [Ca2+]i was maintained at a high concentration 
even after complete repolarization (Figure 5.8C). Increased disparity between AP and CaT leads to 
increased vulnerability for DAD occurrence, resulting from Na-Ca exchanger (NCX) induced Ca2+i 
extrusion and membrane potential depolarization. There was no significant transmural CaD-APD 
difference after β1-stimulation in either D or F hearts. In contrast, β2-stimulation dramatically 
increased CaD-APD in epi- and midmyocardium in F hearts (Figure 5.8C, p<0.01 and p=0.04, 
respectively).  
   130 
 
5.4.1.6 β2 AR stimulation induced a CaT morphology change in F hearts 
suggesting dysregulation of the late phase of Ca extrusion 
CaD30/CaD80 ratio was quantified to evaluate the morphology of CaT. In agreement with 
our previous study[166], we observed greater ratio in F than D hearts. This ratio also demonstrated a 
heterogeneous spatial distribution, with greater CaD30/CaD80 in the endo- compared with 
epicardium in both groups at baseline (Figure 5.8D). β1-stimulation did not alter CaD30/CaD80 
between F and D hearts, but eliminated transmural heterogeneity. However, β2-stimulation 
completely abolished the ratio difference between two groups of hearts, indicating a change in CaT 
morphology resulted from β2-stimulation (Figure 5.8E). We analyzed CaT further to determine the 
mechanisms of changes in different phases of the transient. Given that the rise time shows no 
difference (Figure5.9), we analyzed the Ca extrusion phase that has been separated into two parts: 
the early phase (fast Ca decline component), represented by T50, and late phase (slow Ca decline 
component), represented by Ca decay constant (Figure 5.8G).  T50 dramatically decreased after β2-
stimulation in both groups, whereas a similar Ca decay constant was observed before and after β2-
stimulation in F hearts, suggesting that abrogation of β2 regulation occurred during the slow Ca 
decline phase. 
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Figure 5.9 CaT rise time was calculated to evaluate the upstroke speed for CaT. No 
significant difference in rise time was observed between D and F hearts under all conditions. 
 
 
5.4.2 Effects of β2 versus β1 AR stimulation on arrhythmic triggers in HF 
5.4.2.1 β-AR stimulation is important for ectopic activity in human HF  
Ectopic activity can trigger VT. In our study, we measured the frequency and spatial location 
of automaticity or premature ventricular contractions (PVC) during 8 minutes of S1S1 pacing. No 
spontaneous automaticity or PVCs were observed under any studied condition in D hearts. In 
contrast, F hearts exhibited both ectopic PVCs and automatic rhythm under all β-stimulation 
conditions. Automaticity and PVCs with different morphology originated in different locations as 
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shown in a representative example recorded after β2-stimulation (Figure 5.10A). PVC #1 represents 
a series of irregularly occurring PVCs with smaller amplitude and slow upstroke that propagated 
through a limited area as circled before they terminated. On the other hand, PVC #2 had a greater 
amplitude and fast upstroke and propagated through the whole transmural surface of the 
preparation.  
We analyzed PVCs originating from identical locations as PVC #1 and PVC #2. AP-CaT 
delay map confirmed that one mechanism for PVC formation is Ca-overload. Figure 5.10B shows a 
PVC, which was triggered by Ca release prior to the AP upstroke. Delay maps of PVC #1 were 
analyzed and confirmed that the PVC was Ca-driven, resulting from β2-stimulation. These events all 
originated from epi- and midmyocardial layers (Figure 5B), which were the transmural regions with 
the prolongation of CaD-APD (Figure 5.8C), but did not occur subendocardially.  
In Figure 5.10C, we confirmed that PVC #2 shared the same location with a series of regular 
beats of enhanced automaticity. This rhythm originated from subendocardium with a rate of 33 
beats/min and was eliminated by rapid delivery of Lugol’s solution to the subendocardial surface, 
implicating the Purkinje fiber automaticity.[172]  
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Figure 5.10 Multiple mechanisms of automaticity and PVC observed in F hearts. A) Multiple 
types of PVCs were captured in one recording after β2-stimulation. PVC #1 represents the series of 
PVCs with small amplitude and slow upstroke. PVC #2 represents the series of PVCs with larger 
amplitude and faster upstroke. Membrane potential signal amplitudes maps were constructed at T1 
and T2 time points to determine the location of the origination of both types of PVCs: PVC #1 
originated from mid, while PVC #2 was from endo. Pseudo-ECG signal was also depicted. PVC #1 
was not captured in ECG as it only propagated through a limited area as circled in orange before it 
terminated. B) A series of regular beats of enhanced automaticity were observed to share the 
identical location with PVC #2. C) Ca-driven PVC was confirmed by AP-CaT delay map and found 
to share the identical location with PVC #1. First beat showing that a paced beat (in green box) with 
its AP activation earlier than CaT does not exhibit the same AP-CaT delay as the second beat (in 
blue box) whose CaT activation preceded the AP, suggesting that the second spontaneous beat was 
calcium-driven. # 1, 2, 3 and 4 are labeled on the activation and Ca propagation maps of this PVC 
with the activation times of the 4 points shown. # 1 and 3 represent the origination on AP and CaT 
activation maps, respectively. # 2 and 4 represent an adjacent location close to the origination on 
each map, respectively. Activation time of 3 (CaT,22 ms) is earlier than 1 (AP, 26 ms), and this 
difference is reversed shortly after AP propagated: activation time of 2 (AP, 28 ms) is before 4 (CaT, 
30 ms). 
 
 
5.4.2.2 β-AR stimulation increased occurrence and frequency of spontaneous 
PVCs and rapid pacing induced VT in failing human hearts 
The mechanisms of automaticity and ectopy illustrated in previous sections were confirmed 
in all studied F, but not D hearts. Using real-time pseudo-ECG and MAP during all experiments, we 
monitored the occurrence and calculated the frequency of PVCs as well as restitution pacing induced 
ventricular tachycardia (VT) (Figure 5.11A). The frequency and occurrence of PVCs and inducible 
VT dramatically increased after β-AR stimulation in F hearts, while neither could be induced in D 
hearts under any condition (Figure 5.11C). Thus, triggers were only present in F hearts. Figure 5.11B 
shows the spatial distribution of PVCs captured during optical imaging.  Both β1- and β2-stimulation 
induced a relatively greater amount of automaticity vs. PVCs in subendocardium, which mainly 
originate in Purkinje fibers. Unlike β1-stimulation, β2 agonist treatment also induced PVCs in epi- 
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and midmyocardial areas in addition to endocardially, among which more than 40% of ectopy/PVCs 
were confirmed to be Ca-mediated. No Ca-driven PVCs were observed during β1-stimulation.  
 
 
 
 
 
Figure 5.11 Ectopic Activity observed by location and frequency. A) Representative rapid 
pacing induced ectopic activity (VT) with AP, CaT, and MAP. B) Location distribution of ectopic 
activity with most originating from endo. All 4 Ca-driven PVCs were confirmed to only originated 
from epi and mid from β2-stimulation. C) Statistic of induced VT and ectopy, all three agonist 
produced a large amount of ectopy and VT in F hearts as expected. Very few ectopic beats and no 
VT occurred at baseline. No ectopy or VT was observed D hearts. D) Expanded view of ectopy 
occurrence. β1- and β2-stimulation exhibited similar frequencies, with non-selective having more than 
either. E) Expanded view of VT occurrence. Again, β1- and β2-stimulation exhibited similar 
frequencies, with non-selective having more than either. 
 
 
5.5 Discussion  
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This report demonstrates, for the first time, functional and molecular mechanisms of 
electrophysiological remodeling associated with differential β1 versus β2-AR system regulation in 
failing human hearts. We found that only in F hearts both β1- and β2-AR stimulation provoke 
frequent automaticity and PVCs with two different mechanisms. Both β1 and β2 activation increase 
automaticity in the Purkinje fibers. However, only β2-AR stimulation leads to Ca-driven PVCs. We 
also observed that β2-stimulation predisposes to arrhythmia more significantly as compared to β1 by 
creating arrhythmogenic substrates via spatially heterogeneous augmentation of CV, repolarization, 
and CaD. In particular, β2-stimulation increased the transmural difference between CaD and APD 
thus facilitating the formation of DAD. 
 
5.5.1 Remodeled adrenergic control of repolarization in F hearts may be due to 
switching of β2-AR coupling from Gi to Gs  
Desensitization of β1-AR and preserved effects of β2-AR has been reported through 
gene/protein expression,[181] and in cardiac mechanics[165] studies in human HF patients. We 
confirmed gene/protein expression by q-PCR in our study (Figure 5.12). However, 
electrophysiological investigation had not been conducted in human until now. In this report, we 
present evidence for attenuated β1 regulation of CV, APD, and CaD in F hearts. In contrast, β2 
regulation is not only maintained at a high level, but is also remodeled at the molecular and organ 
levels. We observed that β2-AR stimulation resulted in significantly greater average APD reduction 
transmurally, particularly in epi- and midmyocardial areas, suggesting an enhanced β2 regionally 
mediated ion channel regulation in F versus D hearts. This anatomically heterogeneous β2 
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augmentation could be due to the switching of β2-AR signaling from Gi to Gs. Unlike β1-AR, β2-AR 
is known to couple not only to Gs, but also Gi.[182] By coupling to Gi, it mediates an anti-apoptotic 
regulation through p38, MAPK activation,[183] which is considered to be protective for various 
cardiac diseases.[184, 185] It has been reported that β2-AR can switch its coupling from Gs to Gi 
when it is phosphorylated by PKA, which in turn is also activated by Gs.[176] This forms a negative 
feedback control of the coupling of β2-AR to Gs. Significantly reduced phosphorylation of β2-AR 
was observed in F hearts, which could switch back the coupling of β2-AR from Gi to Gs (Figure 5.7) 
switching negative feedback to positive feedback adrenergic control in HF. Therefore, β2-AR could 
enhance its control of EC coupling though Gs, as evident from enhanced APD reduction in F hearts.  
This theory is supported by studies from Harding’s group. According to their work, the 
amplitude of myocyte contractions was used to evaluate the inotropic effect due to Gs signaling. 
Dramatically negative inotropic effect was observed in failing human ventricular cardiomyocytes 
after the application of a β2-AR antagonist (ICI118,551). No statistically different decrease of 
inotropic effect was observed in non-failing hearts. These data supported our theory that greater 
proportion of β2-AR coupling with Gs occurs in HF. Inhibition on this increased Gs contribution 
in failing hearts resulted in significantly negative inotropic effect. In non-failing hearts, as coupling 
of β2-AR with Gs was not comparable to that in HF, the inhibitory effect was not observed.[186] 
Additionally, in mouse models, when β2-AR is overexpressed, the same negative inotropic effect 
was also observed following treatment with ICI118,551.[186] Increased proportion of β2-AR-Gs 
coupling was reported in this transgenic mouse model[187], which together with the previously 
described work done in human hearts lends support to our theroy.[186]    
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Figure 5.12 mRNA expression of selected β adrenergic signaling target proteins. mRNA 
expression of selected β adrenergic signaling target proteins was investigated by q-PCR. mRNA of 
β1 expression is dramatically decreased in F hearts. NCX and Gi expression increased in F hearts. 
 
 
The enhanced β2-AR regulation of APD is dependent upon the transmural layer and results 
in pathological remodeling of spatial repolarization heterogeneity.  Intrinsic APD distribution 
accounts for the activation delays necessary for synchronizing ventricular repolarization.[188, 189] 
Thus altering APD dispersion could enhance dispersion of repolarization and arrhythmia 
vulnerability.[190] We quantified APD and repolarization heterogeneity resulting from β1- and β2-
stimulation in human HF. In the F hearts, APD shortening induced by β2-stimulation was more 
significant in the epi- and mid-, but not in the endocardium, which is opposite from the gradient 
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observed in D hearts. The molecular and functional epi-endo reversal induced by activation of the 
β2-system severely disrupts transmural synchronization in failing hearts.  
 
5.5.2 Switching Coupling of β2-AR from Gi to Gs Abrogates β2-Stimulation 
Based Increase of NCX Activity 
Between the two major cytoplasmic Ca extrusion influencing proteins, NCX is recognized to 
contribute more during CaT late phase of slow decline,[191] when membrane potential is lower than 
the equilibrium potential of NCX (ENa/Ca).[192] When NCX is over-expressed, such as during HF, 
β2-stimulation was reported to further up-regulate its activity through its β2-AR coupling to Gi 
protein.[180] However, this increase in NCX activity from β2-stimulation was not supported by our 
result showing that the CaT decay constant did not change between F vs. D hearts (Figure 5.8F). 
Given that NCX is over-expressed in HF (Figure 5.12), we postulate that such reduced β2 regulation 
is due to a decrease of β2 AR-Gi coupling as discussed above. This switch from Gi to Gs could 
explain the CaT morphology change in HF. 
 
5.5.3 Disproportional Transmural Regulation of APD and CaD by β2-
Stimulation Provides Crucial DAD Substrate 
Unlike the enhanced APD regulation, β2-stimulation did not exhibit increased control of Ca 
handling in F hearts nor transmural CaD heterogeneity in either group of hearts. This resulted in an 
increase of CaD-APD difference, which widened a vulnerable period for DAD initiation. During 
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this period, when a cell has already repolarized, due to β2 stimulation-induced shortening of the 
refractory period, to its excitable state [193], a net inward current is generated by NCX Ca extrusion 
while the [Ca2+]i is still relatively high. Given upregulated mRNA expression of NCX in F hearts 
(Figure 5.12), we conclude that β2-stimulation increased cardiac vulnerability to DAD in F human 
hearts. β-Adrenergic dependent DAD mechanism has been studied at the cellular level.[194] For the 
first time, we present evidence of DAD triggered PVCs in failing human LV myocardium that is 
associated with Ca release preceding AP upstroke. Interestingly, such PVCs were only observed 
during β2-, but not β1-stimulation. Moreover, PVCs concentrated at the subepi- and mid-
myocardium, where CaD-APD is prolonged. In HF, given NCX activity is not further augmented by 
β2-stimulation due to receptor uncoupling with Gi, the electrophysiological CaD-APD substrate 
could play a major role in DAD initiation by β-AR stimulation rather than increased NCX activity. 
During β1-stimulation, on the other hand, we did not observe DADs even with upregulated NCX 
expression in F hearts, which could be due to unchanged CaD-APD difference during β1-AR 
stimulation.  
 
5.5.4 Purkinje fibers account for the majority of ectopy induced by β-
stimulation in HF 
Low frequency occurrence of PVCs in normal hearts are thought to be benign.[195] 
However, frequent PVCs in failing hearts have been related to LV dysfunction, and such 
dysfunction could be ameliorated after elimination of the PVCs by RF ablation in HF patients.[196] 
Given that the majority of observed PVCs originated from subendocardium, PVCs evoked by both 
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β1-AR and β2-AR selective stimulation are mainly from the Purkinje fibers in HF. This suggests that 
both subtypes of β1-AR and β2-AR preserve functional state in the Purkinje fibers, which is different 
in myocytes, where β1-AR is functionally desensitized. Additionally, β2-stimulation also evokes 
DAD-induced triggered activity in epi- and midmyocardium, although less frequently.  
In the present study of the human failing left ventricle, β2-stimulation was shown to increase 
arrhythmia vulnerability by facilitating arrhythmogenic triggers and substrates in contrast to β1-
stimulation, which suggests that non-selective or β2-selective blockers could improve the treatment 
of arrhythmogenesis in HF, as compared to β1-selective blockers. These results may also explain the 
limited efficiency of β1-selective blockers in preventing arrhythmias.  
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Chapter 6  
Summary and Future Directions 
 
6.1 Summary 
This dissertation demonstrated the design of dual optical mapping system that allows high 
spatial-temporal resolution imaging of action potential and Ca transient signals simultaneously. 
Multiple projects were applied using this system to investigate calcium remodeling through different 
signaling pathways in heart failure, thus revealing the complexity on how distinct impaired signaling 
pathways associated with arrhythmogenesis. Ca is critical in both electrical and mechanical 
properties of cardiac myocytes, and much is already known about its ionic basis. In HF, there are 
significant alterations in how cardiac Ca is regulated through different stimulatory and signaling 
pathways. These alterations are critical for dictating contractile dysfunction and facilitating the 
arrhythmias that are characteristic of heart failure. However these alterations from distinct signaling 
pathway impairment are not clearly revealed.  
The goals of the dissertation were fulfilled by 1) investigating the role of Pyk2 in cardiac 
arrhythmogenesis; 2) identifying regional calcium misleading in aged mdx mouse during ventricular 
stretch conditions; and 3) confirming arrhythmogenic remodeling of β2 versus β1 adrenergic 
signaling in human failing heart. 
Pyk2 is an important component protein along with c-Src, P38 and other proteins consisting 
a typical stress activated signaling pathway. Its phosphorylation was found dramatically increased in 
heart failure. I found huge vulnerability of arrhythmogenesis in Pyk2 knockout mice suggesting a 
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protective role of Pyk2 with respect to ventricular tachyarrhythmia, thus indicating the increased 
phosphorylation of Pyk2 in heart failure is a compensatory response.  
 Mechanical defect is by now the most ideal predictor of heart failure. It not only affects the 
contraction and results in decrease of cardiac output, but also activates cytoskeletal signaling 
pathways. In the study, it is suggested deficiency of dystrophin is involved in Ca regulation. 
Associated with mechanical stretch, it can result in significant change of Ca release from and 
reuptake back to SR. Such remodeling is closely related with mechanical stimulation, as it only 
appeared in the ventricular base, which might be due to “decent of the base”. The resulting 
dispersion of Ca mishandling induces Ca alternans. 
 Over-activity of β adrenergic receptor signaling is a hall marker of heart failure. However the 
endpoint researches mainly focused on left ventricular functions and mechanics, leaving 
electrophysiological remained unclear. The electrophysiology after β adrenergic stimulation was 
investigated on donor and explanted human failing hearts. Different β adrenergic receptor subtype 
was found perform differently. The association between remodeling of action potential and Ca 
transient provides a crucial arrhythmic substrate in heart failure. 
 In summary, dysfunction of Ca handling is associated with distinct impaired signaling 
pathways in heart failure and directly or by associated with electrical remodeling facilities 
arrhythmogenesis. Revealing such mechanisms expends understands of both Ca handling and 
signaling in heart failure and provides potential target or directions for heart failure treatment. 
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6.2 Future Directions 
 In this dissertation we thoroughly analyzed Ca handling remodeling through three distinct 
signaling pathways, there are still questions to answer. 
 Conclusions derived from genetic manipulated mouse models need to be tested from human 
tissue to provide solid and accurate suggestion for clinical application. The design for mechanical 
stretch stimulation is by loading solution to inflate the ventricular chamber, which stretches 
myocytes instead of contraction while providing similar systole inner pressure. Thus, this design was 
not following physiological condition. Ideal stimulation should come from heart contraction but 
introduces motion artifact from it on the other side. The future direction requires accurate optical 
mapping on heart while it maintains normal contraction. The advantage of the success on beating 
heart optical mapping not only can facilitate the mechanical stimulation investigation, but also avoid 
the application of EC uncouplers, which allows a wider range of studies on signaling pathways 
including those EC uncoupler participated. 
 In the dual optical mapping system, we can accurately analyze the time scale of both action 
potential and Ca transient, but not the absolute amplitude of action potential or intracellular Ca 
concentration. These absolute values promise more comprehensive understanding of remodeling of 
these parameters, since intracellular Ca concentration alteration triggers different signaling pathways. 
However, in our system, slight change of focal distance, stability of light source and dye loading will 
dramatically affect fluorescent intensity and avoid appropriate interpretation on amplitude of action 
potential or intracellular Ca concentration they represent. Application of ratiometric dye is a future 
direction of optical mapping. 
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 For β adrenergic receptor signaling investigation, further investigation work should include 
other subtypes of β adrenergic receptor, thus providing a thorough picture of the whole signaling 
system in heart failure, such as β3 adrenergic receptor. The study by using specific Gi and Gs 
signaling pathway blocker will extend and promise for better understanding on β2 adrenergic 
receptor switching from Gi to Gs. 
 After all, future work will be focusing on both experimental design and modulation.  
  
 
   146 
References 
 1. Tomaselli, G.F. and E. Marban, Electrophysiological remodeling in hypertrophy and 
heart failure. Cardiovasc Res, 1999. 42(2): p. 270-83. 2. Bers, D.M., Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda), 2006. 21: p. 380-7. 3. Prestle, J., F.R. Quinn, and G.L. Smith, Ca(2+)-handling proteins and heart failure: 
novel molecular targets? Curr Med Chem, 2003. 10(11): p. 967-81. 4. Berridge, M.J., M.D. Bootman, and H.L. Roderick, Calcium signalling: dynamics, 
homeostasis and remodelling. Nat Rev Mol Cell Biol, 2003. 4(7): p. 517-29. 5. Lohse, M.J., S. Engelhardt, and T. Eschenhagen, What is the role of beta-adrenergic 
signaling in heart failure? Circ Res, 2003. 93(10): p. 896-906. 6. Anilkumar, N., A. Sirker, and A.M. Shah, Redox sensitive signaling pathways in cardiac 
remodeling, hypertrophy and failure. Front Biosci (Landmark Ed), 2009. 14: p. 3168-87. 7. de Tombe, P.P. and R.J. Solaro, Integration of cardiac myofilament activity and 
regulation with pathways signaling hypertrophy and failure. Ann Biomed Eng, 2000. 
28(8): p. 991-1001. 8. Hunter, J.J. and K.R. Chien, Signaling pathways for cardiac hypertrophy and failure. N Engl J Med, 1999. 341(17): p. 1276-83. 9. Go, A.S., et al., Heart disease and stroke statistics--2013 update: a report from the 
American Heart Association. Circulation, 2013. 127(1): p. e6-e245. 10. Sabir, I.N., et al., Ventricular arrhythmogenesis: insights from murine models. Prog Biophys Mol Biol, 2008. 98(2-3): p. 208-18. 11. Marban, E., S.W. Robinson, and W.G. Wier, Mechanisms of arrhythmogenic delayed 
and early afterdepolarizations in ferret ventricular muscle. J Clin Invest, 1986. 78(5): p. 1185-92. 12. Fink, M., P.J. Noble, and D. Noble, Ca(2)(+)-induced delayed afterdepolarizations are 
triggered by dyadic subspace Ca2(2)(+) affirming that increasing SERCA reduces 
aftercontractions. Am J Physiol Heart Circ Physiol, 2011. 301(3): p. H921-35. 13. Wiener, N. and A. Rosenblueth, The mathematical formulation of the problem of 
conduction of impulses in a network of connected excitable elements, specifically in 
cardiac muscle. Arch Inst Cardiol Mex, 1946. 16(3): p. 205-65. 14. Mines, G.R., On dynamic equilibrium in the heart. J Physiol, 1913. 46(4-5): p. 349-83. 15. Durrer, D., et al., The role of premature beats in the initiation and the termination of 
supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation, 1967. 36(5): p. 644-62. 16. Coumel, P., Cabrol, C., Fabiato, A., Gourgon, R., & Slama, R., Tachycardie permanente 
par rythme reciproque. Arch Mal Coeur, 1967. 60: p. 34. 17. Malik, M., Arrhythmic substrate. Heart, 2008. 94(4): p. 402-3. 18. de Bakker, J.M. and H.M. van Rijen, Continuous and discontinuous propagation in 
heart muscle. J Cardiovasc Electrophysiol, 2006. 17(5): p. 567-73. 
   147 
19. Song, Y.N., et al., Connexin 43, a new therapeutic target for cardiovascular diseases. Pharmazie, 2009. 64(5): p. 291-5. 20. Ai, X. and S.M. Pogwizd, Connexin 43 downregulation and dephosphorylation in 
nonischemic heart failure is associated with enhanced colocalized protein phosphatase 
type 2A. Circ Res, 2005. 96(1): p. 54-63. 21. Nielsen, P.M., et al., Mathematical model of geometry and fibrous structure of the 
heart. Am J Physiol, 1991. 260(4 Pt 2): p. H1365-78. 22. Peters, N.S. and A.L. Wit, Myocardial architecture and ventricular arrhythmogenesis. Circulation, 1998. 97(17): p. 1746-54. 23. Napolitano, C., et al., Evidence for a cardiac ion channel mutation underlying drug-
induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol, 2000. 11(6): p. 691-6. 24. Gaita, F., et al., Short QT Syndrome: a familial cause of sudden death. Circulation, 2003. 108(8): p. 965-70. 25. Choi, B.R. and G. Salama, Simultaneous maps of optical action potentials and calcium 
transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol, 2000. 529 Pt 1: p. 171-88. 26. Nolasco, J.B. and R.W. Dahlen, A graphic method for the study of alternation in cardiac 
action potentials. J Appl Physiol, 1968. 25(2): p. 191-6. 27. Qu, Z. and J.N. Weiss, Dynamics and cardiac arrhythmias. J Cardiovasc Electrophysiol, 2006. 17(9): p. 1042-9. 28. Garfinkel, A., et al., Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A, 2000. 97(11): p. 6061-6. 29. Riccio, M.L., M.L. Koller, and R.F. Gilmour, Jr., Electrical restitution and 
spatiotemporal organization during ventricular fibrillation. Circ Res, 1999. 84(8): p. 955-63. 30. Qu, Z., J.N. Weiss, and A. Garfinkel, Cardiac electrical restitution properties and 
stability of reentrant spiral waves: a simulation study. Am J Physiol, 1999. 276(1 Pt 2): p. H269-83. 31. Koller, M.L., M.L. Riccio, and R.F. Gilmour, Jr., Dynamic restitution of action potential 
duration during electrical alternans and ventricular fibrillation. Am J Physiol, 1998. 
275(5 Pt 2): p. H1635-42. 32. Karma, A., Spiral breakup in model equations of action potential propagation in 
cardiac tissue. Phys Rev Lett, 1993. 71(7): p. 1103-1106. 33. Verduyn, S.C., et al., Further observations to elucidate the role of interventricular 
dispersion of repolarization and early afterdepolarizations in the genesis of acquired 
torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using 
the dog as its own control. J Am Coll Cardiol, 1997. 30(6): p. 1575-84. 34. Verduyn, S.C., et al., Role of interventricular dispersion of repolarization in acquired 
torsade-de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res, 1997. 34(3): p. 453-63. 35. Pruvot, E.J., et al., Role of calcium cycling versus restitution in the mechanism of 
repolarization alternans. Circ Res, 2004. 94(8): p. 1083-90. 36. Berridge, M.J., P. Lipp, and M.D. Bootman, The versatility and universality of calcium 
signalling. Nat Rev Mol Cell Biol, 2000. 1(1): p. 11-21. 
   148 
37. Wehrens, X.H. and A.R. Marks, Novel therapeutic approaches for heart failure by 
normalizing calcium cycling. Nat Rev Drug Discov, 2004. 3(7): p. 565-73. 38. Fill, M. and J.A. Copello, Ryanodine receptor calcium release channels. Physiol Rev, 2002. 82(4): p. 893-922. 39. Bers, D.M., Cardiac excitation-contraction coupling. Nature, 2002. 415(6868): p. 198-205. 40. Bers, D.M. and J.H. Bridge, Relaxation of rabbit ventricular muscle by Na-Ca exchange 
and sarcoplasmic reticulum calcium pump. Ryanodine and voltage sensitivity. Circ Res, 1989. 65(2): p. 334-42. 41. Jones, L.R., et al., Purification and characterization of phospholamban from canine 
cardiac sarcoplasmic reticulum. J Biol Chem, 1985. 260(12): p. 7721-30. 42. O'Rourke, B., et al., Mechanisms of altered excitation-contraction coupling in canine 
tachycardia-induced heart failure, I: experimental studies. Circ Res, 1999. 84(5): p. 562-70. 43. Pogwizd, S.M., et al., Upregulation of Na(+)/Ca(2+) exchanger expression and function 
in an arrhythmogenic rabbit model of heart failure. Circ Res, 1999. 85(11): p. 1009-19. 44. Chen, X., et al., L-type Ca2+ channel density and regulation are altered in failing 
human ventricular myocytes and recover after support with mechanical assist devices. Circ Res, 2002. 91(6): p. 517-24. 45. Joyner, R.W., et al., Modulating L-type calcium current affects discontinuous cardiac 
action potential conduction. Biophys J, 1996. 71(1): p. 237-45. 46. Luscher, C., et al., Control of action potential propagation by intracellular Ca2+ in 
cultured rat dorsal root ganglion cells. J Physiol, 1996. 490 ( Pt 2): p. 319-24. 47. Rohr, S. and J.P. Kucera, Involvement of the calcium inward current in cardiac impulse 
propagation: induction of unidirectional conduction block by nifedipine and reversal 
by Bay K 8644. Biophys J, 1997. 72(2 Pt 1): p. 754-66. 48. Chudin, E., et al., Intracellular Ca(2+) dynamics and the stability of ventricular 
tachycardia. Biophys J, 1999. 77(6): p. 2930-41. 49. Blatter, L.A., et al., Local calcium gradients during excitation-contraction coupling and 
alternans in atrial myocytes. J Physiol, 2003. 546(Pt 1): p. 19-31. 50. Diaz, M.E., D.A. Eisner, and S.C. O'Neill, Depressed ryanodine receptor activity 
increases variability and duration of the systolic Ca2+ transient in rat ventricular 
myocytes. Circ Res, 2002. 91(7): p. 585-93. 51. Wehrens, X.H., et al., FKBP12.6 deficiency and defective calcium release channel 
(ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell, 2003. 113(7): p. 829-40. 52. Salama, G. and B. London, Mouse models of long QT syndrome. J Physiol, 2007. 578(Pt 1): p. 43-53. 53. Demolombe, S., et al., Transgenic mice overexpressing human KvLQT1 dominant-
negative isoform. Part I: Phenotypic characterisation. Cardiovasc Res, 2001. 50(2): p. 314-27. 54. Nerbonne, J.M., et al., Genetic manipulation of cardiac K(+) channel function in mice: 
what have we learned, and where do we go from here? Circ Res, 2001. 89(11): p. 944-56. 
   149 
55. Guo, W., et al., Molecular basis of transient outward K+ current diversity in mouse 
ventricular myocytes. J Physiol, 1999. 521 Pt 3: p. 587-99. 56. Nerbonne, J.M., Studying cardiac arrhythmias in the mouse--a reasonable model for 
probing mechanisms? Trends Cardiovasc Med, 2004. 14(3): p. 83-93. 57. Liu, G., et al., In vivo temporal and spatial distribution of depolarization and 
repolarization and the illusive murine T wave. J Physiol, 2004. 555(Pt 1): p. 267-79. 58. Lang, D., et al., Optical mapping of action potentials and calcium transients in the 
mouse heart. J Vis Exp, 2011(55). 59. Kleber AG, J.M., Fast VG, Normal and abnormal conduction in the heart, in Handbook 
of Physiology. 2001, Oxford University Press. p. 455-530. 60. Efimov, I.R., Rendt, J.M. & Salama, G, Optical maps of intracellular [Ca2+]i transients 
and action-potentials from the surface of perfused guinea-pig hearts. Circulation, 1994. 90: p. 1. 61. Efimov, I.R., V.P. Nikolski, and G. Salama, Optical imaging of the heart. Circ Res, 2004. 
95(1): p. 21-33. 62. Fast, V.G., Recording action potential using voltage sensitive dyes, in Practical methods 
in cardiovascular research, F.W.M. In S. Dhein, & M. Delmoar, Editor. 2005, Springer: New York. p. 233-255. 63. Efimov, I.R., et al., Optical mapping of repolarization and refractoriness from intact 
hearts. Circulation, 1994. 90(3): p. 1469-80. 64. Kim, J.H., et al., Imaging of cerebellar surface activation in vivo using voltage sensitive 
dyes. Neuroscience, 1989. 31(3): p. 613-23. 65. Holcomb, M.R., et al., The potential of dual camera systems for multimodal imaging of 
cardiac electrophysiology and metabolism. Exp Biol Med (Maywood), 2009. 234(11): p. 1355-73. 66. Glukhov, A.V., et al., Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol, 2009. 67. Baker, L.C., et al., Enhanced dispersion of repolarization and refractoriness in 
transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res, 2000. 
86(4): p. 396-407. 68. Sutherland, F.J. and D.J. Hearse, The isolated blood and perfusion fluid perfused heart. Pharmacol Res, 2000. 41(6): p. 613-27. 69. Efimov, I.R., et al., Virtual electrode polarization in the far field: implications for 
external defibrillation. Am J Physiol Heart Circ Physiol, 2000. 279(3): p. H1055-70. 70. Hammouda, M. and R. Kinosita, The coronary circulation in the isolated heart. J Physiol, 1926. 61(4): p. 615-28. 71. Salama, G. and S.M. Hwang, Simultaneous optical mapping of intracellular free 
calcium and action potentials from Langendorff perfused hearts. Curr Protoc Cytom, 2009. Chapter 12: p. Unit 12 17. 72. Lou, Q., et al., Quantitative panoramic imaging of epicardial electrical activity. Ann Biomed Eng, 2008. 36(10): p. 1649-58. 73. Salama, G., et al., Properties of new, long-wavelength, voltage-sensitive dyes in the 
heart. J Membr Biol, 2005. 208(2): p. 125-40. 74. Lang, D., et al., Role of Pyk2 in cardiac arrhythmogenesis. Am J Physiol Heart Circ Physiol, 2011. 301(3): p. H975-83. 
   150 
75. Kyriakis, J.M., et al., The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 1994. 369(6476): p. 156-60. 76. Levi, A.J., et al., Role of intracellular sodium overload in the genesis of cardiac 
arrhythmias. J Cardiovasc Electrophysiol, 1997. 8(6): p. 700-21. 77. Scoote, M. and A.J. Williams, Myocardial calcium signalling and arrhythmia 
pathogenesis. Biochem Biophys Res Commun, 2004. 322(4): p. 1286-309. 78. Tokiwa, G., et al., Activation of Pyk2 by stress signals and coupling with JNK signaling 
pathway. Science, 1996. 273(5276): p. 792-4. 79. Avraham, H., et al., RAFTK/Pyk2-mediated cellular signalling. Cell Signal, 2000. 
12(3): p. 123-33. 80. Lev, S., et al., Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of 
ion channel and MAP kinase functions. Nature, 1995. 376(6543): p. 737-45. 81. Dikic, I., et al., A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP 
kinase activation. Nature, 1996. 383(6600): p. 547-50. 82. Park, S.Y., H.K. Avraham, and S. Avraham, RAFTK/Pyk2 activation is mediated by 
trans-acting autophosphorylation in a Src-independent manner. J Biol Chem, 2004. 
279(32): p. 33315-22. 83. Felsch, J.S., T.G. Cachero, and E.G. Peralta, Activation of protein tyrosine kinase PYK2 
by the m1 muscarinic acetylcholine receptor. Proc Natl Acad Sci U S A, 1998. 95(9): p. 5051-6. 84. Schaller, M.D., Cellular functions of FAK kinases: insight into molecular mechanisms 
and novel functions. J Cell Sci, 2010. 123(Pt 7): p. 1007-13. 85. Bayer, A.L., et al., Pyk2 expression and phosphorylation in neonatal and adult 
cardiomyocytes. J Mol Cell Cardiol, 2001. 33(5): p. 1017-30. 86. Murasawa, S., et al., Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in 
angiotensin II induced Ras/ERK signaling. Hypertension, 1998. 32(4): p. 668-75. 87. Sabri, A., et al., Calcium- and protein kinase C-dependent activation of the tyrosine 
kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res, 1998. 83(8): p. 841-51. 88. Frank, G.D., et al., PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in 
vascular smooth muscle cells. Biochem Biophys Res Commun, 2000. 270(3): p. 761-5. 89. Matsui, A., et al., Central role of calcium-dependent tyrosine kinase PYK2 in endothelial 
nitric oxide synthase-mediated angiogenic response and vascular function. Circulation, 2007. 116(9): p. 1041-51. 90. Bayer, A.L., et al., PYK2 expression and phosphorylation increases in pressure 
overload-induced left ventricular hypertrophy. Am J Physiol Heart Circ Physiol, 2002. 
283(2): p. H695-706. 91. Melendez, J., et al., Activation of pyk2/related focal adhesion tyrosine kinase and focal 
adhesion kinase in cardiac remodeling. J Biol Chem, 2002. 277(47): p. 45203-10. 92. Heidkamp, M.C., et al., PYK2 regulates SERCA2 gene expression in neonatal rat 
ventricular myocytes. Am J Physiol Cell Physiol, 2005. 289(2): p. C471-82. 93. Melendez, J., et al., Cardiomyocyte apoptosis triggered by RAFTK/pyk2 via Src kinase 
is antagonized by paxillin. J Biol Chem, 2004. 279(51): p. 53516-23. 
   151 
94. Hirotani, S., et al., Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent 
signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy. J Mol Cell Cardiol, 2004. 36(6): p. 799-807. 95. Guo, J., et al., Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway 
that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes. Circ Res, 2006. 99(12): p. 1367-75. 96. Menashi, E.B. and J.C. Loftus, Differential effects of Pyk2 and FAK on the hypertrophic 
response of cardiac myocytes. Cell Tissue Res, 2009. 337(2): p. 243-55. 97. Hart, D.L., et al., CRNK gene transfer improves function and reverses the myosin heavy 
chain isoenzyme switch during post-myocardial infarction left ventricular remodeling. J Mol Cell Cardiol, 2008. 45(1): p. 93-105. 98. Okigaki, M., et al., Pyk2 regulates multiple signaling events crucial for macrophage 
morphology and migration. Proc Natl Acad Sci U S A, 2003. 100(19): p. 10740-5. 99. Schindler, E.M., et al., The role of proline-rich protein tyrosine kinase 2 in 
differentiation-dependent signaling in human epidermal keratinocytes. J Invest Dermatol, 2007. 127(5): p. 1094-106. 100. Fabritz, C.L., et al., Myocardial vulnerability to T wave shocks: relation to shock 
strength, shock coupling interval, and dispersion of ventricular repolarization. J Cardiovasc Electrophysiol, 1996. 7(3): p. 231-42. 101. Fedorov, V.V., et al., Atria are more susceptible to electroporation than ventricles: 
implications for atrial stunning, shock-induced arrhythmia and defibrillation failure. Heart Rhythm, 2008. 5(4): p. 593-604. 102. Rockman, H.A., et al., Segregation of atrial-specific and inducible expression of an 
atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A, 1991. 88(18): p. 8277-81. 103. Rockman, H.A., et al., Molecular and physiological alterations in murine ventricular 
dysfunction. Proc Natl Acad Sci U S A, 1994. 91(7): p. 2694-8. 104. Huang, Y., et al., CAKbeta/Pyk2 kinase is a signaling link for induction of long-term 
potentiation in CA1 hippocampus. Neuron, 2001. 29(2): p. 485-96. 105. Ling, S., J.Z. Sheng, and A.P. Braun, The calcium-dependent activity of large-
conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced 
tyrosine phosphorylation. Am J Physiol Cell Physiol, 2004. 287(3): p. C698-706. 106. Cheng, Y.J., et al., Focal but reversible diastolic sheet dysfunction reflects regional 
calcium mishandling in dystrophic mdx mouse hearts. Am J Physiol Heart Circ Physiol, 2012. 303(5): p. H559-68. 107. Bigger, J.T., Jr., et al., The relationships among ventricular arrhythmias, left ventricular 
dysfunction, and mortality in the 2 years after myocardial infarction. Circulation, 1984. 69(2): p. 250-8. 108. Laurita, K.R. and D.S. Rosenbaum, Cellular mechanisms of arrhythmogenic cardiac 
alternans. Prog Biophys Mol Biol, 2008. 97(2-3): p. 332-47. 109. McGavin, M.D.a.J.F.Z., Congenital or Inherited Myopathies, in Pathologic Basis of 
Veterinary Disease (4th Edition). 2007, Mosby/Elsevier St. Louis. p. 1026-1027. 110. Gulati, S., et al., Duchenne muscular dystrophy: prevalence and patterns of cardiac 
involvement. Indian J Pediatr, 2005. 72(5): p. 389-93. 111. Wagner, K.R., N. Lechtzin, and D.P. Judge, Current treatment of adult Duchenne 
muscular dystrophy. Biochim Biophys Acta, 2007. 1772(2): p. 229-37. 
   152 
112. Ahuja, R., et al., Prevalence and patterns of cardiac involvement in duchenne muscular 
dystrophy. Indian Pediatr, 2000. 37(11): p. 1246-51. 113. Ishikawa, Y., J.R. Bach, and R. Minami, Cardioprotection for Duchenne's muscular 
dystrophy. Am Heart J, 1999. 137(5): p. 895-902. 114. McNally, E.M., Duchenne muscular dystrophy: how bad is the heart? Heart, 2008. 
94(8): p. 976-7. 115. Romfh, A. and E.M. McNally, Cardiac assessment in duchenne and becker muscular 
dystrophies. Curr Heart Fail Rep, 2010. 7(4): p. 212-8. 116. Nolan, M.A., et al., Cardiac assessment in childhood carriers of Duchenne and Becker 
muscular dystrophies. Neuromuscul Disord, 2003. 13(2): p. 129-32. 117. Hermans, M.C., et al., Hereditary muscular dystrophies and the heart. Neuromuscul Disord, 2010. 20(8): p. 479-92. 118. Finsterer, J. and C. Stollberger, Cardiac involvement determines the prognosis of 
Duchenne muscular dystrophy. Indian J Pediatr, 2007. 74(2): p. 209; author reply 210-2. 119. Townsend, D., S. Yasuda, and J. Metzger, Cardiomyopathy of Duchenne muscular 
dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic 
approach. Expert Rev Cardiovasc Ther, 2007. 5(1): p. 99-109. 120. Gailly, P., New aspects of calcium signaling in skeletal muscle cells: implications in 
Duchenne muscular dystrophy. Biochim Biophys Acta, 2002. 1600(1-2): p. 38-44. 121. Li, W., et al., Early manifestation of alteration in cardiac function in dystrophin 
deficient mdx mouse using 3D CMR tagging. J Cardiovasc Magn Reson, 2009. 11: p. 40. 122. van Deutekom, J.C., et al., Antisense-induced exon skipping restores dystrophin 
expression in DMD patient derived muscle cells. Hum Mol Genet, 2001. 10(15): p. 1547-54. 123. Banks, G.B. and J.S. Chamberlain, The value of mammalian models for duchenne 
muscular dystrophy in developing therapeutic strategies. Curr Top Dev Biol, 2008. 84: p. 431-53. 124. Cullen, M.J. and E. Jaros, Ultrastructure of the skeletal muscle in the X chromosome-
linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol, 1988. 77(1): p. 69-81. 125. Tanabe, Y., K. Esaki, and T. Nomura, Skeletal muscle pathology in X chromosome-
linked muscular dystrophy (mdx) mouse. Acta Neuropathol, 1986. 69(1-2): p. 91-5. 126. Bulfield, G., et al., X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A, 1984. 81(4): p. 1189-92. 127. Allen, D.G., et al., Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol, 2010. 88(2): p. 83-91. 128. Williams, I.A. and D.G. Allen, Intracellular calcium handling in ventricular myocytes 
from mdx mice. Am J Physiol Heart Circ Physiol, 2007. 292(2): p. H846-55. 129. Fanchaouy, M., et al., Pathways of abnormal stress-induced Ca2+ influx into dystrophic 
mdx cardiomyocytes. Cell Calcium, 2009. 46(2): p. 114-21. 130. Balzer, P., et al., Regional assessment of wall curvature and wall stress in left ventricle 
with magnetic resonance imaging. Am J Physiol, 1999. 277(3 Pt 2): p. H901-10. 131. DeAnda, A., Jr., et al., Estimation of regional left ventricular wall stresses in intact 
canine hearts. Am J Physiol, 1998. 275(5 Pt 2): p. H1879-85. 
   153 
132. Ashford, M.W., Jr., et al., Occult cardiac contractile dysfunction in dystrophin-deficient 
children revealed by cardiac magnetic resonance strain imaging. Circulation, 2005. 
112(16): p. 2462-7. 133. Dellorusso, C., et al., Tibialis anterior muscles in mdx mice are highly susceptible to 
contraction-induced injury. Journal of muscle research and cell motility, 2001. 22(5): p. 467-75. 134. Chen, J., et al., Regional ventricular wall thickening reflects changes in cardiac fiber 
and sheet structure during contraction: quantification with diffusion tensor MRI. Am J Physiol Heart Circ Physiol, 2005. 289(5): p. H1898-907. 135. Munch, D.F., H.T. Comer, and J.M. Downey, Barium contracture: a model for systole. Am J Physiol, 1980. 239(3): p. H438-42. 136. Toyota, E., et al., Dynamic changes in three-dimensional architecture and vascular 
volume of transmural coronary microvasculature between diastolic- and systolic-
arrested rat hearts. Circulation, 2002. 105(5): p. 621-6. 137. Judd, R.M., et al., Feasibility of 19F imaging of perfluorochemical emulsions to measure 
myocardial vascular volume. Magn Reson Med, 1992. 28(1): p. 129-36. 138. Dunphy, G., et al., The effects of mannitol, albumin, and cardioplegia enhancers on 24-
h rat heart preservation. The American journal of physiology, 1999. 276(5 Pt 2): p. H1591-8. 139. Watts, J.A. and P.C. Maiorano, Trace amounts of albumin protect against ischemia and 
reperfusion injury in isolated rat hearts. Journal of molecular and cellular cardiology, 1999. 31(9): p. 1653-62. 140. Robinson, L.A. and D.L. Harwood, Lowering the calcium concentration in St. Thomas' 
Hospital cardioplegic solution improves protection during hypothermic ischemia. J Thorac Cardiovasc Surg, 1991. 101(2): p. 314-25. 141. Scollan, D.F., et al., Histological validation of myocardial microstructure obtained from 
diffusion tensor magnetic resonance imaging. Am J Physiol, 1998. 275(6 Pt 2): p. H2308-18. 142. Tseng, W.Y., et al., Diffusion tensor MRI of myocardial fibers and sheets: 
correspondence with visible cut-face texture. J Magn Reson Imaging, 2003. 17(1): p. 31-42. 143. LeGrice, I.J., Y. Takayama, and J.W. Covell, Transverse shear along myocardial 
cleavage planes provides a mechanism for normal systolic wall thickening. Circ Res, 1995. 77(1): p. 182-93. 144. Pope, A.J., et al., Three-dimensional transmural organization of perimysial collagen in 
the heart. Am J Physiol Heart Circ Physiol, 2008. 295(3): p. H1243-H1252. 145. LeGrice, I.J., et al., Laminar structure of the heart: ventricular myocyte arrangement 
and connective tissue architecture in the dog. Am J Physiol, 1995. 269(2 Pt 2): p. H571-82. 146. Gilbert, S.H., et al., Regional localisation of left ventricular sheet structure: integration 
with current models of cardiac fibre, sheet and band structure. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007. 32(2): p. 231-49. 147. Helm, P., et al., Measuring and mapping cardiac fiber and laminar architecture using 
diffusion tensor MR imaging. Annals of the New York Academy of Sciences, 2005. 
1047: p. 296-307. 
   154 
148. Costa, K.D., et al., Laminar fiber architecture and three-dimensional systolic mechanics 
in canine ventricular myocardium. Am J Physiol, 1999. 276(2 Pt 2): p. H595-607. 149. Nielsen, J.M., et al., Left ventricular volume measurement in mice by conductance 
catheter: evaluation and optimization of calibration. Am J Physiol Heart Circ Physiol, 2007. 293(1): p. H534-40. 150. Simonson, J.S. and N.B. Schiller, Descent of the base of the left ventricle: an 
echocardiographic index of left ventricular function. J Am Soc Echocardiogr, 1989. 
2(1): p. 25-35. 151. !!! INVALID CITATION !!! 152. Sapp, J.L., J. Bobet, and S.E. Howlett, Contractile properties of myocardium are altered 
in dystrophin-deficient mdx mice. Journal of the neurological sciences, 1996. 142(1-2): p. 17-24. 153. Phillips, M.F. and R. Quinlivan, Calcium antagonists for Duchenne muscular dystrophy. Cochrane Database Syst Rev, 2008(4): p. CD004571. 154. Wachter, S.B. and E.M. Gilbert, Beta-adrenergic receptors, from their discovery and 
characterization through their manipulation to beneficial clinical application. Cardiology, 2012. 122(2): p. 104-12. 155. Lombardi, W.L. and E.M. Gilbert, Carvedilol in the failing heart. Clin Cardiol, 2001. 
24(12): p. 757-66. 156. Anderson, J.L., et al., ACC/AHA 2007 guidelines for the management of patients with 
unstable angina/non ST-elevation myocardial infarction: a report of the American 
College of Cardiology/American Heart Association Task Force on Practice Guidelines 
(Writing Committee to Revise the 2002 Guidelines for the Management of Patients 
With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in 
collaboration with the American College of Emergency Physicians, the Society for 
Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: 
endorsed by the American Association of Cardiovascular and Pulmonary 
Rehabilitation and the Society for Academic Emergency Medicine. Circulation, 2007. 
116(7): p. e148-304. 157. Krum, H., The Task Force for the diagnosis and treatment of chronic heart failure of 
the European Society of Cardiology. Guidelines for the diagnosis and treatment of 
chronic heart failure: full text (update 2005). Eur Heart J, 2005. 26(22): p. 2472; author reply 2473-4. 158. Connolly, S.J., et al., Comparison of beta-blockers, amiodarone plus beta-blockers, or 
sotalol for prevention of shocks from implantable cardioverter defibrillators: the 
OPTIC Study: a randomized trial. JAMA, 2006. 295(2): p. 165-71. 159. Ferreira-Gonzalez, I., L. Dos-Subira, and G.H. Guyatt, Adjunctive antiarrhythmic drug 
therapy in patients with implantable cardioverter defibrillators: a systematic review. Eur Heart J, 2007. 28(4): p. 469-77. 160. Singh, B.N. and D.E. Jewitt, Beta-adrenergic receptor blocking drugs in cardiac 
arrhythmias. Drugs, 1974. 7(6): p. 426-61. 161. Ruwald, M.H., et al., Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT 
(multicenter automatic defibrillator implantation trial with cardiac resynchronization 
therapy). J Am Coll Cardiol, 2013. 61(14): p. 1518-26. 162. Poole-Wilson, P.A., et al., Comparison of carvedilol and metoprolol on clinical 
outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol 
   155 
European Trial (COMET): randomised controlled trial. Lancet, 2003. 362(9377): p. 7-13. 163. Lechat, P., et al., Clinical effects of beta-adrenergic blockade in chronic heart failure: a 
meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation, 1998. 98(12): p. 1184-91. 164. de Peuter, O.R., et al., A systematic review of selective and non-selective beta blockers 
for prevention of vascular events in patients with acute coronary syndrome or heart 
failure. Neth J Med, 2009. 67(9): p. 284-94. 165. Bristow, M.R., et al., Beta 1- and beta 2-adrenergic-receptor subpopulations in 
nonfailing and failing human ventricular myocardium: coupling of both receptor 
subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart 
failure. Circ Res, 1986. 59(3): p. 297-309. 166. Lou, Q., et al., Transmural heterogeneity and remodeling of ventricular excitation-
contraction coupling in human heart failure. Circulation. 123(17): p. 1881-90. 167. Lang, D., et al., Optical mapping of action potentials and calcium transients in the 
mouse heart. J Vis Exp, (55). 168. Noguchi, K., et al., Cardiac effects of beta-2 adrenoceptor stimulation with 
intracoronary procaterol in the absence and presence of regional myocardial ischemia 
in dogs. J Pharmacol Exp Ther, 1991. 259(2): p. 732-7. 169. Bartel, S., et al., New insights into beta2-adrenoceptor signaling in the adult rat heart. Cardiovasc Res, 2003. 57(3): p. 694-703. 170. Sato, H., et al., Hemodynamic effects of the beta 1-adrenoceptor partial agonist 
xamoterol in relation to plasma norepinephrine levels during exercise in patients with 
left ventricular dysfunction. Circulation, 1987. 75(1): p. 213-20. 171. Engelhardt, S., et al., Constitutive activity of the human beta(1)-adrenergic receptor in 
beta(1)-receptor transgenic mice. Mol Pharmacol, 2001. 60(4): p. 712-7. 172. Damiano, R.J., Jr., et al., The effect of chemical ablation of the endocardium on 
ventricular fibrillation threshold. Circulation, 1986. 74(3): p. 645-52. 173. Myles, R.C., et al., Local beta-adrenergic stimulation overcomes source-sink mismatch 
to generate focal arrhythmia. Circ Res, 2012. 110(11): p. 1454-64. 174. Beuckelmann, D.J., M. Nabauer, and E. Erdmann, Alterations of K+ currents in isolated 
human ventricular myocytes from patients with terminal heart failure. Circ Res, 1993. 
73(2): p. 379-85. 175. Xiao, R.P., et al., Coupling of beta2-adrenoceptor to Gi proteins and its physiological 
relevance in murine cardiac myocytes. Circ Res, 1999. 84(1): p. 43-52. 176. Daaka, Y., L.M. Luttrell, and R.J. Lefkowitz, Switching of the coupling of the beta2-
adrenergic receptor to different G proteins by protein kinase A. Nature, 1997. 
390(6655): p. 88-91. 177. Nobles, K.N., et al., Distinct phosphorylation sites on the beta(2)-adrenergic receptor 
establish a barcode that encodes differential functions of beta-arrestin. Sci Signal. 
4(185): p. ra51. 178. Gerhardstein, B.L., et al., Identification of the sites phosphorylated by cyclic AMP-
dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium 
channels. Biochemistry, 1999. 38(32): p. 10361-70. 179. Simmerman, H.K. and L.R. Jones, Phospholamban: protein structure, mechanism of 
action, and role in cardiac function. Physiol Rev, 1998. 78(4): p. 921-47. 
   156 
180. Sato, M., et al., Loss of beta-adrenoceptor response in myocytes overexpressing the 
Na+/Ca(2+)-exchanger. J Mol Cell Cardiol, 2004. 36(1): p. 43-8. 181. Beau, S.L., T.K. Tolley, and J.E. Saffitz, Heterogeneous transmural distribution of beta-
adrenergic receptor subtypes in failing human hearts. Circulation, 1993. 88(6): p. 2501-9. 182. Asano, T., et al., Activation of the inhibitory GTP-binding protein of adenylate cyclase, 
Gi, by beta-adrenergic receptors in reconstituted phospholipid vesicles. J Biol Chem, 1984. 259(15): p. 9351-4. 183. Communal, C., W.S. Colucci, and K. Singh, p38 mitogen-activated protein kinase 
pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-
stimulated apoptosis. Evidence for Gi-dependent activation. J Biol Chem, 2000. 
275(25): p. 19395-400. 184. Zhu, W.Z., et al., Dual modulation of cell survival and cell death by beta(2)-adrenergic 
signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A, 2001. 98(4): p. 1607-12. 185. Zheng, M., Q.D. Han, and R.P. Xiao, Distinct beta-adrenergic receptor subtype signaling 
in the heart and their pathophysiological relevance. Sheng Li Xue Bao, 2004. 56(1): p. 1-15. 186. Gong, H., et al., Specific beta(2)AR blocker ICI 118,551 actively decreases contraction 
through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation, 2002. 105(21): p. 2497-503. 187. Milano, C.A., et al., Enhanced myocardial function in transgenic mice overexpressing 
the beta 2-adrenergic receptor. Science, 1994. 264(5158): p. 582-6. 188. Litovsky, S.H. and C. Antzelevitch, Rate dependence of action potential duration and 
refractoriness in canine ventricular endocardium differs from that of epicardium: role 
of the transient outward current. J Am Coll Cardiol, 1989. 14(4): p. 1053-66. 189. Glukhov, A.V., et al., Transmural dispersion of repolarization in failing and nonfailing 
human ventricle. Circ Res. 106(5): p. 981-91. 190. Akar, F.G. and D.S. Rosenbaum, Transmural electrophysiological heterogeneities 
underlying arrhythmogenesis in heart failure. Circ Res, 2003. 93(7): p. 638-45. 191. Crespo, L.M., C.J. Grantham, and M.B. Cannell, Kinetics, stoichiometry and role of the 
Na-Ca exchange mechanism in isolated cardiac myocytes. Nature, 1990. 345(6276): p. 618-21. 192. Bers, D., Excitation-contraction coupling and cardiac contractile force. Vol. Vol. 237. 2001: Kluwer Academic Pub. 193. Sharma, A.D., M.B. Waxman, and F.I. Huerta, Effect of adrenergic stimulation and 
blockade on ventricular defibrillation in the rat. J Pharmacol Exp Ther, 1983. 227(3): p. 716-22. 194. Desantiago, J., et al., Arrhythmogenic effects of beta2-adrenergic stimulation in the 
failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res, 2008. 102(11): p. 1389-97. 195. Kennedy, H.L., et al., Long-term follow-up of asymptomatic healthy subjects with 
frequent and complex ventricular ectopy. N Engl J Med, 1985. 312(4): p. 193-7. 196. Bogun, F., et al., Radiofrequency ablation of frequent, idiopathic premature ventricular 
complexes: comparison with a control group without intervention. Heart Rhythm, 2007. 4(7): p. 863-7. 
   157 
 
 
